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Thesis Abstract 
Delaying Alzheimer’s disease (AD), the most common form of dementia, by five years could 
decrease the global prevalence of AD by 57% and halve the annual economic impact which is 
currently estimated to surpass US$2 trillion by 2030. Since no treatment or cure for dementia 
exist, identifying modifiable factors to reduce the incidence of dementia has become a public 
health priority. Increased physical activity (PA) has been associated with a lower risk of 
developing dementia in observational studies. Observational studies have also linked 
bilingualism (the ability to speak two languages) with a delayed onset of dementia but no 
risk-reduction in dementia in bilinguals relative to monolinguals. Differences in study 
outcomes in the fields of PA- and bilingualism- related research to methodological 
limitations including poor measurement of the exposure (PA and language profiles), small 
sample sizes, and recruitment of participants with different dementia etiologies. The purpose 
of this thesis was twofold: i) to explore the roles of PA and bilingualism in dementia risk and 
ii) to inform the development of a randomized controlled trial (RCT) to test whether studying
a foreign language combined with increasing PA can improve cognitive performance in 
seniors who are at a higher risk of developing AD.   
The aim of Chapter two was to review the available evidence linking PA with the risk of 
developing dementia as well as to explore the effects of increasing PA on cognition in 
individuals with dementia. Results showed that aerobic, and high-intensity, habitual PA was 
associated with improved cognition-related biomarkers and lower dementia risk in 
epidemiological studies. Experimental evidence showed increasing PA improved cognition-
related biomarkers and cognition in preclinical phases of dementia, but not in clinical phases. 
The findings showed that PA is linked with a lower risk of dementia in epidemiological 
studies, but experimental studies showed little to no improvements in cognition in 
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participants with dementia following a structured PA program. There was evidence indicating 
that increasing PA levels in the preclinical phase of AD may result in greater translation 
impact than in participants at the more advanced clinical stage of AD. Most studies assessed 
PA with self-report measures questioning the accuracy and precision of exposure and 
recruited participants with dementia irrespective of aetiology, which makes it problematic to 
discern whether PA is differentially related to varying dementia aetiologies.  
 
The aim of Chapter three was to systematically review the association between bilingualism 
and the delay in the diagnosis of dementia and AD. Here, we retrieved a total of 20 studies, 
15 of which were meta-analysed. Results showed that bilinguals were on average 3.2 (95% 
CI: 1.5, 4.9) years older than monolinguals at the time of dementia. Moreover, at the time of 
dementia diagnosis, bilinguals and monolinguals demonstrated a similar level of global 
cognitive impairment (Hedges’ g = 0.05 95% CI: -0.10, 0.21). Prediction intervals however 
showed a large dispersion of effect sizes in the meta-analysis comparing monolinguals to 
bilinguals on the age of dementia diagnosis. To explore possible reasons for the observed 
dispersion in effect sizes, we conducted subgroup analyses. In one subgroup meta-analysis 
comparing studies that had recruited participants with dementia to studies that had recruited 
participants with AD, bilinguals were 4.2 (95% CI: 2.0, 6.2) and 1.7 (95% CI: -1.4, 4.7) years 
older than monolinguals at dementia and AD diagnosis, respectively. Meta-analytic results 
combining prospective longitudinal studies showed no risk reduction in dementia among 
bilinguals compared to monolinguals (Odds Ratio: 0.85; 95% CI: 0.69-1.05). Risk of bias 
assessment revealed that most studies carried several methodological limitations including 
poor measurement of participants’ language profiles and small sample sizes. 
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The aim of Chapter four was to explore the underlying mechanisms in the brain that may be 
responsible for the observed findings in the first systematic review (Chapter three). In this 
study, we observed that bilinguals compared to monolinguals had greater brain volume in the 
frontostriatal and frontoparietal circuits. Also, functional neuroimaging studies showed that 
bilinguals made use of relevant brain areas more efficiently than monolinguals when 
completing interference cognitive tasks. Results from the cross-sectional studies showed that 
higher levels of language acculturation were associated with significantly greater verbal and 
psychomotor speed performance than lower levels of language acculturation.  
 
The aim of the Chapter five was to explore the link between language acculturation and 
cognition in older individuals from ethnic minorities (Hispanic and Asian) living in the 
United States of America using an epidemiological dataset. In this cross-sectional 
epidemiological study, we analyzed data from the National Health and Nutrition Examination 
Survey using a larger sample size than previous studies. We found that higher levels of 
language acculturation (i.e. speaking the native language and that of the recipient’s country at 
home) was associated with greater psychomotor speed processing than lower levels of 
language acculturation (mostly speaking the native language at home) and some, but not all, 
measures of verbal fluency. Overall, the findings suggest that higher levels of language 
acculturation are associated with greater cognitive performance in older individuals from 
ethnic minorities.  
 
Overall, the evidence gathered in the previous chapters indicate that i) increasing PA in 
individuals who are at a higher risk of developing AD might be more useful in improving 
cognitive performance than in individuals who already have developed AD and ii) 
bilingualism might render the brain areas typically affected by AD such as the frontostriatal 
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and frontoparietal brain circuits more resilient against neurodegeneration and in turn, delay 
the onset of AD symptoms and diagnosis. Therefore, because no randomized-controlled trial 
(RCT) testing the combined effects of increased PA with studying a foreign language 
currently exist, Chapter five presents a detailed study protocol for an RCT addressing this gap 
in the literature while addressing the limitations of previous studies in the fields of PA- and 
bilingualism-based research. 
 
The purpose of this thesis was to explore the roles of PA and bilingualism in dementia onset 
and risk and to inform the development of a randomized controlled trial (RCT) testing the 
effects of studying a foreign language with increased PA in individuals at a higher risk of 
dementia. Increasing PA levels are associated with greater cognition in individuals at the 
preclinical phase of AD rather than in participants with a diagnosis of dementia or AD.  
Bilingualism was also associated with later age of AD diagnosis on average by 4.7 years. 
This finding is clinically relevant because a five-year delay in the onset of AD could lower 
the number of individuals with AD worldwide by 57% and as a consequence, halving the 
associated economic costs. Moreover, we also showed that bilingualism may be responsible 
for rendering brain areas typically affected by AD more resilient against neuropathology. 
Moreover, this thesis revealed that studies in the field of exercise science and bilingualism 
research in dementia carry important methodological limitations that question the internal 
validity of these two lines of research. Consequently, the evidence gathered within this thesis 
led us to propose a novel RCT exploring the effects of increasing PA levels and studying a 
foreign language in monolingual individuals at a higher risk of AD while addressing the most 
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An estimated 43.8 million individuals had dementia in 2016 (Nichols et al., 2019) and 
projections indicate that by 2050 there will be more than 115 million individuals living with 
this disease (Prince et al., 2013). The global economic cost of dementia is estimated to 
surpass US$2 trillion by the year 2030 (Wimo et al., 2017). Dementia is an umbrella term 
that describes a range of neurodegenerative diseases affecting cognition; the most common 
cause is Alzheimer’s disease (AD; Boyle et al., 2018; Schneider et al., 2007), which accounts 
for approximately 70% of all dementia cases (Graham, Bonito-Oliva, & Sakmar, 2017). The 
clinical phenotype of AD is marked by a progressive and irreversible decline in thinking 
abilities such as episodic memory (the ability to learn new information) in the first instance 
and executive functions, language, and praxis in the latter stages of the disease (Herrup, 
2015). Neuropsychiatrist symptoms including depression and anxiety are also common in 
AD (Echávarri et al., 2013; Jacobs, Riphagen, Ramakers, & Verhey, 2019). Ultimately, AD 
will lead to total dependence on a caregiver and lastly, death to due secondary causes such as 
pneumonia (McKhann et al., 2011). Despite decades of research, however, there is still no 
cure or treatment for AD (Wortmann, 2012).  
  
Since AD is not part of the normal aging process (McKhann et al., 2011) and its aetiology 
and pathogenic course are largely driven by lifestyle behaviours, identifying modifiable risk 
factors that are associated with developing AD has become a global public health 
priority (Wortmann, 2012). While there is a clear link between certain modifiable risk factors 
including low levels of education, smoking, and social isolation among others with the risk of 
developing AD (Livingston et al., 2017), other lifestyle behaviours such as physical inactivity 
[not meeting physical activity (PA) recommendations for public health] or monolingualism 
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(speaking only one language) have received considerable scientific attention but their link 
with AD is still equivocal (Gold, 2015; Gold, Johnson, & Powell, 2013; Kivimäki et al., 
2019).  
  
Prolonged physical inactivity is a serious public health concern contributing to increased risk 
of obesity, type II diabetes mellitus, and metabolic syndrome, each of which can 
independently elevate the risk of developing AD (Bellou, Belbasis, Tzoulaki, & Evangelou, 
2018; Kivimäki et al., 2019). By contrast, increasing PA is associated with improved health 
outcomes from preventing the developing of chronic cardiometabolic conditions such as 
cardiovascular disease (Wahid et al., 2016), and cancer (Rezende et al., 2018) to decreasing 
the risk of mortality (Ekelund et al., 2016). Individuals with low-moderate or high-intensity 
PA relative to those who were sedentary (e.g. sitting for a prolonged time) had a 35% 
decreased risk of cognitive impairment later in life (Sofi et al., 2011) and PA was associated 
with a 45% decreased AD risk (Hamer & Chida, 2009). However, epidemiological studies 
tended to use self-report measures of PA and did not generally differentiate between the 
different type of PA such as walking, gardening, etc. (Hamer & Chida, 2009; Sofi et al., 
2011), Also, questionnaires are susceptible to recall bias which might have influenced the 
magnitude of the relationship between and PA the risk of AD (Sallis & Saelens, 2000). 
Evidence gathered with accelerometers, which measure PA objectively and do not rely on 
participants' need to assess and recall their past PA levels, nonetheless support the 
epidemiological evidence suggesting that high PA is associated with a lower risk of 
AD (Buchman et al., 2012). However, a recent large individual-level meta-analysis including 
400,000 European and North American participants concluded that targeting physical 
inactivity alone may have limited effects in preventing AD (Kivimäki et al., 2019). 
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Nevertheless, even modest departures from physical inactivity can have notable implications 
for improving a wide range of health-related outcomes (Sofi et al., 2011; Wahid et al., 2016).  
  
What is more, randomized-controlled trials (RCTs) testing the impact of increasing PA on 
cognition in individuals with AD have shown little translation impact. Typically, increasing 
the intensity and frequency of PA can improve cognition in individuals with mild cognitive 
impairment a prodromal phase of AD (Öhman, Savikko, Strandberg, & Pitkälä, 2014), but 
not in those who had already reached a diagnosis of dementia (Öhman et al., 2014). Although 
others showed that increasing PA might improve cognition in people with dementia (Forbes, 
Forbes, Blake, Thiessen, & Forbes, 2015). However, the magnitude of the observed 
improvement was only modest and therefore likely carried limited translational 
impact (Forbes et al., 2015). The majority of studies were also fairly short (no more than 
three months), did not report dropout rate, and several studies were statistically 
underpowered (Öhman et al., 2014). Low statistical power can increase the risk of Type I 
error and inflate the effect size (Ioannidis, 2005, 2008). Therefore, while increasing PA levels 
may be to some extent beneficial in some individuals (Forbes et al., 2015), it may carry 
limited clinical relevance in those with dementia who have accumulated a greater degree of 
neuropathology (Öhman et al., 2014; Sperling, Jack, & Aisen, 2011). Increasing PA in 
individuals who have not yet reached such an advanced degree of neuropathology to warrant 
a diagnosis of AD, but are nonetheless at a higher risk of developing it, may carry greater 
clinical utility (Frank Jessen et al., 2014; Sperling, Jack, et al., 2011).  
  
Approximately 50% of individuals aged 60 years and above experience subjective cognitive 
decline (SCD), which is a subjective feeling of diminishing cognitive abilities whose decline 
cannot be detected with objective measures of cognition (F. Jessen et al., 2014). The 
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relationship between SCD and memory performance in objective measures is 
weak (Crumley, Stetler, & Horhota, 2014). While several possible explanations may 
contribute to SCD including the presence of depressive and anxiety-related 
symptoms (Balash et al., 2013; Molinuevo et al., 2017), the experience of SCD may signal 
the earliest phase of AD (F. Jessen et al., 2014; Slot et al., 2019). This is because, individuals 
with SCD are more likely to convert to AD than those without SCD, which places them at a 
greater risk of developing AD (Slot et al., 2019). As such, being at the earliest phase of AD, 
individuals with SCD may not have yet accumulated substantial neuropathology to exclude 
the possibility of slowing down the future expected cognitive decline or delay the clinical 
manifestation of AD. Interestingly, one RCT recruiting participants with memory complaints 
(a feature of SCD) showed that while cognitive performance decline by 1.04 points in the 
Alzheimer Disease Assessment Scale–Cognitive Subscale in the control group, those who 
increased their PA (walking more) across six months experienced an improvement of 0.26 
points at the end of the trial (Lautenschlager et al., 2008). Another study recruiting 
cognitively intact individuals who were nonetheless at a higher risk of developing AD 
showed that a multicomponent behavioral strategy improved cognitive performance in the 
experimental relative to the control group after two years (Ngandu et al., 2015). These studies 
suggest targeting behavioral risk factors such as PA in individuals at a higher risk of AD such 
as those with SCD phase, may not only slow down the expected cognitive decline but also 
improve cognitive performance in this target group.  
  
Another potentially modifiable risk factor for dementia is bilingualism, which refers to the 
ability to speak two or more languages (Luk & Bialystok, 2013). Several studies have shown 
that bilinguals, as opposed to monolinguals, are diagnosed with dementia and AD four to five 
years later (Alladi et al., 2013; Bialystok, Craik, Binns, Ossher, & Freedman, 2014; 
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Bialystok, Craik, & Freedman, 2007). Moreover, these studies have shown that while 
bilinguals were older at the time of dementia diagnosis, they demonstrated a similar degree of 
global cognitive impairment as monolinguals (Alladi et al., 2013; Bialystok et al., 2014; 
Bialystok et al., 2007). This might mean that bilingualism may help maintain a working level 
of cognition despite the progression of AD-related neurodegenerative processes (Gold et al., 
2013). Bilingualism may render the brain more resilient against neurodegeneration by 
strengthening frontostriatal and frontoparietal circuits which are severely affected in AD 
and, in turn, delay its clinical manifestation (Gold, 2015; Gold et al., 2013). While these 
findings are promising, results are based on studies with several methodological limitations. 
For example, participants’ language profiles were generally poorly measured and not all 
studies controlled for other important lifestyle factors such as PA that might have explained 
the observed delay in dementia diagnosis among bilinguals. Furthermore, prospective 
longitudinal studies, however, have not shown that bilingualism can decrease the risk of 
dementia (Mukadam, Sommerlad, & Livingston, 2017). 
  
While studies in exercise science and bilingualism research show that increasing PA may 
lower the risk of AD and bilingualism may delay AD diagnosis, there remain several 
unanswered questions. The analytic samples of previous studies assessing the impact of 
increasing PA on cognition included participants with SCD and mild cognitive impairment 
together and did not use a validated measure of SCD (Lautenschlager et al., 2008) or did not 
measure SCD altogether (Ngandu et al., 2015). To our knowledge, there is limited evidence 
applying specific criteria for recruiting individuals with SCD testing the effect of increasing 
PA on cognition (Andrieu et al., 2017; Molinuevo et al., 2017; Sperling, Aisen, et al., 2011). 
Therefore, it is not known whether modifying risk factors in people with SCD may be useful 
in improving cognition and as such, trials targeting risk factors in this cohort are urgently 
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needed. What is critical, however, is that increasing PA alone may not be sufficient in 
protecting against AD (Kivimäki et al., 2019) and since bilingualism may protect against AD, 
increasing PA in combination with studying a foreign language (Antoniou, Gunasekera, & 
Wong, 2013; Bialystok, Abutalebi, Bak, Burke, & Kroll, 2016) in individuals with SCD may 
generate more clinically relevant outcomes than modifying each behaviour in 
isolation (Kivimäki et al., 2019; National Academies of Sciences & Medicine, 2017).  
 
Putative underlying mechanisms  
 
There is evidence showing that increasing PA levels and learning a second language may 
promote neural reserve, neural compensation, and cognitive reserve. Broadly defined, these 
terms refer to the brain’s ability to maintain functioning cognition despite presence of an 
underlying neuropathological disorder such as AD. While brain reserve refers to gross brain 
tissue including neurons and synapses and how much brain damage an individual may 
receive before experiencing cognitive impairment, cognitive reserve refers to how flexible 
and adaptable a person’s thinking ability is in response to age- or neuropathological related 
decline in cognition (Stern, Barnes, Grady, Jones, & Raz, 2019). Increasing PA may promote 
the supramolecular mechanisms including the formation of new neurons and synapses (Lista 
& Sorrentino, 2010), which could result in greater brain reserve. Cognitively stimulating 
activities such as studying a foreign language may also promote these two processes (Perani 
& Abutalebi, 2015). These underlying processes may explain why some individuals who 
report high levels of PA or the ability to speak more than one language, also develop AD at a 
later age and carry a lower risk of developing AD than those with low PA and monolinguals 
(Perani & Abutalebi, 2015).  
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Neurodegenerative disorders including AD severely affect brain regions such as striatal and 
frontostriatal areas; atrophy of these areas of the brain is common in AD (Bertoux, 
O’Callaghan, Flanagan, Hodges, & Hornberger, 2015). Engaging in mentally stimulating 
activities may be useful to counteract the neurodegenerative effects on these brain regions 
(Gold, 2015). For example, observational studies show that bilinguals relative to 
monolinguals of similar ages demonstrate greater striatal and frontostriatal areas and that 
studying a foreign language may increase volume in the same regions (Li, Legault, & 
Litcofsky, 2014). This evidence suggests that PA and bilingualism could strengthen the same 
brain areas that are typically affected by AD. The underlying mechanisms responsible for the 
observed delays in the onset and in lowering the risk of developing AD, particularly when 
combining PA with bilingualism, have not been systematically nor empirically explored.  
 
Purpose of this thesis  
 
One of the aims of this thesis was to determine whether increasing PA might be an effective 
intervention in improving cognitive performance among individuals at a higher risk of 
developing AD such as those with SCD. Another aim was to determine whether bilingualism 
relative to monolingualism can delay the onset and lower the risk of developing AD. As such, 
the purpose of this thesis was to i) review the available evidence exploring the link between 
PA and dementia by conducting a narrative review of the literature (Chapter 2), ii) conduct a 
systematic review of the literature exploring the link between bilingualism and dementia 
onset and risk (Chapter 3), iii) conduct a systematic review of literature exploring the 
underlying link between bilingualism and the brain (Chapter 4), iv) conduct a cross-sectional 
epidemiological study investigating the link between language acculturation and cognition in 
older individuals from ethnic minorities living in the United States (Chapter 5), and v) the 
evidence gathered from the previous chapters resulted in the development of a proposal for 
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an RCT investigating the effects of increasing PA levels and studying a foreign language 
among English senior monolinguals at a higher risk of AD. We chose to conduct a narrative 
review of the literature (Chapter 2) because several systematic reviews in this field answering 
specific questions had already been published and due to the multiple components of exercise 
(e.g., the intensity, duration, frequency, and type) and difficulty in measuring different types 
of habitual physical activity. We chose to conduct systematic reviews in Chapters 3 and 4 
because no systematic reviews existed addressing our research questions assessing the role of 
bilingualism in dementia risk and the brain at the start of this project.   
  
Therefore, we hypothesized that i) increasing the intensity and frequency of PA particularly 
at the preclinical phase of AD is associated with improvements in cognitive performance 
(Chapter 2), ii) bilingualism relative to monolingualism will be associated with a delayed 
onset of dementia (Chapter 3), iii) bilingualism will be associated with stronger frontostriatal 
and frontoparietal circuits in the brain of bilinguals relative to monolinguals (Chapter 4), and 
iv) higher levels of language acculturation are associated with greater cognitive performance 
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Chapter 2 Physical activity in preventing 
Alzheimer’s disease and cognitive decline: a 
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A large body of epidemiological and experimental data exploring the relationship between 
physical activity (PA) and Alzheimer’s disease (AD) are now available. Despite 
observational evidence supporting a role for PA in delaying the onset of AD, randomized-
controlled trials have reported mixed findings; this is likely due to the heterogeneity in study 
cohorts, outcome measures and the adopted PA intervention. The primary objective of this 
narrative review is to evaluate the extant evidence on the relationship between PA, cognitive 
decline and AD in older populations. The interaction between PA and the putative 
mechanisms underlying AD progression, including genetic factors and amyloid beta levels 
will be explored. In this context, particular attention will be given to studies assessing PA in 
the early clinical and preclinical, asymptomatic stages of AD. Based on current evidence, 
clinical considerations for implementation of exercise-based interventions are discussed, 




Dementia is an umbrella term encompassing many neurodegenerative disorders such as 
Alzheimer’s Disease (AD). The global estimated costs of dementia in 2015 were US$818 
billion annually and these are expected to extend to US$2 trillion by the year 2030 [1]. 
Without a treatment or cure, the worldwide estimated prevalence of dementia will be 115.5 
million people by the year 2050 [2]. Consequently, the World Health Organization (WHO) 
has labelled dementia a public health priority [3].  
The most common form of dementia is AD, which accounts for 60-70% of all 
dementia cases and for which no treatment or cure currently exist [4, 5]. While most 
individuals experience subtle decreases in cognitive performance with advancing age [6], the 
pronounced cognitive deterioration resulting from AD is not part of the normal ageing 
process [7]. Cognitive decline associated with AD can be divided into three stages: a 
preclinical, asymptomatic stage referred to as subjective cognitive decline (SCD; [8, 9]), a 
symptomatic, preclinical stage of mild cognitive impairment (MCI; [10]), and finally AD, 
which is characterised by cognitive impairment and significant dysfunction in daily living 
activities [7]. Importantly, SCD or MCI are not always considered as part of the preclinical 
phase of AD, since many individuals with SCD or MCI do not always progress to AD [11].  
Research has traditionally focused on tertiary preventions aiming to alleviate or slow 
the pathogenic processes in the symptomatic preclinical and clinical stages of AD. However 
interventions in these stages have, to a large degree, been unsuccessful in achieving these 
aims [4, 7, 12]. This is likely due to the presence of advanced neuronal damage in individuals 
within symptomatic stages, and this neuronal damage has proven difficult to reverse with 
current interventions [12, 13]. Administering disease-modifying interventions such as 
increasing levels of physical activity (PA) in the asymptomatic stage (i.e. SCD) may be an 
important strategy in delaying the onset or slowing the progression of AD pathogenesis 
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before the neurodegeneration becomes irreversible [9, 13, 14]. Specifically, a 5-year delay in 
the onset of AD, could reduce the number of AD patients by 57% and the associated 
economic costs by half [15]. 
 
The pathophysiology of AD 
AD is a complex neurodegenerative disorder with a clinical phenotype characterized by 
insidious and progressive decline in episodic memory, attention, executive functions, 
language, and praxis, followed by loss of motor control, resulting in complete dependence 
and ultimately death [16]. A definitive diagnosis for AD can only be achieved 
histopathologically at post-mortem. For many years the amyloid cascade hypothesis was the 
prevailing explanation for the pathogenesis of AD [17]. This hypothesis arose from 
histopathological observations showing accumulation of intra- and extracellular misfolded 
proteins called amyloids, which contain phosphorylated tau and amyloid plaques, comprising 
of beta amyloid (Aβ) peptides. The accumulation of these Aβ peptides was observed to 
exacerbate synaptic dysfunction resulting in tau hyper-phosphorylation which aggregate and 
deposit intracellularly, ultimately leading to synaptic loss and neuronal death [18]. This 
process can be confirmed during post-mortem examination of AD brain tissues which reveals 
microscopic lesions such as senile plaques and neurofibrillary tangles across the central 
nervous system, particularly in the cerebral cortex. Gross inspection of the AD brain post-
mortem also reveals normally distributed and hemi-symmetrical atrophy of the neocortex 
suggesting neurodegeneration [17].  
This cascade of neuropathological events arising from the abnormal accumulation of 
the Aβ peptide is thought to be a central event in AD pathophysiology, indicating that 
selectively targeting Aβ with pharmacotherapy would successfully treat AD [18]. 
Consequently, the amyloid cascade hypothesis was used as a benchmark from which 
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therapeutic interventions were developed [17], many of which however, have not been 
successful [4, 19]. Indeed, it now appears the AD pathophysiology cannot be reduced to a 
single aetiology as had been previously hypothesized; rather, it likely arises from several 
toxic pathogenic processes [5, 16].  
 
Risk Factors for AD 
The relationship between subjective cognitive decline and AD 
Subjective cognitive decline (SCD) and subjective memory complaints (SMC) are used 
interchangeably in the literature. While SMC remains the prominent feature during the 
asymptomatic, preclinical stage of AD, researchers have preferentially adopted SCD when 
referring to this stage. The prevalence of SCD among individuals aged 60 and over ranges 
between 25% and 50% [20], with the prevalence increasing concurrently with age [21]. A 
person with SCD experiences subjective impairment in memory and cognitive functions, but 
these subjective impairments cannot be detected by objective measures [22]. The conversion 
rate from SCD to MCI in studies conducted over four years is 24.4%, while the conversion 
rate to dementia over this time-period is 10.9% compared to 4.6% in individuals without 
SCD [23]. Overall, individuals with SCD (but without objectively measurable complaints) 
have twice the risk of developing dementia than those without SCD [23]. Structural Magnetic 
Resonance Imaging has also indicated that participants with SCD have a significantly smaller 
mean left-hippocampal volume [n = 20; 2.0 (0.4) cm3] compared to control particpants [n = 
28; 2.3 (0.4) cm3] without memory complaints [24]. Consequently, SCD is an important risk 
indicator in the natural history across the AD spectrum [25].  
 There is experimental evidence indicating that PA interventions may be more 
successful when delivered in the early preclinical (Table 1 [26-28]) and early clinical 
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populations [29], as opposed to the latter clinical phase of AD (Table 2; [30]). For example, 
in a randomized-controlled trial, Lautenschlager et al. [26] tested the effects of increased PA 
levels on cognition among individuals with SCD and MCI and found a significant 
improvement in cognition as measured by the Alzheimer's Disease Assessment Scale-
cognitive subscale (ADAS-cog). This difference was still detectable at the 18-month follow-
up. Another trial comparing an active control (regular health advice) and a multi-domain 
intervention comprising diet, exercise, and cognitive training among AD at-risk individuals 
across two years, revealed that the multidomain intervention improved memory and 
processing speed tasks [28]. Similarly, Shah et al. [27] demonstrated that in older individuals 
at risk of AD but without SCD or MCI, a combination of PA and computer-based cognitive 
training improved cognition and cerebral glucose metabolism, which is a marker of cognitive 
performance, more than each intervention alone. Finally, that early intervention is likely 
associated with improved cognitive outcomes is supported by systematic reviews that PA 
interventions seem to be more successful when delivered during the MCI stage rather than at 
the AD stage (Table 2 and 3; i.e., [29]).  
 
Cardiovascular diseases and low PA as risk factors for AD  
Several modifiable, cardiovascular risk factors have been associated with increased risk of 
AD including obesity and obesity-related diseases such as Type 2 Diabetes Mellitus (T2DM) 
and Cardiovascular Disease (CVD). While individuals with obesity have a higher risk of AD 
[31-33], the magnitude of the association, independently of other risk factors, remains a 
matter of debate. Nevertheless, two systematic reviews with meta-analyses have since 
confirmed overweight and obesity in mid-life, as independent risk factors for AD [34, 35], 
while obesity later in life has been associated with a lower risk of AD [36]. Although, the 
strength of these relationships were found to be less than the relationshhip with 
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Apolipoprotein E (APOE), which is a major genetic risk factor for AD [35]. T2DM has also 
been associated with poorer cognitive performance in working memory, executive functions, 
and attention in older adults [37, 38], as well as immediate and delayed verbal recall, and 
verbal fluency among elderly women [39, 40] which are cognitive abilities that are strongly 
affected by AD. Moreover, improving glycaemic control has been shown to improve 
cognitive performance [41]. That T2DM has been found to accelerate cognitive decline and 
increase AD risk independently of other comorbid factors (e.g. obesity) [35, 42] is therefore 
unsurprising. Similarly, individuals with CVD have an elevated risk for AD [43-45]. The 
independent and direct relationship between CVD and AD is likely related to hypoperfusion 
and microemboli which may present in CVD and can accelerate the pathogenesis of AD [45, 
46]. Also, reduced PA and sedentary behaviour are strongly associated with obesity [47], 
T2DM and CVD [44, 47, 48], both of each increase the risk of developing AD [49-51]. 
Indeed, a sedentary lifestyle is associated with increased AD risk [52] with physical inactivity 
being the single largest modifiable risk factor for AD, while increased PA is considered 










Table 0-1 Experimental trials investigating the effects of PA programs on persons with increased risk of dementia or SCD/MCI 
Study N; age Type of PA program Neurological condition Findings 
Lautenschlager 
(2008) [26] 
170; PA n = 
68.6 (8.7), 
control n = 68.7 
(8.5) 
Three 50 minute home-based 
sessions/week of moderate intensity 
PA 
SCD; MCI i) Tx ↑ 0.26 ADAS-Cog 
ii) Cx ↓ 1.04 ADAS-Cog  
iii) Absolute difference (Tx 
and Cx): −1.3 points 
     
Shah (2014) 
[27] 
224; 67.6 (5.42) PA: 48 walking sessions 60 min/day, 
3 days/week and 32 resistance 
training sessions 40/day, 2 
days/week; CS: 40 sessions at 
60min/day for 5 days/week for the 
auditory-based Brain Fitness 
Program and the visual-based Insight 
Program; PA+CS: both PA and CS 
sessions 
Elderly individuals at a 
higher risk of AD 
i) NS ↑ in cognition in the PA 
or CS group 
ii) Significant ↑ in the RAVLT: 
LTDR in the PA+CS group 
relative to controls 
     
Ngandu (2015) 
[28] 
1260; 69.4 (4.7) 
years 
Progressive muscle strength training 
(1–3 times/week), aerobic exercise 
(2–5 times/week), and exercises to 
enhance postural balance 
Elderly individuals at a 
higher risk of AD 
i) Tx Z scores ↑ 0.20 NTB 
ii) Cx Z scores ↑ 0.16 NTB  
iii) Between-group difference 
(Tx and Cx): 0·022    
SCD: subjective cognitive decline; MCI: mild cognitive impairment; CS: Cognitive stimulation; RAVLT: LTDR: Rey Auditory Verbal Learning 
Test: Long-Term Delayed Recall; NS: no significant  
 
Table 0-2 Systematic reviews of intervention studies investigating the effects of increased PA on cognitive decline/dementia 




22 RCTs; 1699 Walking, Tai Chi, ergocycling, and 
strength training lasting from 6 to 12 
months 
MCI; dementia i) PA ↑ global cognition, 
executive function, 
attention, and delayed 
recall in MCI subjects 
ii) NS effects on cognition in 
subjects with dementia 
     
Forbes (2015) 
[30] 
17 RCTs; 1067 Tx: any combination of aerobic, 
strength, or balance training vs. Cx: 
usual care, or social 
contact/activities; PA programs; 
frequency (range: 2 to 5 times/week, 
to daily, from 20 to 75 mins/session, 
from 2 weeks to 18 months 
Dementia  i) NS effects on cognitive 
performance  
     
Groot (2016) 
[74] 
18 RCTs; 802 i) Aerobic only, ii) non-aerobic, and 
iii) combined aerobic with non-
aerobic exercise; high and low 
frequency  
Dementia; AD i) PA ↑ cognitive function in 
AD and non-AD related 
dementia 
ii) Greater ↑ for combined 
PA than aerobic-only 
iii) NS effect for non-aerobic 
PA;  
iv) Both high and low 
frequency ↑ cognition   
     
van Uffelen 
(2008) [154] 
8 RCTs; 543 Aerobic exercise only, strength 
exercise, strength and balance 
exercise, all-round exercise including 
aerobic, strength, balance, and 
flexibility training, from 6 to 52 
CD; dementia i) Significant ↑ in general 
cognitive function, 
executive functions, and 
memory 
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weeks of 20 to 65 min sessions at a 
frequency of 1 to 3 times/week 
RCT: randomized-controlled trial; PD: Parkinson’s Disease 
Table 0-3 Systematic reviews on epidemiological studies investigating the relationship between PA and cognitive decline/impairment/dementia 










Self-report PA  CD or CI 
 
i) PA ↓ CI risk by 35% versus 
sedentary individuals   
ii) High-intensity PA by 38% 
versus sedentary 
individuals   








Self-report PA  Dementia; AD; PD i) PA associated 28% ↓ 
dementia risk and 45% AD 
risk 
ii) NS association between PA 
and PD 








PA, cognition and risk of AD: Epidemiological findings 
The epidemiological evidence (Table 4) suggests a strong association between moderate or 
high levels of PA and improved cognitive performance later in life [54], even after adjusting 
for factors such as sex, age, baseline cognitive status, and depression. Women who reported 
being physically active at different ages (30, 50, late life) had a reduced likelihood of 
developing cognitive impairment later in life compared to physically inactive women, 
particularly when they engaged in higher PA in their earlier years [55]. A meta-analysis of 
prospective studies confirmed a consistent protection of PA against cognitive impairment 
later in life and this protection occurred at all levels of PA (Table 3; [56]). The beneficial 
effects of PA have also been extended to a reduced risk of all-cause dementia and AD [57]; a 
finding confirmed in a systematic review of prospective studies demonstrating a link between 
increased PA and a lower risk of dementia and AD [58]. Of particular note is one study 
adopting actigraphy to objectively measure PA, as opposed to self-reported PA, which found 
that high total daily PA was associated with lower risk of AD [59]. Compared to self-report, 
actigraphy is a valid and objective measure of PA in aging [60, 61] and does not rely on 
participants’ subjective recall of previous PA levels, which is often challenging and 
inaccurate [62].  
 While the association between PA and lower risk of AD is well established, this effect 
might be mediated or moderated by additional factors not easily accounted for such as social 
engagement, educational level, depression, cognitive activity, and the number of different 
types of activities (as opposed to total duration alone) performed [56, 63]. Indeed, some 
studies have found that a previously significant relationship between PA and cognitive 
impairment became non-significant after adjusting for such factors [64-67]. For example, 
Podewils et al. [67] found that individuals engaging in a greater number of activities (≥4) had 
a significant lower relative risk of dementia and AD than those engaging in 0-1 activities; 
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individuals with the highest quartile of energy expenditure were not protected from relative 
risk of dementia after multivariate adjustment. Overall, the epidemiological data suggest a 
strong association between higher PA levels and a lower risk of cognitive impairment and 
AD later in life [55, 56] even after multivariate adjustment. However, due to the clustering of 
multiple risk factors with lower levels of PA, the magnitude of the independent association of 




















Table 0-4 Epidemiological studies investigating the relationship between PA and cognitive decline/impairment as well as dementia 
Study N Assessment of PA Neurological condition Findings 
Etgen (2010) 
[54] 
N = 3903 No activity, moderate activity (<3 
times/week), and high activity (≥3 
times/week) 
Incident CI at two-year 
follow-up 
i) Baseline moderate or high 
PA was associated with ↓ 
incident CI risk, compared 
to no PA 
     
Middleton 
(2010) [55] 
N = 9344 Current (late life) yearly frequencies 
of low (e.g. walking or gardening), 
moderate (e.g. dancing or tennis), or 
high (jogging or skiing) intensity PA; 
modified Paffenbarger questionnaire 
CI i) PA during youth, age 30 
and 50, and late life was 
associated with a ↓ 
likelihood of CI later in life 
compared to physical 
inactivity 
     
Laurin (2001) 
[57] 
N = 6434 Combination of two questions from a 
risk factor questionnaire: frequency 
(low, moderate, or high: ≥3 times per 
week, weekly, or less than weekly) 
and intensity (more vigorous, equal 
to, or less vigorous than walking) 
Incident CI and 
dementia 
i) High PA was associated 
with ↓ risk of CI, AD, and 
dementia of any type 
     
Buchman 
(2012) [59] 
N = 716 Actigraphy for 10 days (total daily 
PA) 
AD at four-year follow-
up 
i) Lowest 10th PA percentile 
compared to highest 90th 
was associated with ↑ AD 
risk 
     
Sturman 
(2005) [64] 
N = 4055 US Health Interview Survey 
(walking for exercise, jogging, yard 
CD i) Each additional hour of 
PA/week was associated 
with ↓ rate of CD 
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work, etc.); PA was measured as 
hours/week 
     
Wang (2002) 
[65] 
N = 776 Mental, physical, social, productive, 
and recreational activities; social and 
leisure activity data were gathered 
during personal interview with 
trained nurses 
Dementia i) Mental, social, or 
productive activity 





N = 1635 Social activities (attending 
church/temple/mosque), productive 
activities (shopping, hobbies), PA 
activities (walking, jogging, sports) 
CD i) Higher LA was associated 
with ↓ CD risk more than 
PA or SA 
     
Podewils 
(2005) [67] 
N = 5888 MLTAQ (walking, household 
chores, mowing, raking, gardening, 
etc.) 
Dementia i) Highest PA quartile was 
associated with ↓ 
dementia risk versus 
lowest PA quartile 
ii) Engaging in ≥4 activities 
was associated with ↓ 
dementia risk than 0–1 
activity  






PA and cognition in dementia: Experimental findings  
Whether PA interventions improve cognition in clinical populations with existing AD is also 
contentious [29, 30]. Additional details regarding studies’ methodologies and findings can be 
found in Table 5. A two-point increase in Mini-Mental State Examination (MMSE) scores 
has been observed following a three-month music-based exercise intervention in a clinical 
population with moderate dementia, which ranges from 10 to 18 MMSE points [68]. 
However, when considering a two-point increase from baseline (M = 12.87; SD = 5.01) in the 
experimental group, at the end of the trial participants were still in the moderate phase of 
dementia, therefore the clinical implications of these findings are likely limited. Using 
treadmill walking, Arcoverde et al. [69] found that MMSE scores remained similar from 
baseline to post-intervention, while the control group experienced a decrease in MMSE 
scores suggesting exercise slowed the rate of cognitive decline in this clinical AD group. 
Similarly, Venturelli et al. [70] found that aerobic walking significantly slowed cognitive 
decline when global cognition was measured with the Cambridge Cognitive Examination 
(CAMCOG) but not with the MMSE in individuals with borderline moderate-severe AD. 
This is likely explained on the basis that the MMSE has low sensitivity in detecting changes 
across periods of fewer than six months [71], which could explain why Venturelli et al. [70] 
observed significant changes in the CAMCOG but not in the MMSE scores. However, 
aerobic walking was found not to improve global cognition in nursing home residents with 
moderate dementia, but the intervention in this study lasted only six weeks [72]. 
There is experimental evidence which also shows that combining aerobic with non-
aerobic exercise (i.e. resistance or strength exercises) can improve cognition more than 
aerobic-exercise alone [73, 74]. For example, global cognition, executive functions, verbal 
and visual memory were improved more in individuals with dementia combining nine weeks 
of aerobic (walking) and non-aerobic exercise (strength exercises) than individuals 
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completing aerobic based exercises only [73]. However, despite similar methodology and 
good adherence Steinberg et al. [75] showed only modest (non-significant) improvements in 
global cognition following a multi-modal exercise program by the end of the study [75]. 
Similarly, Miu et al. [76] did not detect improvements in global cognition following a 
combination of treadmill, bicycle, and arm ergometry relative to controls, among individuals 
with dementia. Recently, a meta-analysis revealed that although aerobic-based PA 
interventions were beneficial in AD patients, the combination of aerobic with non-aerobic 
exercise produced greater effects on cognition [74]. However, a systematic review by Forbes 
et al. [30] reported a similar effect size for exercise on cognition as in Groot et al. [74], but 
concluded that a meta-analysis could not be conducted due to substantial unexplained 
statistical heterogeneity (I2 = 80).  
To date, there is promising evidence supporting a role for exercise in improving 
cognition in individuals with dementia, but the field does have several studies yielding 
conflicting results [30]. There appear to be several key elements required for a PA 
intervention to demonstrate significant and clinically meaningful improvements in cognition 
among individuals with AD. These include multimodal PA interventions with at least one 
aerobic component [74] consisting of at least 150 minutes during the week, and which is 
delivered for longer than 10 weeks [29, 77]. The exercise intervention should be supported by 
additional PA (incidental) throughout the day to improve global cognition [78]. Moreover, 
since physical exercise likely affects particular dementia subtypes in different ways, the 
specific programming (duration, intensity, type, frequency) of exercise is likely to be an 
important consideration for studies in individuals with existing AD [29, 30, 79].  
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Table 0-5 Experimental trials investigating the effects of single-intervention PA programs on clinical dementia 




PA: n = 15, 
81.33 (4.24); 
control: n = 10, 
81.90 (4.18) 
Daily face-to-face 30min PA 
sessions focusing on upper and lower 
body strengthening, balance, trunk 
movements, and flexibility training, 
which was supported by music such 
as folkloric accordion songs 
including polka, folk, country, and 
western music  
AD; MID i) Tx ↑ from 12.87 to 15.53 
MMSE 




PA: n = 10, 79 
(74.7-82.2); 
control n = 10, 
78.5 (64-81.2) 
PA on a treadmill for 30 mins, twice 
a week at moderate intensity (60% 
VO2max) for 3 months 
AD i) Tx ↑ 6.10 (6.7) CAMCOG 
ii) Cx ↓ 6.10 (4.3) CAMCOG 
iii) NS effects on the MMSE 
     
Venturelli 
(2011) [70] 
PA: n = 12, 83 
(6); control: n = 
12, 85 (5)  
At least 30 mins of moderate aerobic 
exercise (walking) 4 times/week 
AD i) Tx showed slower ↓ (-
13%) compared to Cx (-
47%) in MMSE*  
     
Eggermont 
(2009) [72] 
PA: n = 51, NA; 
n = 46, NA 
Walking for 30 mins, 5 days/week, 
for 6 weeks 
 
Dementia i) NS effects on cognitive 
performance  
Experimental trials investigating the effects of multimodal PA programs on clinical dementia 




group: n = 37, 
85.7 (5.1); 
aerobic group: n 
= 36, 85.4 (5.4); 
Combined group: strength exercises 
(lower-limb strengthening) and 
aerobic exercise (moderate-high 
intensity walking); aerobic group 
received only the aerobic exercise; 
Dementia  
i) Combined Tx ↑ 2.3 MMSE 
ii) Aerobic Tx ↑ 1 MMSE  
iii) Cx ↑ 0.72 MMSE  
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social group: n = 
36, 85.4 (5.0) 
social group: social and intellectual 
engagement (30-minute one-to-one 
social visits); intervention lasted 9 
weeks 
     
Steinberg 
(2009) [75] 





Combined group = aerobic fitness 
(brisk walking), strength training 
(major muscle groups), balance and 
flexibility training (shifting center of 
gravity, tandem walks, forward and 
backward walks, and chair sit to 
stands); daily exercises for 12 weeks; 




i) Combined Tx showed NS 
↑ in primary outcome 
(global cognition)  
ii) Combined Tx showed 
worse depression and QOL 
iii) Combined Tx ↑ JTT after 
controlling for MMSE 
scores,  




group: n = 36, 
75 (7); control 
group: n = 49, 
78 (6),  
Combined group = treadmill, bicycle 
and arm ergometry, and ten-minute 
flexibility training (at the start of 
each session) for three months, 
twice/week for 45-60mins 
Dementia i) NS effects on cognitive 
performance 
ii) Combined Tx showed ↑ in 
physical function 







Genetic markers and risk of cognitive decline and AD 
Several genetic markers have been associated with increased AD risk including APOE, 
klotho, WW domain-containing protein 1 (WWC1), and brain derived neurotrophic factor 
(BDNF). Although klotho (encoding the transmembrane protein klotho; [80]) and WWC1 
(encoding the KIBRA protein; [81]) have both been implicated in cognitive impairment, their 
involvement in cognitive decline and AD development are equivocal [82, 83].  As such, 
BDNF and APOE have garnered the greatest attention in this field.  
The APOE gene is polymorphic, with three major alleles, namely ε2, ε3, and ε4, with 
a global prevalence of 8.4%, 77.9%, and 13.7%, respectively; the ε4 is ~40% prevalent 
among individuals with AD [84]. Presence of at least one copy of the ε4 allele (ε2/ε4; ε3/ε4) 
increases the risk of AD by 2.6 and 3.2 odds ratio respectively, while two copies (ε4/ε4) by 
14.9 odds ratio among Caucasian people [84] and presence of one or two APOE ε4 alleles 
can trigger the onset of AD five years or 10 years earlier, respectively [85]. Therefore, the 
APOE ε4 is a major non-modifiable risk factor for AD and is associated with a younger age 
of onset [86]. While the APOE ε4 is a risk factor for CVD [87], coronary heart disease [88], 
and higher amyloid aggregation which is in itself a risk factor for AD [89], the exact 
mechanisms explaining the link between APOE ε4 and increased AD risk are still unclear. Of 
particular relevance to this review, individuals with SCD who are also carriers of the APOE 
ε4 allele are twice as likely to progress to AD than those without SCD and the APOE ε4 
allele, suggesting that both factors produce an additive effect in cognitive decline [90]. 
Additionally, SCDs who test positive for APOE ε4 allele demonstrate glucose hypo-
metabolism in brain areas typically affected by AD such as the parieto-temporal lobe when 
compared to non-carriers [91].  
 The BDNF gene encodes the brain-derived neurotrophic factor (BDNF), which is a 
growth factor in the central nervous system that has been shown to regulate neuronal growth, 
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promote neuronal survival, and regulate synaptic plasticity [92]. In addition, BDNFs may 
regulate neuroplastic processes such as long-term potentiation in the hippocampus [93], and 
as such, BDNFs may play an important role in the pathogenesis of AD [94]. Phillips et al. 
[95] were the first to show reduced post-mortem in situ expression of BDNF mRNA in the 
hippocampal formation of nine AD compared to six controls donors. Since then, several 
studies have shown decreased BDNF serum levels among individuals in the preclinical [96] 
and clinical phase of AD [97, 98] and that the BDNF levels correlate with the degree of 
cognitive impairment [99]. A large cross-sectional study including 4463 community-living 
elderly participants, found that after adjusting for covariates, lower serum BDNF levels were 
associated with a decline in memory performance and with an elevated risk for MCI [100]. 
Importantly, circulating BDNF is generally accepted as a suitable surrogate marker of total 
(central and peripheral) BDNF concentration, however, the short half-life and low blood 
brain barrier perfusion capacity of BDNF [101] require further investigation.  
 
Apolipoprotein ε4 allele and PA 
Given that presence of at least one of the APOE ε4 alleles is associated with poorer 
performance on cognitive tasks [102] and increased risk of AD [85], researchers have 
assessed whether cognitive benefits arising from PA are moderated by APOE ε4 allele status. 
Indeed, evidence indicates that PA levels have a greater effect on cognitive function and 
future incidence of cognitive decline among individuals who carry at least one copy of the 
APOE ε4 allele [103-105]; although some researchers have not observed the same 
relationship [67]. For example, less than an hour/day of PA was associated with an increased 
risk of cognitive decline (N = 347; odds ratio 2.0, 95% CI: 0.9-4.8) and this effect was 
stronger in APOE ε4 allele carriers (adjusted odds ratio 3.7, 95% CI: 1.1-12.6) even after 
adjusting for additional confounders [103]. Similarly, a longitudinal population-based survey 
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(mean follow-up period: 21 years) found that the beneficial effects of PA on dementia risk 
were more robust between APOE ε4 allele carriers (odds ratio = 0.23) compared to non-
carriers (odds ratio = 0.59) among 1449 older adults (age range: 65–79) [106]. In contrast 
however, Podewils et al. [67] found an inverse association between PA and dementia risk for 
APOE ε4 non-carriers, but found no association for APOE ε4 carriers in their prospective 
study including 3075 men and women (age: ≥65; mean follow-up: 5.4 years). In this study, 
PA levels were obtained via self-report and the kcal/week and number of activities (range: 0-
14) performed in the previous two weeks reported. It was interesting to note that participation 
in multiple (≥4) different types of activities appeared to be as important if not more important 
than the self-reported PA levels in this cohort [67].   
 
Brain-derived neurotrophic factors (BDNF) and PA 
There is evidence [107, 108] suggesting a possible association between habitual PA or 
cardiorespiratory fitness (CRF) and BDNF concentration, although this is not consistently 
observed [109-112]. For example, Zoladz et al. [108] found that basal BDNF concentration 
was significantly higher in trained athletes (n = 16) compared to untrained individuals (n = 
13) which agrees with findings by Correia et al. [107] in international and domestic level 
sprinters (versus sedentary individuals). In contrast however, Winker et al. [112] found no 
difference in BDNF concentration between active elderly marathon runners and cyclists (n = 
56) matched for age, sex, and years of education to sedentary individuals (n = 58). While 
Nofuji et al. [111] found basal BDNF concentrations were lower in a group of trained males 
(n = 12) compared to a group of sedentary males (n = 14).  In line with this view, Chan et al. 
[109] and Jung et al. [110] observed an inverse relationship between BDNF concentrations 
and PA level (n = 85) and CRF (n = 995) respectively. Therefore, based on the current 
evidence, a clear relationship between PA or CRF and BDNF cannot be made [113]. While 
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these mixed findings may be attributed to several potential confounders, the circadian 
variation in circulating BDNF concentrations (typically reflecting cortisol concentration) in 
both men [114] and women [115] may partly explain some of the variance in study outcomes.   
Findings from prospective research assessing the effects of aerobic exercise on serum 
BDNF concentration have also been mixed, with resting BDNF concentration remaining 
largely unchanged in response to chronic exercise training despite acute exercise yielding 
substantial transient increases in BDNF concentration [113]. Aerobic exercise training (three 
or five weeks) did not alter basal BDNF concentrations in 47 sedentary adult males [116]. 
Likewise, a six-month longitudinal intervention testing the effects of low and moderate PA in 
62 cognitively healthy elderly subjects found only a non-significant positive trend between 
BDNF and PA [117]. More specific to the current review is the finding that in individuals 
with amnestic MCI (N = 33), chronic (six months, four days/week, supervised) aerobic 
exercise did not significantly alter BDNF levels, although a potential sex difference has been 
proposed [118]. In contrast, a robust albeit transient increase in BDNF concentration has been 
observed in response to acute aerobic exercise [113] and this has occurred concomitant with 
improved cognitive performance. For example, acute cycling [119-123], stepping [124], and 
rowing [125] have been shown to increase serum BDNF levels in healthy and clinical 
populations with major depression [121] and individuals with spinal cord injury [123]. There 
is evidence that the magnitude of change in BDNF concentration is intensity-dependent, with 
acute high-intensity exercise having a greater effect on peripheral BDNF concentration 
compared to acute low-intensity exercise [113, 119, 122]. For example, Ferris et al. [119] 
showed a pre-post significant increase in serum BDNF concentration following 30 minutes of 
cycling at 10% above, but not at 20% below ventilatory threshold. Nevertheless, increases in 
peripheral BDNF following acute exercise seem to be transient, since concentrations in 
BDNF return to baseline during passive recovery [126]. Moreover, Ferris et al. [119] and 
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Griffin et al. [116] also observed improvements in cognitive performance (as assessed using 
the Stroop colour/word test and face-name matching task respectively); however, Ferris et al. 
[119] lacked a control group and cognitive scores did not correlate with circulating BDNF 
levels. It is worth noting that some of these studies had small sample sizes including eight 
[125], 11 [120], and 15 [119] participants. Nevertheless, a recent review concluded that acute 
(n = 14 studies) and chronic (n = 6 studies) aerobic exercise increased peripheral BDNF 
concentrations [113], albeit this effect was more robust for the transient increase in response 
to acute exercise. 
 There is currently little evidence to suggest that resistance training performed in 
isolation will increase BDNF concentration [113]. However, in a convenience sample of 48 
elderly women Coelho et al. [127] found increases in plasma BDNF levels following 
resistance training three times/week for 10 weeks, while Yarrow et al. [128] found transient 
increases in serum BDNF after an acute bout of resistance training in 20 males but did not 
observe changes in resting BDNF levels after five weeks of training. The lack of effect on 
serum BDNF following acute resistance training has been replicated in healthy males (N = 
16) [129], sports students (N = 19; 12 weeks) [130], and untrained older individuals [(mean 
age: 50.9 (6.2)) who trained three times/week for 10 weeks [131].  
In sum, observational and experimental evidence in healthy and cognitively impaired 
populations suggest that increased PA is associated with increases in basal BDNF levels. 
These increases may be moderated by the type of exercise, with aerobic exercise generating 
more robust effects on BDNFs and by a dose-response relationship which may be intensity-
dependent [113, 119, 122], but the observed increases return to baseline (15-60 minutes) 
during passive recovery [126]. In some cases, increases in BDNF levels correlate with 
improved cognitive performance [116], while in other they do not [119]. It is worth 
mentioning that blood processing (serum: clotting time and temperature; plasma: platelet 
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stores) [132], circadian rhythms [114, 115], and phases of the menstrual cycle [115] may 
affect BDNF concentrations.   
 
Brain biomarkers in AD pathophysiology and their 
interaction with PA  
Pathophysiological abnormalities can occur years before clinical symptoms manifest which 
makes neuroimaging techniques particularly useful in the preclinical and early clinical stages 
of AD [15, 133]. Because a definitive AD diagnosis can only be achieved with 
histopathological confirmation, the inclusion of neuroimaging methods can increase 
specificity and diagnostic value in clinical and research settings [134]. Neuroimaging 
methods used in diagnosing neurodegenerative disorders include structural imaging such as 
magnetic resonance imaging (MRI), computer-assisted tomography (CT), functional imaging 
such as single photon emission tomography (SPECT), and positron emission tomography 
(PET) [135]. For diagnosing AD and compared to other neuroimaging techniques, PET has 
one of the highest rates of sensitivity (86%) and specificity (86%; [136]). Therefore, the 
following sections will only discuss PET imaging.  
 
PA findings on Pittsburgh compound B-PET 
Currently, PET imaging using radioactive tracers are available to detect Aβ deposits in the 
brain. The Pittsburgh compound B (PiB), which is the analogue of thioflavin T, is the most 
commonly used tracer for amyloid imaging [137]. In PiB-PET, the compound binds to 
fibrillar Aβ, while it does not bind to diffuse plaques and soluble Aβ, and can be used to 
differentiate AD and healthy controls [138, 139]. Moreover, individuals with subtle decline in 
episodic memory- the first cognitive faculty affected by AD- and a PiB-PET positive scan, 
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have a 50% increased risk of progressing to MCI and AD within three years [140]. Nordberg 
et al. [139] found that individuals with MCI with PiB-PET positive scans, not only had 
greater memory impairment compared to those with PiB-PET negative scans at baseline, but 
also progressed to AD at a rate of ~25% per year compared to a 0% conversion rate in those 
with PiB-PET negative scans. It is worth noting however, that while some individuals who 
are PiB positive progress to AD, others do not; indeed, PiB retention alone, does not appear 
to correlate well with cognitive impairment [141]. 
There is evidence that PA levels might affect Aβ levels in the brain, cerebrospinal 
fluid (CSF), and blood. For example, Liang et al. [142] found that individuals (N = 69) 
meeting the American Heart Association guidelines of 7.5 metabolic equivalent (MET)-
hours/week of exercise showed significantly lower PiB binding and higher levels of Aβ42 
(considered the more fibrillogenic form of Aβ and more closely associated with disease 
states) levels in the CSF. Importantly, Aβ42 levels in the CSF are inversely associated with 
Aβ42 aggregation in the brain and as such, higher levels in the CSF are generally accepted as 
being indicative of a healthier amyloid profile. In a larger sample (N = 546), Brown et al. 
[143] found that higher PA was negatively associated with lower plasma Aβ1−42/1−40 ratio, 
and, after stratifying participants by APOE ε4 allele status, this association was present in 
APOE ε4 allele non-carriers but absent in APOE ε4 allele carriers. Conversely, there was an 
association between higher PA levels and lower amyloid brain load as measured by PiB PET, 
in APOE ε4 allele carriers only [143]. Furthermore, in a sample of 201 cognitively intact 
adults, Head et al. [144] found a sedentary lifestyle was associated with higher PiB binding 
and lower CSF Aβ42 levels. Moreover, a significant interaction between APOE ε4 allele 
status and exercise engagement for PiB binding was revealed, with a sedentary lifestyle being 
associated with higher PiB binding in APOE ε4 allele carriers (p = .013) but not for APOE ε4 
non-carriers.  
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PA findings on [18F] fluorodeoxyglucose  
At rest, brain activity almost exclusively depends on glucose metabolism; therefore, glucose 
hypo-metabolism is considered a more robust surrogate marker of cognitive decline 
compared to presence of excessive Aβ [145]. The [F18] fluorodeoxyglucose (FDG-PET) can 
be used to generate images of glucose uptake into neural cells in different brain regions. 
Topographical patterns of reduced uptake, shown by reduced [18F] signal intensity, indicate 
neurodegeneration even after correcting for cortical atrophy in AD patients [146]. Therefore, 
FDG-PET can be used to investigate the relationship between PA and glucose metabolism. 
Deeny et al. [147] found that during a working memory task among individuals with the 
APOE ε4 allele, highly fit (indicative of high PA) compared to low fit (indicative of low PA) 
elderly females, showed greater glucose uptake in the temporal lobe, which is a brain region 
affected by AD. In contrast, low fit APOE ε4 allele carriers, showed greater cerebral glucose 
uptake in the frontal and parietal regions; this relationship however, was not observed during 
resting glucose metabolism. This indicates that CRF levels likely affect glucose metabolism 
in the brain in APOE ε4 allele carriers compared to non-carriers, which is in line with 
previous studies having found that the effects of exercise on cognition tend to be more 
pronounced in APOE ε4 allele carriers compared to non-carriers [103, 104]. This conclusion 
is supported by experimental data showing that a combination of PA and computerized brain 
training improved glucose metabolism in the left sensorimotor cortex even after adjusting for 
age, sex, premorbid IQ, APOE ε4 allele status, and history of head injury among non-clinical 
older individuals [27]. Together, the findings from Shah et al. [27] and Deeny et al. [147] 
suggest that increased PA may improve cerebral glucose metabolism and counteract the 
decline in brain glucose uptake that is often present in the preclinical phases of AD.  
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Limitations of studies on PA and AD with 
suggestions for future research  
Epidemiological data  
Findings drawn from the epidemiological and experimental literature are limited by several 
methodological shortcomings. For example, in many observational studies, researchers 
assessed PA through a single self-report questionnaire [56, 58, 67, 148]. These are 
susceptible to information bias [149], which threatens internal validity [150], and self-rated 
fitness has been shown to be inversely related to perceived physical exertion in men and 
women [151]. Additionally, some epidemiological studies administered PA questionnaires 
that were not designed for elderly populations [67] or lacked psychometric properties [103, 
106, 152]. Several studies have also used different methods to classify duration and intensity 
of PA or combined frequency, duration, and intensity [56] making it difficult to establish a 
clear dose-response relationship [153]. From the extant epidemiological literature it is unclear 
whether lifelong engagement in high PA is necessary to alter disease-risk profiles, due to 
most studies having focused in elderly populations [56]. Finally, the effects of PA might at 
least in part be mediated by other factors including social engagement [63] and number of 
different activity-types [67], which could explain some of the variance in the incidence rate 
of AD; but this has not been considered in all epidemiological literature [148].  
 
Experimental data 
A limitation of studies in the field relates to the different types of dementia and the different 
severity-levels being assessed [29, 30] with PA likely affecting different dementia subtypes 
to a varying extent [79]. Also, studies included a wide range of different types of exercise 
programs which included both supervised and unsupervised training prescribed with different 
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intensities, frequencies, and durations. Similarly, to the epidemiological studies, the 
assessment of cognition (e.g. MMSE versus executive function tasks) and chosen risk-
markers of AD or cognitive impairment (blood samples versus CSF samples; neuroimaging 
techniques versus protein concentrations) vary widely in the extant literature, making 
comparisons problematic [30]. In addition to these methodological limitations, some trials did 
not report intention-to-treat analyses [68, 77], adherence or attrition rates [77], and were 
likely statistically underpowered [29, 69, 154] particularly when multivariate adjustments 
were conducted.   
 
Suggestions for future research  
Drawing from the limitations identified above, to improve methodology and decrease risk of 
bias, several suggestions for future epidemiological and experimental research are warranted. 
Since the extant epidemiological evidence has mostly focused on elderly individuals [56], 
from a public health perspective, it is not possible to generate recommendations for different 
age groups for mitigating the age-related decline in cognition [6] or alter risk profiles for 
dementia. While not without complications, future epidemiological research should focus on 
exploring the relationship between lifelong exposure to PA and dementia [153] using a 
validated tool in combination with a CRF test or by linking with existing longitudinal studies 
which have collected PA levels or data-linkage programs which have access to individuals 
PA levels. The level of PA needs to be assessed in a more precise way using objective 
measures such as accelerometery [59] over at least a 2-week period, although these devices 
are not without short-comings [155]. While in experimental trials with smaller numbers, 
direct supervision of exercise participation is critical to generate more precise estimates of 
PA. Since AD populations find it difficult to adhere to PA interventions [148, 156], it is also 
important to investigate what type of PA intervention is appropriate for cognitively impaired 
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individuals [148] in prospective studies, particularly since comorbid conditions (e.g., 
osteoarthritis) often present in elderly population [157].  
Additionally, most experimental studies have focused on cognition as the primary 
outcome measure excluding other important variables [30]. The European consensus on 
endpoints for trials on AD advises to include functional and proxy endpoints to capture a 
more comprehensive functioning of the patient [158]. Thus, to render the findings more 
clinically relevant, the implementation of an exhaustive battery of global functioning (with a 
priori adjustment for Type I error) including cognitive and functional tests is important for 
establishing whether the intervention has helped the patient to meaningfully regain quality of 
life [158, 159]. In studies focussed on individuals at greater risk of progressing to AD (e.g., 
SCD), reports of SCDs by proxy (e.g., informant) correlate better with objective performance 
[160] and is a robust predictor of progression to AD [161] and should therefore be 
considered. Finally, to assess the role of exercise in altering AD-risk and progression in the 
early stages (e.g., SCD and MCI), adoption of the multiple biomarkers which can better 
predict AD-risk and progression are recommended.     
 
Conclusions  
There is compelling evidence that exercise improves biomarkers of AD and cognitive 
performance and that greater engagement in chronic PA is associated with improved 
cognition, a later-onset AD, and slowed disease progression. However, conflicting results are 
prevalent in the extant literature. Epidemiological evidence suggests a clear benefit of PA on 
improving cognition and reducing AD risk, particularly when the PA is performed at high-
intensity, however the magnitude of these associations are typically diminished after analyses 
are adjusted for the multiple confounding variables (i.e. age, sex, BMI, APOE ε4 status, 
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educational level, smoking, alcohol intake, social support, difficulty in activities of daily 
living, and instrumental activities of daily living) which often cluster with PA levels.  
The experimental studies assessing the impact of acute exercise suggest (i) a transient 
(minutes to hours) increase in BDNF following aerobic exercise, which is not observed 
following resistance exercise; (ii) greater BDNF responses following higher intensity aerobic 
exercise; (iii) improvement in executive function tasks. While the experimental studies 
assessing exercise training suggest (i) improvements in cognition following exercise training 
in pre-clinical and early clinical stages of dementia/AD (i.e., SMC, MCI), but mixed results 
in individuals with dementia/AD; (ii) greater improvements in cognition across the 
dementia/AD spectrum when training incorporated a greater frequency of both aerobic and 
non-aerobic activities. The findings from studies adopting neuroimaging techniques, which 
are considered more sensitive than other outcome measures, suggest that exercise and PA 
plays an important protective role against AD pathophysiology, particularly in individuals 
with an APOE ε4 allele, which is consistent with the findings from studies using cognitive 
outcome measures in this cohort. Despite the equivocal nature of the available evidence, it 
remains noteworthy that a single modifiable risk factor such as PA has largely been shown to 
affect both the onset and progression of a disease as complex as AD. From a public health 
perspective, it is important that future research addresses the limitations of previous research 
and establish the direct association between PA and AD.      
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Between-chapter (2-3) rationale  
In Chapter two, we found that increasing PA in individuals with AD does not appear to 
generate clinically relevant improvements in cognitive symptoms. It is possible that 
increasing PA may not be beneficial once the disease has reached an irreversible degree of 
neuropathology. A small number of studies have indicated that increasing PA in seniors 
without a diagnosis of AD but are at a higher risk of developing it, for example those with 
SCD, can improve cognitive performance. As such, increasing PA in this target population 
may be a more useful strategy in delaying the onset of AD. There is also evidence indicating 
that targeting only one risk factors (low PA) may be not be sufficient in delaying the onset of 
AD, however. Targeting another risk in combination with increasing PA may therefore 
generate more clinically relevant outcomes than targeting PA in isolation. Bilingualism (the 
ability to speak two or more languages) has been linked with a delayed onset of AD 
symptoms and diagnosis. Not all studies have documented such benefits, however. The 
purpose of the next Chapter is to determine whether bilingualism may be a potential 
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Abstract 
Some studies have linked bilingualism with a later onset of dementia, Alzheimer’s disease 
(AD), and mild cognitive impairment (MCI). Not all studies have observed such 
relationships, however. Differences in study outcomes may be due to methodological 
limitations and the presence of confounding factors within studies such as immigration status 
and level of education. We conducted the first systematic review with meta-analysis 
combining cross-sectional studies to explore if bilingualism might delay symptom onset and 
diagnosis of dementia, AD, and MCI. Primary outcomes included the age of symptom onset, 
the age at diagnosis of MCI or dementia, and the risk of developing MCI or dementia. A 
secondary outcome included the degree of disease severity at dementia diagnosis. There was 
no difference in the age of MCI diagnosis between monolinguals and bilinguals [mean 
difference: 3.2; 95% confidence intervals (CI): −3.4, 9.7]. Bilinguals vs. monolinguals 
reported experiencing AD symptoms 4.7 years (95% CI: 3.3, 6.1) later. Bilinguals vs. 
monolinguals were diagnosed with dementia 3.3 years (95% CI: 1.7, 4.9) later. Here, 95% 
prediction intervals showed a large dispersion of effect sizes (−1.9 to 8.5). We investigated 
this dispersion with a subgroup meta-analysis comparing studies that had recruited 
participants with dementia to studies that had recruited participants with AD on the age of 
dementia and AD diagnosis between mono- and bilinguals. Results showed that bilinguals vs. 
monolinguals were 1.9 years (95% CI: −0.9, 4.7) and 4.2 (95% CI: 2.0, 6.4) older than 
monolinguals at the time of dementia and AD diagnosis, respectively. The mean difference 
between the two subgroups was not significant. There was no significant risk reduction (odds 
ratio: 0.89; 95% CI: 0.68–1.16) in developing dementia among bilinguals vs. monolinguals. 
Also, there was no significant difference (Hedges’ g = 0.05; 95% CI: −0.13, 0.24) in disease 
severity at dementia diagnosis between bilinguals and monolinguals, despite bilinguals being 
significantly older. The majority of studies had adjusted for level of education suggesting that 
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education might not have played a role in the observed delay in dementia among bilinguals 
vs. monolinguals. Although findings indicated that bilingualism was on average related to a 
delayed onset of dementia, the magnitude of this relationship varied across different settings. 
This variation may be due to unexplained heterogeneity and different sources of bias in the 
included studies. Registration: PROSPERO CRD42015019100. 
 
Registration: PROSPERO CRD42015019100 
 
Keywords: bilingualism; mild cognitive impairment; dementia; Alzheimer’s disease; meta-
analysis 
Key points  
• Meta-analytic results showed that bilinguals vs. monolinguals were older at the 
time of Alzheimer’s symptom onset and dementia diagnosis  
• Meta-analytic results did not show a reduction in the risk of developing dementia 
among bilinguals vs. monolinguals 
• Several sources of bias were identified including poor measurement of 









Approximately 43.8 million people lived with dementia worldwide in the year 2016 
(Nichols et al., 2019) and this number is projected to increase to 115.5 million people by 
2050 (Prince et al., 2013). The global economic cost of dementia is estimated to surpass 
US$2 trillion per year by 2030 (Wimo et al., 2017). A five-year delay in the onset of 
Alzheimer’s disease (AD), the most common form of dementia, could reduce the number of 
patients living with the disease worldwide by 57%, thereby alleviating the associated eco- 
nomic costs by half (Sperling et al., 2011). Therefore, identifying modifiable lifestyle factors 
that can slow or delay the onset of dementia is a world’s public health priority (WHO, 2017; 
Wortmann, 2012). 
One such factor may be bilingualism, which is the ability to speak two languages 
(Luk & Bialystok, 2013). This hypothesis comes from studies showing that bilinguals 
develop mild cognitive impairment (MCI), dementia, and AD, 4–7 years later than 
monolinguals (Alladi et al., 2013; Bialystok, Craik, Binns, Ossher, & Freedman, 2014; 
Bialystok, Craik, & Freedman, 2007). Others, however, have not documented such 
differences (Lawton, Gasquoine, & Weimer, 2015; Yeung, John, Menec, & Tyas, 2014). 
Also, while longitudinal prospective studies showed no risk reduction among bilinguals 
relative to monolinguals (Ljungberg, Hansson, Adolfsson, & Nilsson, 2016; Yeung et al., 
2014; Zahodne, Schofield, Farrell, Stern, & Manly, 2014), foreign language education during 
adolescence has been associated with reduced risk of MCI later in life (Wilson, Boyle, Yang, 
James, & Bennett, 2015). Some authors have argued that confounding factors including 
migration status and education may explain some differences in study outcomes in cross-
sectional and longitudinal studies (Fuller- Thomson, 2015; Fuller-Thomson & Kuh, 2014). 
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One systematic review concluded that “public health policy should… remove 
recommendations regarding bilingualism as a strategy to delay dementia” (Mukadam, 
Sommerlad, & Livingston, 2017). However, the authors conducted a meta- analysis of only 
four longitudinal prospective studies without performing meta-analyses on cross-sectional 
reports. Moreover, while studies without a monolingual control group were excluded from 
this review (Mukadam et al., 2017), their meta-analysis included one study (Sanders, Hall, 
Katz, & Lipton, 2012) which did not clearly define the control group as monolingual. That 
review did not include age at MCI diagnosis as an outcome or studies published more 
recently (Hack, Dubin, Fernandes, Costa, & Tyas, 2019; Ljungberg et al., 2016; Perani et al., 
2017; Ramakrishnan et al., 2017; Zheng et al., 2018). As such, before suggesting that 
bilingualism should not be recommended as a strategy for delaying dementia, a careful re-
evaluation of the available evidence is necessary (Del Maschio, Fedeli, & Abutalebi, 2018). 
 
Objectives 
Differences in study outcomes in the field of bilingualism and dementia research as well as 
the need to identify strategies to delay the onset of dementia as highlighted in the Global plan 
on the public health response to dementia 2017–2025 by the World Health Organization 
(WHO, 2017) prompted this systematic review. We assessed whether bilingualism relative to 
monolingualism might delay the age at which participants experienced the initial symptoms 
of AD and delay the age at which participants were diagnosed with MCI or dementia. We 
also examined whether bilingualism might be associated with a lower risk of dementia. The 
primary objectives were to review cross-sectional and longitudinal prospective studies 
investigating (i) differences in the age of symptom onset and age at diagnosis of MCI or 
dementia between older monolinguals and bilinguals, and (ii) the relationship between 
bilingualism relative to monolingualism and risk of dementia in older cognitively intact 
 92 
adults. A secondary objective was to investigate differences in disease severity at dementia 
diagnosis between older monolinguals and bilinguals. 
 
Methods 
Search strategy and selection criteria 
This systematic review with meta-analyses accords with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses Statement (PRISMA; Moher, Liberati, Tetzlaff, & 
Altman, 2010). Eligible studies had to compare monolingual to bilingual participants on at 
least one of the following outcomes: reported age of symptom onset or age at diagnosis for 
MCI or dementia, degree of cognitive impairment at dementia diagnosis, or risk of dementia 
or MCI. Given the lack of a clear uniform definition of bilingualism in the literature, we 
included studies independently of the way bilingualism was operationalized or measured, or 
whether proficiency in the second language had been objectively assessed. We included 
studies that had recruited participants with MCI or dementia as assessed using clinical 
measures such as the National Institute of Neurological and Communicative Disorders and 
Stroke and the Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) 
as well as cognitively intact individuals. We excluded studies without a group of 
monolinguals. We also excluded reports, conference abstracts, reviews, commentaries, 
editorials, letters, news articles, case series, and discussion forums, as well as grey literature 
including non-peer reviewed empirical studies. We searched cross-sectional, prospective and 
retrospective cohort studies, case-control studies, and randomized controlled trials across 
several databases including CINHAL, The Cochrane Library, PubMed, PsycINFO, LILACS, 
and Embase. Filters were used to exclude animal studies, but no restrictions were placed on 
time and language. The initial search was performed on September 3, 2015 and refreshed 
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several times with the last refresh being complete on December 5, 2018. We used similar 
keywords and criteria for each search. 
The database searches were conducted by S.B., while the screening for title and 
abstract as well as the full-text screening was conducted independently by pairs of review 
authors (S.B., T.J.F., and J.J.H.). Data extraction was completed independently by pairs of 
review authors (S.B., M.F., T.J.F., and J.P.). We used Covidence software for each of these 
steps (Innovation, 2017). Disagreements were resolved through consensus and discussion 
with a third review author. We re- quested additional information from corresponding authors 
when necessary. Details of the protocol for this systematic review were registered a priori 
(PROSPERO 2015 CRD42015019100). 
 
Embase search strategy (example) ‘dementia’/exp. OR dementia’ OR ‘Alzheimer 
disease’/exp. OR ‘Alzheimer disease’ OR ‘frontotemporal dementia’/exp. OR 
‘frontotemporal dementia’ OR ‘multiinfarct dementia’/exp. OR ‘multiinfarct dementia’ OR 
‘mild cognitive impairment’/exp. OR ‘mild cognitive impairment’ OR ‘memory 
disorder’/exp. OR ‘memory disorder’ OR ‘Parkinson disease’/exp. OR ‘parkinson disease’ 
AND (‘multilingualism’/exp. OR ‘multilingualism’) OR ‘multilingualism’/exp. OR 
‘multilingualism’ OR ‘bilingual- ism’/exp. OR ‘bilingualism’ OR ‘English as a second 
language’/exp. OR ‘English as a second language’ AND [article]/lim AND ([adult]/lim OR 
[middle aged]/lim OR [aged]/lim OR [very elderly]/lim) AND [humans]/lim. 
 
Study selection  
The number of studies screened and included for quantitative synthesis is presented in Fig. 1. 
The qualitative synthesis included three cross-sectional studies with age at MCI diagnosis 
(Table 1) and 16 cross-sectional studies with age at AD symptom onset and age at dementia 
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or AD clinical diagnosis (Table 2). There was one longitudinal prospective study with the 










































Figure 0.1 PRISMA flow chart 
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 95 
Description of mild cognitive impairment and dementia 
Years before clinical diagnosis, an individual may experience MCI which can either be of the 
amnestic or non-amnestic type (Pandya et al., 2016). The former is marked by memory 
impartment more severe than would be expected for the age of the individual and this is a risk 
factor for AD. In the non-amnestic type, other cognitive abilities (e.g., language) rather than 
memory are affected and this is a risk factor mainly for other types of dementia. However, 
some individuals who experience MCI of either type do not necessarily progress to AD or 
other forms of dementia (Pandya et al., 2016). Dementia is a progressive clinical syndrome 
presenting with impairment in cognition, daily functioning, and changes in behavior in the 
absence of any impairment in consciousness (Vinters, 2015). While dementia is an umbrella 
that describes a significant cognitive and functional decline usually caused by a wide range of 
neurodegenerative diseases, AD has a specific etiology marked by a progressive and 
irreversible amnestic disorder followed by a decline in other cognitive abilities and behavior 
as well as neuropsychiatric dysfunctions resulting in total dependence (Vinters, 2015). 
Diagnosis of AD is based on clinical presentation (e.g., Diagnostic and Statistical Manual of 
Mental Disorders) and neuropsychological assessment while neuro- imaging is used to 
support clinical evaluation. However, a definite diagnosis can only be given by the NINCDS- 
ADRDA criteria with histopathological evidence supporting clinical diagnosis (Dubois et al., 
2007). 
 
Data extraction and risk of bias 
We extracted information on sample size, sex, mean age at diagnosis, education level, 
language measure, measures to diagnose dementia, dementia subtype, degree of cognitive 
impairment outcomes, and study results. Two authors (SB and MF) independently assessed 
risk of bias at both the study and outcome level by using the modified version of the 
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Newcastle-Ottawa Scale (NOS) to assess risk of bias for cross-sectional studies (Wells et al., 
2015). The modified NOS al- lows to allocate a maximum of 10 stars to each study across 
three domains: selection of study groups (range 0–5), comparability of study groups (range 
0–2), and exposure/outcome ascertainment (range 0–3). For longitudinal studies, we used the 
original version of the NOS for cohort studies, which allows allocating a maximum of nine 
stars across the same domains as in the modified version. 
Because the included studies were sufficiently similar regarding the research question, 
methodology, and outcome, we conducted a quantitative synthesis of the data by meta-
analyzing effect sizes from included studies.  
In cross-sectional studies, the authors reported the age of symptom onset for AD and 
age of clinical diagnosis for MCI, dementia, and AD as absolute numbers in years. 
Longitudinal prospective studies reported the risk of dementia as relative risk – the risk of 
developing dementia in bilinguals relative to monolingual controls and odds ratio – the odds 
of developing dementia given language status (i.e., bilingualism vs. monolingualism). One 
longitudinal prospective study report- ed the proportional hazard ratios in estimating the 
relationship between early foreign language instruction and the risk of developing MCI later 
in life (Wilson et al., 2015). 
 
Data analysis   
Our primary outcome measures were the age of symptom onset and age at diagnosis of MCI 
or dementia and the risk of developing dementia. A secondary outcome included the degree 
of disease severity at dementia diagnosis. Here, age at diagnosis was defined as the age at 
which participants were diagnosed with MCI, AD, or dementia and age of symptom onset 
was defined as the participants’ or informants’ retrospective recall of the age at which the 
first symptoms of cognitive impairment started. However, most studies that reported the age 
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of symptom onset included participants with AD, not dementia. Therefore, we could only 
conduct a meta-analysis on the age of symptom onset for participants with AD, not dementia. 
Our secondary outcome was the degree of cognitive impairment as measured by the Mini-
Mental State Examination (MMSE; Folstein, Folstein, & McHugh, 1975) during dementia or 
AD diagnosis, and dementia risk. 
 All the meta-analyses conducted here were based on random-effects models at an 
alpha level of .05 with the Knapp-Hartung adjustment (IntHout, Ioannidis, & Borm, 2014). 
Because studies did not provide individual-level data, we retrieved summary data. One study 
included two monolingual groups: one Mandarin and one Cantonese (Zheng et al., 2018). To 
increase the sample size, we combined the sample sizes, means, and standard deviations on 
the age of symptom onset, age of clinical diagnosis, and degree of cognitive impairment from 
the Mandarin and Cantonese group to form one monolingual group. For these calculations, 
we used the formula provided by the Cochrane Collaboration (Higgins & Green, 2016). For 
degree of cognitive impairment at dementia diagnosis, we presented MMSE scores (range: 0–
30) as Hedges’ g between monolinguals and bilinguals because one study (Lawton et al., 
2015) reported scores from the Modified Mini-Mental Status Examination (3MSE), which 
uses a scale from 0 to 100 points. Also, as not all prospective studies provided the same 
outcome results (one study provided hazard ratios and others provided log odds ratios), we 
extracted the unadjusted raw values of participants who had remained free of dementia and of 
those who had converted to dementia from the mono- and bilingual group. These values are 
unadjusted values but it was necessary to use these in order to combine results into a meta-
analysis. 
Data were analyzed using Comprehensive Meta-Analysis Software: version 3 
(Borenstein, Rothstein, & Cohen, 2005). For cross-sectional studies, we presented mean 
differences between monolinguals and bilinguals for our primary and secondary outcomes 
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(mean age in years and mean MMSE scores). For longitudinal studies, we presented odds 
ratio. We presented 95% confidence intervals (CI) around the pooled estimates (Riley, 
Higgins, & Deeks, 2011). We also computed 95% prediction intervals (PI), which reflect the 
distribution of effect sizes across different settings and estimate the expected effect sizes for 
future settings (IntHout, Ioannidis, Rovers, & Goeman, 2016). However, we computed PIs 
for meta-analyses with at least 10 studies (Hedges & Vevea, 1998). We used tau-squared 
(T2) to investigate between-study heterogeneity, with a non-zero T2 value indicating 
between-study heterogeneity. To investigate small- study effects, we generated funnel plots 
for meta-analyses that include at least 10 studies (Lau, Ioannidis, Terrin, Schmid, & Olkin, 
2006). To explore the impact that imputing missing studies might have on the pooled 
estimate, we conducted Duval and Tweedie’s trim and fill test (Duval & Tweedie, 2000). We 
did not conduct formal tests for funnel plot asymmetry in meta-analyses with fewer than 10 
studies (Sterne et al., 2011). 
Because we did not pre-specify potential covariates and to avoid data dredging 
(Thompson & Higgins, 2002), we restricted our investigation of heterogeneity to immigration 
status (Fuller-Thomson & Kuh, 2014; Mukadam et al., 2017) and dementia etiology due to its 
clinical relevance (Bialystok, Abutalebi, Bak, Burke, & Kroll, 2016; IntHout et al., 2016). In 
two subgroup meta-analyses, we compared studies that had recruited participants with 
dementia (irrespective of etiology) to studies that had recruited participants with AD (specific 
etiology) on the age of dementia and AD diagnosis. In the other subgroup meta-analysis, we 
compared studies explicitly mentioning that the statistical analyses had been adjusted for 
immigration status or at least that the analytic cohort did not include migrants to studies not 
explicitly mentioning whether the statistical analyses had adjusted for migration status or 
whether the analytic sample had included migrants. We reported the pooled estimates for 
heterogeneity in subgroup meta-analyses. 
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Results 
Data collection process 
We extracted demographic data including sample size, percentage of females in each group, 
and education level. Moreover, we extracted methodological data including the 
operationalization and measurement of participants’ language profiles, type of diagnosis (i.e., 
MCI, dementia, or AD), as well as the measurement tools used for making the clinical 
diagnosis of MCI or any dementia. We also extracted data for each outcome in each group 
including mean age of dementia diagnosis, mean age of dementia symptom onset, risk of 
MCI or dementia, and degree of cognitive impairment. We were able to extract sufficient 
data on age of MCI (k = 4) and dementia clinical diagnosis (k = 13), AD symptom onset (k = 
7), degree of cognitive impairment (k = 12), and risk of dementia (k = 5) to conduct a meta-
analysis on each of these outcomes. The total number of participants in cross-sectional 
studies was 4671 including 2376 monolinguals and 2295 bilinguals (Table 1 and 2). There 
were 121 monolinguals and 159 bilinguals in cross-sectional studies with MCI diagnosis as 
an outcome (Table 1), and 2256 monolinguals and 2136 bilinguals in studies with dementia 
diagnosis as an outcome (Table 2). There were six longitudinal prospective studies 
comprising a total of 4227 participants (Tables 3 and 4). 
 
Study characteristics 
The operationalization of bilingualism differed across studies including: “had spent the 
majority of their lives, at least from early adulthood regularly using at least two languages” 
(Bialystok et al., 2007; Craik, Bialystok, & Freedman, 2010), “the ability to communicate in 
two or more languages in interaction with other speakers of these same languages” (Alladi et 
al., 2013; Alladi et al., 2017), “individuals had spent the majority of their lives, beginning at 
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least in early adult- hood, speaking two or more languages fluently—ideally daily, but at least 
weekly” (Bialystok et al., 2014; Chertkow et al., 2010; Ossher, Bialystok, Craik, Murphy, & 
Troyer, 2012), “able to communicate fluently at least in 2 languages and made regular use for 
both” (Estanga et al., 2017), “ability to meet the communicative demands of the self and the 
society in their normal functioning in 2 or more languages in their interaction with other 
speakers of any or all of these languages” (Ramakrishnan et al., 2017), “fluent in a second 
language and had used both languages consistently throughout most of his or, her life” 
(Schweizer, Ware, Fischer, Craik, & Bialystok, 2012), “determined on the basis of second 
language proficiency and frequency of use” (Woumans et al., 2015) or did not apply a 
specific definition (Lawton et al., 2015; Ljungberg et al., 2016; Perani et al., 2017; Wilson et 
al., 2015; Yeung et al., 2014; Zahodne et al., 2014). One study used more strict definitions for 
monolingualism and bilingualism including “speaking English for all or most of one’s life 
and being fluent in English, but not in any other language” and “speaking both Welsh and 
English for all or most of one’s life and being fluent in both languages, but not in any other 
languages”, respectively (Clare et al., 2016).  
Studies used different types of measurements for bilingual- ism (Tables 1, 2, 3, and 
4). While several cross-sectional studies used validated measures including questionnaires to 
measure bilingualism (Bialystok et al., 2014; Clare et al., 2016; Estanga et al., 2017; Lawton 
et al., 2015; Ossher et al., 2012), others used non-validated methods (Alladi et al., 2013; 
Bialystok et al., 2007; Chertkow et al., 2010; Schweizer et al., 2012; Woumans et al., 2015), 
or did not report the method of collection (Craik et al., 2010; Ramakrishnan et al., 2017). 
Similarly, one longitudinal study assessed participants’ language profiles with a non-
validated measure (Wilson et al., 2015), two used a questionnaire but did not report their 
psychometric properties (Hack et al., 2019; Ljungberg et al., 2016), while one study validated 
their measure as part of the study (Zahodne et al., 2014). 
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There were differences in the type of MCI and dementia across studies (Table 1–4). 
Four studies recruited participants with MCI (Bialystok et al., 2014; Ossher et al., 2012; 
Ramakrishnan et al., 2017; Wilson et al., 2015). The type of MCI differed across studies with 
two studies recruiting individuals with MCI without describing its subtype (Bialystok et al., 
2014; Wilson et al., 2015), another study recruited individuals with single and multiple 
domain amnestic MCI (Ossher et al., 2012), while still another study recruited individuals 
with amnestic and non-amnestic MCI (Ramakrishnan et al., 2017). 
The tools for diagnosing MCI and dementia as well as the dementia subtypes differed 
across studies (Table 1–4). For MCI, studies either did not report the method of diagnosis 
(Bialystok et al., 2014), diagnosed MCI during a clinical interview with neuropsychological 
tests (Ossher et al., 2012), adopted the Mayo Clinic MCI criteria [(Ramakrishnan et al., 2017) 
Table 1], or the NINCDS-ADRDA criteria (Wilson et al., 2015). The diagnosis of dementia 
was often based on a clinical interview conducted by medical staff (e.g., a neurologist) and a 
neuropsychological assessment and using NINCDS-ADRDA criteria (Bialystok et al., 2007; 
Chertkow et al., 2010; Lawton et al., 2015; Ljungberg et al., 2016), the International 
Classification of Diseases 10 (Clare et al., 2016), or the Diagnostic and Statistical Manual of 
Mental Disorders, 4th Edition (Alladi et al., 2013), among others (Table 2). 
Studies recruited participants with a wide range of dementia subtypes including the 
behavioral variant frontotemporal dementia, progressive non-fluent aphasia, semantic 
dementia, frontotemporal dementia-motor neuron disease, corticobasal degeneration, and 
progressive supranuclear palsy (Alladi et al., 2017), AD (Clare et al., 2016; Ljungberg et al., 
2016; Woumans et al., 2015), vascular dementia (Alladi et al., 2013; Ljungberg et al., 2016; 
Zahodne et al., 2014), mixed AD with cardiovascular disease, frontotemporal dementia, 
dementia with Lewy bodies (Alladi et al., 2013; Zahodne et al., 2014), probable AD 
(Bialystok et al., 2014; Chertkow et al., 2010; Craik et al., 2010; Lawton et al., 2015; Perani 
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et al., 2017; Schweizer et al., 2012; Zahodne et al., 2014), possible AD (Bialystok et al., 
2007; Lawton et al., 2015; Zahodne et al., 2014), dementia due to other neurodegenerative 
disorders, cardiovascular disease (Bialystok et al., 2007), preclinical AD (Estanga et al., 
2017), frontal lobe dementia (Ljungberg et al., 2016), and dementia [(Hack et al., 2019; 
Yeung et al., 2004) Table 2]. 
Studies also recruited participants with a wide range of dementia subtypes including 
the behavioural variant frontotemporal dementia, progressive non-fluent aphasia, semantic 
dementia, frontotemporal dementia-motor neuron disease, corticobasal degeneration, and 
progressive supranuclear palsy (Alladi et al., 2017), AD (Clare et al., 2016; Ljungberg et al., 
2016; Woumans et al., 2015), vascular dementia (Alladi et al., 2013b; Ljungberg et al., 2016; 
Zahodne et al., 2014), mixed AD with cardiovascular disease, frontotemporal dementia, 
dementia with Lewy bodies (Alladi et al., 2013b; Zahodne et al., 2014), probable AD 
(Bialystok et al., 2014; Chertkow et al., 2010; Craik et al., 2010; Lawton et al., 2015; Perani 
et al., 2017; Schweizer et al., 2012; Zahodne et al., 2014), possible AD (Bialystok et al., 
2007; Lawton et al., 2015; Zahodne et al., 2014), dementia due to other neurodegenerative 
disorders, cardiovascular disease (Bialystok et al., 2007), preclinical AD (Estanga et al., 











Table 0-1 Cross-sectional studies investigating the relationship between bilingualism and MCI 




Effect sizes (MD = BL age minus ML age, 95%: CI) 
Study N (% of females) Mean age of dx & sx onset Education level Language measure MCI dx and type MMSE scores 
 
Age of dx Age of onset Cognitive impairment 
Bialystok 2014 ML: 28 (50%); 
BL: 26 (56%) 
 
ML: 66.5 (12.3)  
BL: 70.0 (10.7) 
ML: 15.5 (3.8) 
BL: 14.3  
LSBQ 
 
MCI ML: 29 (1.4) 






Ossher 2013 ML (SDaMCI): 
49 (55%) 






ML (SDaMCI): 74.9 (6.9) 
BL (SDaMCI): 79.4 (6.3) 
ML (MDaMCI): 75.2 (8.5) 









































ML: 22 (18.2%) 
BL: 93 (20.4%) 
ML: 58.1 (11.4); 55.8 (12.2)  
BL: 65.2 (9.9); 63.2 (10.1)    
ML: 10.4 (3.7) 
BL: 15.5 (3.3)  
NA Clinicians used Petersen 
criteria for final dx; 
MCI: amnestic MCI & 
non-amnestic MCI    

















Table 0-2 Cross-sectional studies on the relationship between bilingualism and dementia or AD 




Effect sizes (MD = BL age minus ML age, 95%: CI) 
Study N (% of females) Mean age of dx & sx onset Education level Language 
measure 
Dementia dx and type MMSE/3MSE scores 
 
Age of dx Age of onset Cognitive 
impairment 
Alladi 2017 ML: 72 (52.8%) 
BL: 121 (36.4%) 
Dementia 
ML: 61.0 (9.5), 58.4 (9.3) 
BL: 64.2 (9.4), 61.7 (9.1) 
 
ML: 6.9 (5.3) 




MMSE, ACE-R, FrSBe; 
bvFTD, PNFA, SD, 
FTD-MND, CBD, PSP 
ML: 15.9 (10.3) 







Alladi 2013 ML: 257 (49.0%) 
BL: 391(25.1%) 
Dementia 
ML: 63.4 (11.4), 61.1 (11.4)  
BL: 68.1 (10.0), 65.6 (10.0) 
 
AD (onset) 
ML: 65.4 (10.0)  
BL: 68.6 (9.6)  
ML: 5.9 (5.1)  
BL: 12.9 (4.9) 
Family member 
interview 
DSM-IV; AD, VaD, 
mixed AD with CVD, 
FTD, DLB 
ML: 16.7 (7.5) 

















Bialystok 2014 ML: 35 (54%) 
BL: 40 (55%) 
ML: 74.2 (11.2), 70.9 (11.0) 
BL: 81.4 (8.4), 78.2 (8.9)  
ML: 12.5 (3.7) 
BL: 12.2 (4.9) 
LSBQ  NA; Probable AD ML: 23.4 (3.8) 
BL: 22.3 (4.5) 
 
7.2 (2.68-11.72) 7.3 (2.72-11.88) 1.1 (-0.83-3.03)  
Bialystok 2007 ML: 91 (53%) 
BL: 93 (59%) 
Dementia 
ML: 75.4 (9.3); 71.4 (9.6)  
BL: 78.6 (8.4); 75.5 (8.5) 
 
AD 
ML: 75.8 (9.8) 
BL: 79.2 (8.7)  
ML: 12.4 (3.8) 
BL: 10.8 (4.2) 
Medical records  NINCDS–ADRDA; AD, 
possible AD, 
dementia due to other 
neurodegenerative 
disorders, and CVD  
ML: 21.3 (6.4) 








4.1 (1.4-6.74) AD  
1.2 (-3.24-5.64)  
Chertkow 2010 ML: 379 (63%) 
BL: 253 (51%) 
ML: 76.7 (7.8)  
BL: 77.6 (7.2) 
ML: 10.9 (3.5) 






ML: 23.1 (3.9) 
BL: 22.9 (4.3) 
 
0.9 (- 0.31-2.11)  NA 0.2 (-0.45-0.85)  
Clare 2014 ML: 49 (45%) 
BL: 37 (57%) 
ML: 76.2 (8.8), 73.7 (9.9) 
BL: 79.3 (6.8), 76.9 (7.1) 
ML: 12.31 (3.04) 
BL: 11.84 (2.46) 
LQ-SV ICD-10; AD ML: 23.90 (3.19) 
BL: 22.68 (3.16) 
 
 1.22 (-0.16-2.60) 3.21 (-0.65-7.07) 1.94 (-1.33-5.21) 
 
Craik 2010 ML: 109 (55%) 
BL: 102 (59%) 
ML: 76.5 (10), 72.6 (10.0) 
BL: 80.8 (7.7), 77.7 (7.9) 
ML: 12.6 (4.1) 
BL: 10.6 (5.1) 
NA  NINCDS-ADRDA; 
probable AD  
ML: 21.5 (5.7) 
BL: 20.4 (5.6) 
 
4.3 (1.87-6.63) 5.1 (2.64-7.56) 1.1 (-0.43-2.63)  
Lawton 2015 ML: 54 (65%) 
BL: 27 (63%) 
ML: 81.10 (NA) 
BL: 79.31 (NA) 
ML: 4.99 (4.17) 




Possible and probable 
AD  
ML: 78.87 (9.90)  
BL: 79.56 (15.57)  
 
1.79 (-4.55-0.97) NA 0.69 (-4.97-6.35)  
Perani 2017 ML: 40 (52.5%) 
BL: 45 (71%) 
ML: 71.4 (4.9) 
BL: 77.1 (4.5) 
ML: 10.5 (4.07) 
BL: 8.26 (4.55) 
Questionnaire NIAAA; probable AD  ML: 21.10 (4.84)  
BL: 22.40 (4.19)  
 
5.70 (3.71-7.71) NA 1.3 (-0.65-3.25) 
Schweizer 2012 ML: 19 (70%) 
BL: 20 (70%) 
ML: 77.3 (6.8) 
BL: 78.9 (7.7)  
ML: 13.6 (3.5) 





CDR; probable AD  ML: 23.2 (3)  
BL: 22.1 (5.1) 
 
1.60 (-2.95-6.15) NA -1.10 (-3.87-1.67) 
Woumans 2015 ML: 69 (69%) 
BL: 65 (69%) 
ML: 72.5 (9.4) 
BL: 77.3 (10.5) 
ML: 13.5 (2.8) 




Likert scale  
Neurologist in 
consultation with a 
neuropsychologist; AD 
ML: 24.2 (3.1) 
BL: 23.8 (3.4)  
 
4.80 (1.43-8.17) 4.6 (1.17-8.03) 0.40 (-0.70-1.50) 
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BL: 61 (57%)  
Diagnosis 
ML (Cantonese): 67.7 (9.9) 
ML (Mandarin): 67.0 (9.1) 
BL: 74.4 (9.4) 
 
Onset 
ML (Cantonese): 63.9 (9.7) 
ML (Mandarin): 63.4 (8.9) 





BL: 10.79 (4.32) 
 
BAT Two neurologists 
delivered the diagnosis 
using the NINCDS–
ADRDA; probable AD 
ML (Cantonese): 
12.25 (5.39) 
ML (Mandarin): 15.75 
(6.75) 
BL: 16.43 (6.46) 
 
    
 N (% of females) Mean age Education level Language 
measure 
Dementia dx and type MMSE/3MSE scores  Prevalence  Rate ratio 
Estanga 2016 ML: 100 (58%) 
Early BL: 81 
(54.3%) 
Late BL: 97 
(60.8%) 
ML: 57.82 (6.42) 
Early BL: 56.82 (6.48) 
Late BL: 57.56 (6.57) 
ML: 12.33 (3.37) 
Early BL: 14.35 
(3.76) 
Late BL: 14.98 
(3.77) 
BLPQ Cognitively intact ML: 28.44 (1.34) 
Early BL: 28.81 (1.09) 
Late BL: 28.81 (1.09) 
 ML: (stage 1: 11.9%; 
stage 2: 6.8%; and 
SNAP: 6.8%); Early 
BL: (stage 1: 3.6%; 
stage 2: 1.8%; and 
SNAP: 1.8%) 
 The prevalence of 
subjects in preclinical 
AD stage 1 
(abnormal amyloid), 
stage 2 (abnormal 
amyloid and tau), and 
SNAP (abnormal tau) 
was significantly 
different (p = 0.02) 
between early 
bilinguals (stage 1: 
3.6%; stage 2: 1.8%; 
and SNAP: 1.8%) 
and monolinguals 
(stage 1: 11.9%; stage 
2: 6.8%; and SNAP: 
6.8%) 
Yeung 2014 ML: 913 (60.4%) 
BL: 81 (61.7%) 
ESL: 622 (57.4%) 
ML: 77.4 (6.7) 
BL: 77.0 (6.5) 
ESL: 77.1 (7.1) 
 
ML: 10.4 (2.9) 
BL: 11.9 (4.2) 
ESL: 8.1 (3.7) 
 
Self-repot DSM-IIIR; Dementia ML: 89.0 (8.1) 
BL: 89.3 (6.7) 
ESL: 83.3 (11.0) 
 
 ML: 197 (31%), 440 
(69%); 
 BL:  86 (20%), 344 
(80%) 
 Bilingualism was not 
associated with risk 
of developing 
dementia  
ML: monolinguals; BL: bilinguals; dx: diagnosis; sx: symptom; AD: Alzheimer’s Disease; FTD: Frontotemporal Dementia; bvFTD: behavioral variant Frontotemporal Dementia; PNFA: Progressive Non Fluent Aphasia; SD: Semantic Dementia; FTD-
MND: Frontotemporal dementia-motor neuron disease; CBD: Cortico Basal Degeneration; PSP: Progressive Supranuclear Palsy; VaD: Vascular Dementia; CVD: Cardiovascular Disease; DLB: Dementia with Lewy bodies; SNAP: Suspected Non-
Alzheimer Pathophysiology; LSBQ Language and Social Background Questionnaire; LQ-SV Language Questionnaire – Short Version; ARSMA-II Acculturation Rating Scale for Mexican Americans; BLPQ Bilingual Language Profile Questionnaire; 
BAT Bilingual Aphasia Test; MMSE: Mini-Mental State Examination; 3MS: Modified Mini-Mental State; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders Version Four; (ADDTC) NINCDS-ADRDA: (Alzheimer Disease Diagnostic 
and Treatment Centers) National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association; ICD-10:  International Statistical Classification of Diseases and Related Health 
Problems; CDR: Clinical Dementia Rating;  DSM-IIIR: Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised; NA: not available  
 
Table 0-3 Longitudinal prospective study investigating the relationship between bilingualism and MCI 
 
 
Study characteristics Effect size 
Study N (% female); mean age (SD), Ed, MMSE/3MS Language measure, dementia dx and type % with dementia ML/BL % no dementia ML/BL RR, OR, HR 
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Wilson 2015 964 (76.8%), 78.7 (7.4), 14.6 (3.2) Self-report 
NINCDS–ADRDA 
MCI 
During a mean of 5.8 years (SD = 3.5) of annual 
follow-up evaluations, 396 individuals (41.1%) 
developed MCI 
Higher levels (>4 years) of foreign language 
instruction: HR = 0.687, 95% CI: 0.482, 0.961 
NINCDS–ADRDA (Alzheimer Disease Diagnostic and Treatment Centers) National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association; MCI Mild Cognitive Impairment 
Table 0-4 Longitudinal prospective studies investigating the relationship between bilingualism and dementia 
 
 
Study characteristics Effect size 
Study N (% female); mean age (SD), Ed, MSSE/3MSE Language measure, dementia dx and type % with dementia ML/BL % no dementia ML/BL RR, OR, HR 
Lawton 2015 81(64%) 
Baseline 
ML: 4.99 (4.17), 3MSE 78.87 (9.90) 
BL:7.70 (4.88), 3MSE 79.56 (15.57) 
 
Follow-up 
ML: age 81.10 
BL: age 79.31 
 
ARSMA-II ML: 54/1154 
BL: 27/624 
BL did not decrease the risk of dementia p = .72, AD 





818 (51%) 73.6 (8.9) 
 
Baseline  
ML: 73.8 (9.0), 6.9 (1.5), 26.6 (2.3) 
BL: 65.7 (6.6), 14.2 (4.3), 28.7 (1.7) 
Follow-up 
ML: 78.1 (6.1), 6.5 (1.6), 25.3 (2.3) 
BL: 76.0 (7.7), 12.0 (2.4), 26.8 (1.6) 
 
Language History Questionnaire 
DSM-IV, NINCDS–ADRDA 
AD, VaD, LBD, FLD, PD, and UD 
 
ML: 102 (13.86%), 634 (86.14%) 
BL: 10 (12.2%), 72 (87.8) 
 
BL did not decrease risk of dementia (p = .50) or AD 
(p = .36), even after adjusting for age and sex (p = 
.29) 
Yeung 2014 ML: 576 (61.6%), 76.1 (6.2), 10.7 (2.8), 3MS 91.2 
(5.7) 
BL: 54 (70.4%), 75.5 (5.6), 12.4 (4), 91.1 (5.6) 
ESL: 360 (60.6%), 75.7 (6.4), 8.7 (3.5), 87.4 (6.9) 
Self-report 
ML: Dementia 9.4%. 3MS 91.2 (5.7) 
BL: Dementia 11.1, 3MS 91.1 (5.6) 
ESL: Dementia 9.7%, 3MS 87.4 (6.9) 
ML 54 (9.4%), 492 (85.4%) 
BL 6 (11.1%), 46 (85.2%) 
ESL 35 (9.7%), 285 (79.2%) 
Model 1: 1.06 (0.69, 1.63) 
Model 2: .13 (0.73, 1.79) Model 3: 7 (0.67, 1.72) 
Model 4: (0.61, 1.59) 
Time 1 3MS, Time 2 3MS, and Change in the 3MS: 
Unadjusted model, English bilingual: Time 1, 0.6 (-
1.8, 2.9), Time 2, 2.5 (-0.7, 5.7), Changed in 3MS, -




ML: 637 (72%), 75.66 (5.79), 5.05 (3.61) 
BL: 430 (64%), 74.78 (5.66), 8.30 (4.22) 
Self-report (four-point Likert-type) 
DSM-III 
Probable and possible AD, VaD, LBD, and other dementias 
ML: 198/637 
BL:  86/344 
Better self-rated bilingualism was associated with 
lower odds of dementia conversion. Each point on the 
self-report scale was associated with 0.291 lower log 
odds of conversion to dementia 
SD: Standard Deviation; CI: Confidence Intervals; ML: monolinguals; BL: bilinguals; ESL: English as a Second Language; AD: Alzheimer’s Disease; VaD: Vascular Dementia; FLD: Frontal Lobe Dementia; PD: Parkinson’s Disease; DLB: Dementia 













Four; (ADDTC) NINCDS-ADRDA: (Alzheimer Disease Diagnostic and Treatment Centers) National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association; ICD-10:  
International Statistical Classification of Diseases and Related Health Problems; CDR: Clinical Dementia Rating;  DSM-III: Diagnostic and Statistical Manual of Mental Disorders, Third Edition 
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Risk of bias for cross-sectional studies 
Risk of bias for cross-sectional studies is presented in Table 5. Most cross-sectional studies 
employed acceptable sampling methods (k = 16; 100%), but most did not provide evidence 
for power calculations (k = 14; 88%). While some studies (k = 5; 31%) administered a 
validated measure of language ability, half of all studies (k = 8; 50%) used non-validated 
measures, including self- or proxy-reported measures (e.g., family member) or did not report 
the method of data collection (k = 2, 13%). Some studies (k = 14, 88%) controlled for 
important covariates such as immigration status and education either methodologically or 










Risk of bias for longitudinal studies 
Risk of bias for longitudinal studies is presented in Table 6. All longitudinal studies 
employed poor sampling methods and either administered a language questionnaire, of which 
there was no mention of the psychometric properties, or they relied on self-report during a 
structured interview. Potential confounding factors including age, sex, and apolipoprotein E 
(APOE) ε4 allele status (Ljungberg et al., 2016); age, sex, and years of formal education 
(Wilson et al., 2015); age, sex, education, and subjective memory loss (Yeung et al., 2014); 
country of origin, gender, education, time spent in the current home country (United States of 
America), recruitment wave, and age at enrollment (Zahodne et al., 2014); occupation, 
education, baseline age, immigration status, APOE ε4 allele status, idea density, and 
grammatical complexity (Hack et al., 2019) were controlled for. Finally, all studies had 
 
Table 5 Risk of bias for cross-sectional studies 
Study Selection Comparability Outcome Total/10 
 Representativeness 






















Alladi 2017 – – ★ – ★ ★ ★ ★ 5 
Alladi 2013 – – ★ – – ★ ★ ★ 4 
Bialystok 
2014 
– – – ★ ★ ★ ★ ★ 5 
Bialystok 
2007 
– – ★ ★ ★ ★ ★ ★ 6 
Chertkow 
2010 
– – ★ ★ ★ ★ ★ ★ 6 
Craik 2010 – – ★ – – ★ ★ ★ 4 
Clare 2014 – ★ ★ ★ ★ ★ ★ ★ 7 
Estanga 2016 – – ★ ★ ★ ★ ★ ★ 6 
Lawton 2015 – – ★ ★ ★ ★ ★ – 5 
Ossher 2013 – – – – ★ ★ ★ ★ 4 
Perani 2017 ★ – – ★ ★ – ★ ★ 5 
Ramakrishnan 
2017 
– – ★ – ★ ★ ★ ★ 5 
Schweizer 
2012 
– – – – ★ ★ ★ ★ 4 
Woumans 
2015 
– – ★ – ★ ★ ★ ★ 5 
Yeung 2014 – ★ ★ – ★ ★ ★ ★ 6 
Zheng 2018 – – ★ ★ ★ ★ ★ ★ 6 
A maximum of 10 stars can be given to each study 
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adequate assessments of the outcome including blind assessments for dementia diagnosis and 
appropriate follow-up periods, as well as reported sufficient information on attrition rate. 
 
Meta-analyses of cross-sectional studies: age of symptom onset, diagnosis and disease 
severity at dementia diagnosis 
 
Age at Alzheimer’s disease symptom onset 
The mean difference between mono- and bilinguals at the age of AD symptom onset was 4.7 
years (95% CI: 3.3, 6.1; Fig. 2). The t value was 8.06 with a two-tailed p< 0.001. Therefore, 
bilinguals were significantly older than monolinguals at the time of AD symptom onset. The 
Q-value was 6 with 6 df and with p = 0.424. Also, I2 0.00 in true and the variance in true 
effect sizes was T2 = 0.00, with T = 0.00. 
Table 6 Risk of bias for longitudinal prospective studies  














































Hack 2019 – – – ★ ★ ★ ★ ★ ★ 6 
Ljungberg 2016 – – – ★ ★ ★ ★ ★ ★ 6 
Wilson 2015 – – – ★ ★ ★ ★ ★ ★ 6 
Yeung 2014 – – – ★ – – ★ ★ – 3 
Zahodne 2014 – – ★ – ★ ★ ★ ★ – 5 
A maximum of 9 stars can be given to each study 
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Age at MCI, dementia, and AD diagnosis 
Bilinguals were on average 3.2 years (95% CI: −3.4, 9.7; Fig. 3) older than monolinguals at 
MCI diagnosis. This mean difference was not statistically significant (t = 1.53, two-tailed p = 
.223). There was evidence that studies did not share a common effect size but that the true 
effects varied (Q = 8.91, df = 3, p = .031). Approximately 66% of the observed variance 
reflected the difference in true effect sizes rather than sampling error (I2 = 66.34). The 
variance in true effect sizes was T2 = 11.13, with T = 3.34. Bilinguals were on average 3.3 
years (95% CI: 1.7, 4.9; Fig. 4) older than monolinguals at dementia diagnosis. This mean 
difference was statistically significant (t = 4.3, two-tailed p < .001). There was evidence that 
studies in this analysis likely did not share a common effect size but that the true effects 
varied (Q = 48.24, df = 12, p < .001). The I2 was 75.12 indicating that approximately 75% of 
the observed variance reflected the difference in true effect sizes rather than sampling error. 
The variance in true effect sizes was T2 = 4.83, with T = 2.20. The 95% PIs ranged from −1.9 






Statistics for each study MD and 95% CI
MD LL UL p-Value
Alladi 2013 68.6 65.4 3.2 0.7 5.7 0.013
Bialystok 2007 75.5 71.4 4.1 1.5 6.7 0.002
Bialystok 2014 78.2 70.9 7.3 2.7 11.9 0.002
Clare 2014 76.9 73.7 3.2 -0.5 6.9 0.086
Craik 2010 77.7 72.6 5.1 2.7 7.5 0.000
Woumans 2015 76.1 71.5 4.6 1.0 8.2 0.013
Zheng 2018 70.9 63.7 7.3 4.0 10.5 0.000
4.7 3.3 6.1 0.000
-12.0 -6.0 0.0 6.0 12.0
Favours monolinguals Favours bilinguals
Figure 2. Forest plot showing the mean difference (MD) in the age of AD symptom onset between bilinguals (BL) and monolinguals (ML); AD: Alzheimer’s disease; lower limit (LL), upper 
limit (UL); CI: confidence intervals
Total




Subgroup Analysis: Type of Diagnosis (Dementia vs. AD) 
We conducted a post hoc subgroup analysis to explore the source for this heterogeneity. We 
compared studies including participants with AD to studies including participants with 
dementia. Bilinguals in the AD subgroup (k = 8; Fig. 5) were on average 4.2 years (95% CI: 
2.0, 6.4) significantly older than monolinguals (t = 4.13, two-tailed p = .002). Bilinguals in  






Statistics for each study MD and 95% CI
MD LL UL p-Value
Bialystok 2014 70.0 66.5 3.5 -2.7 9.7 0.266
Ossher 2013a 79.4 74.9 4.5 0.9 8.1 0.014
Ossher 2013b 72.6 75.2 -2.6 -7.3 2.1 0.280
Ramakrishnan 2017 65.2 58.1 7.1 2.4 11.8 0.003
3.2 -3.4 9.7 0.223
-12.0 -6.0 0.0 6.0 12.0
Favours monolinguals Favours bilinguals
Figure 3. Forest plot showing the mean difference (MD) in the age of MCI diagnosis between bilinguals (BL) and monolinguals (ML); MCI: Mild cognitive impairment; LL: lower limit, 
UP: upper limit; CI: confidence interval
Total






Statistics for each study MD and 95% CI
MD LL UL p-Value
Alladi 2013 68.1 63.4 4.7 3.0 6.4 0.000
Alladi 2017 64.2 61.0 3.2 0.4 6.0 0.023
Bialystok 2007 78.6 75.4 3.2 0.6 5.8 0.014
Bialystok 2014 78.2 70.9 7.3 2.8 11.8 0.001
Chertkow 2010 77.6 76.7 0.9 -0.3 2.1 0.143
Clare 2014 79.3 76.2 3.0 -0.4 6.4 0.080
Craik 2010 80.8 76.5 4.3 1.9 6.7 0.000
Lawton 2015 81.1 79.3 -1.8 -4.9 1.3 0.257
Ljungberg 2016 80.7 81.9 -1.2 -5.0 2.6 0.537
Perani 2017 77.1 71.4 5.7 3.7 7.7 0.000
Schweizer 2012 78.9 77.3 1.6 -3.0 6.2 0.492
Woumans 2015 77.3 72.5 4.8 1.4 8.2 0.005
Zheng 2018 74.4 67.5 6.9 3.6 10.2 0.000
3.3 1.7 4.9 0.000
-12.0 -6.0 0.0 6.0 12.0
Favours monolinguals Favours bilinguals
Figure 4. Forest plot showing the mean difference (MD) in the age of dementia diagnosis between bilinguals (BL) and monolinguals (ML); 
LL: lower limit, UP: upper limit; CI: confidence interval
Total
Q = 48.24, df = 12, p < .001; I2 = 75.12; T = 2.20; T2 =  4.83
95% PI: -1.9 to 8.5 years
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older than monolinguals, but this between-group difference was not statistically significant (t 
= 1.52, two-tailed p = .157). We also compared the mean difference  for  the  AD  and  
dementia  subgroups  to  explore whether there were any significant differences between the 
two subgroups (Fig. 5). The mean difference in years (2.3, 95% CI: −5.9, 1.2) between the 
two subgroups was not statistically different (F = 2.04, df = 1, 11, two-tailed  p = 0.181). The 
pooled estimates for heterogeneity in this subgroup analysis were T2 = 4.83, T = 2.20, I2 = 




Subgroup analysis: immigration status (adjusted vs. did not adjust for immigration) 
We conducted a post-hoc subgroup analysis (Fig. 6) exploring whether immigration status 
was a potential source of heterogeneity. Bilinguals in studies adjusting for immigration status 
(k = 8) were on average 3.1 years (95% CI: 0.9, 5.2) older than monolinguals at dementia 
diagnosis (t = 3.17, two-tailed p = .009). In studies that did not adjust for immigration status 
(k = 5), bilinguals were on average 3.6 years (95% CI: 0.8, 6.5) older than monolinguals at 
dementia diagnosis (t = 2.97; two-tailed p = .018). The mean difference in years (0.5, 95% 
Group by
Diagnosis
Study name Statistics for each study MD and 95% CI
AD Bialystok 2014 78.2 70.9 7.3 2.8 11.8 0.001
AD Chertkow 2010 77.6 76.7 0.9 -0.3 2.1 0.143
AD Clare 2014 79.3 76.2 3.0 -0.4 6.4 0.080
AD Craik 2010 80.8 76.5 4.3 1.9 6.7 0.000
AD Perani 2017 77.1 71.4 5.7 3.7 7.7 0.000
AD Schweizer 2012 78.9 77.3 1.6 -3.0 6.2 0.492
AD Woumans 2015 77.3 72.5 4.8 1.4 8.2 0.005
AD Zheng 2018 74.4 67.5 6.9 3.6 10.2 0.000
AD: total 4.2 2.0 6.4 0.002
Dementia Alladi 2013 68.1 63.4 4.7 3.0 6.4 0.000
Dementia Alladi 2017 64.2 61.0 3.2 0.4 6.0 0.023
Dementia Bialystok 2007 78.6 75.4 3.2 0.6 5.8 0.014
Dementia Lawton 2015 81.1 79.3 -1.8 -4.9 1.3 0.257
Dementia Ljungberg 2016 80.7 81.9 -1.2 -5.0 2.6 0.537
Dementia: total 1.9 -0.9 4.7 0.157
-12.0 -6.0 0.0 6.0 12.0




mean age MD LL UL p-Value
Figure 5. Forest plot showing the mean difference (MD) in the subgroup meta-analysis comparing studies including participants with AD to studies including 
participants with dementia on the age of AD and dementia diagnosis between bilinguals (BL) and monolinguals (ML); AD: Alzheimer’s disease; LL: lower limit, 
UP: upper limit; CI: confidence interval
Q = 48.24, df = 12, p < .001; I2 = 75.12; T = 2.20; T2 =  4.83
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CI: −4.1, 3.0) between the two subgroups was not statistically different (F = 0.10, df = 1, 11, 
two-tailed p = 0.752). The pooled estimates for heterogeneity in this subgroup analysis were 








Disease severity   
There was no significant difference between mono- and bilinguals in disease severity at the 
age of dementia diagnosis (Hedges’ g= 0.05; 95% CI: −0.13, 0.24; t = 0.62, two-tailed p = 
.547; Fig. 7). The Q-value was 33.82 with df = 11 and p < .001. Approximately 67% (I2) of 
the observed variance reflected the difference in true effect sizes rather than sampling error. 
The variance in true effect sizes was T2 = .05 and T = .21. The PIs ranged between -0.47 and 








Statistics for each study MD and 95% CI
MD LL UL p-Value
No Lawton 2015 81.1 79.3 -1.8 -4.9 1.3 0.257
No Perani 2017 77.1 71.4 5.7 3.7 7.7 0.000
No Schweizer 2012 78.9 77.3 1.6 -3.0 6.2 0.492
No Woumans 2015 77.3 72.5 4.8 1.4 8.2 0.005
No Zheng 2018 74.4 67.5 6.9 3.6 10.2 0.000
No: total 3.6 0.8 6.5 0.018
Yes Alladi 2013 68.1 63.4 4.7 3.0 6.4 0.000
Yes Alladi 2017 64.2 61.0 3.2 0.4 6.0 0.023
Yes Bialystok 2007 78.6 75.4 3.2 0.6 5.8 0.014
Yes Bialystok 2014 78.2 70.9 7.3 2.8 11.8 0.001
Yes Chertkow 2010 77.6 76.7 0.9 -0.3 2.1 0.143
Yes Clare 2014 79.3 76.2 3.0 -0.4 6.4 0.080
Yes Craik 2010 80.8 76.5 4.3 1.9 6.7 0.000
Yes Ljungberg 2016 80.7 81.9 -1.2 -5.0 2.6 0.537
Yes: total 3.1 0.9 5.2 0.009
-12.0 -6.0 0.0 6.0 12.0
Favours monolinguals Favours bilinguals
Figure 6. Forest plot showing the mean difference (MD) in the subgroup meta-analysis comparing studies that had adjusted for immigrations status to studies that had 
not adjusted for immigration status on the age of dementia diagnosis between bilinguals (BL) and monolinguals (ML); LL: lower limit, UP: upper limit; CI: confidence 
interval. Studies that had not adjusted for immigration status are categorized as No and studies that had adjusted for immigration status are categorized as Yes.
Q = 48.24, df = 12, p < .001; I2 = 75.12; T = 2.20; T2 =  4.83
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Meta-analysis of prospective longitudinal studies: Risk of dementia    
We performed a meta-analysis on longitudinal prospective studies (Fig. 8). Results from this 
meta-analysis (k = 5) showed that bilingualism was not associated with a reduction in the risk 
of dementia (OR: 0.89; 95% CI: 0.68, 1.16, t = −1.22, two-tailed p = 0.289) when compared 
to monolingualism. There was no evidence of heterogeneity (Q = 3.22, df = 4, p = .522; I2 = 
0.00; T2 = 0.00; T = 0.00). 
 




Alladi 2013 0.28 0.12 0.44 0.000
Alladi 2017 0.21 -0.08 0.51 0.150
Bialystok 2007 -0.18 -0.47 0.11 0.230
Bialystok 2014 -0.26 -0.71 0.19 0.259
Chertkow 2010 -0.05 -0.21 0.11 0.545
Clare 2014 -0.38 -0.83 0.06 0.094
Craik 2010 -0.19 -0.46 0.08 0.159
Lawton 2015 0.06 -0.40 0.51 0.808
Ljungberg 2016 0.66 0.01 1.31 0.046
Perani 2017 0.29 -0.14 0.71 0.187
Woumans 2015 -0.12 -0.46 0.21 0.477
Zheng 2018 0.50 0.15 0.85 0.005
0.05 -0.13 0.24 0.547
-1.50 -0.75 0.00 0.75 1.50
Favours monolinguals Favours bilinguals
Figure 7. Forest plot showing the standardized mean difference (Hedges’s g) in the degree of disease 
severity at dementia diagnosis between bilinguals (BL) and monolinguals (ML); LL: lower limit, UP: 
upper limit; CI: confidence interval
Total
Q = 33.82, df = 11, p < .001; I2 = 67.47; T = .21; T2 = .05 
95% PI: -0.47, 0.57
Study name Statistics for each study OR and 95% CI
OR LL UL p-Value
Hack 2019 1.17 0.69 1.98 0.563
Lawton 2015 0.92 0.57 1.47 0.723
Ljungberg 2016 0.86 0.43 1.73 0.678
Yeung 2014 1.06 0.69 1.63 0.781
Zahodne 2014 0.74 0.55 0.99 0.045
0.89 0.68 1.16 0.289
0.1 0.2 0.5 1 2 5 10
Favours bilinguals Favours monolinguals
Figure 8. Forest plot showing the odds of developing dementia between monolinguals and bilinguals; OR: odds ratio; 
LL: lower limit, UP: upper limit; CI: confidence interval
Q = 3.22, df = 4, p = .522; I2 = 0.00; T = 0.00; T2 = 0.00 
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Small-study effects  
To address small-study effects, we generated funnel plots (Figs. 9 and 10). One funnel plot 
(Fig. 9) shows the observed (white dots) and imputed (black dots) effect sizes. Here, visual 
inspection showed that the observed data points tend to cluster on the right-hand side of the 
funnel plot indicating a minor asymmetry, suggesting the presence of small-study effects. 
However, Egger’s test was not significant with an intercept of 1.03 and CIs including −2.15 
and 4.20 and with a t value of 0.71, df = 11, and a 1-tailed p value of 0.246. The Duval and 
Tweedie’s Trim and Fill test showed that the adjusted effect size (black diamond) would be 
2.7 (95% CIs 1.3, 4.1) if the imputed studies had been included in the analysis. This indicates 
that even the adjusted effect size remained statistically significant.  
Visual inspection of the second funnel plot (Figure 9) for the meta-analysis on disease 
severity (Fig. 10) showed a slight asymmetry on the right-hand side of the plot indicating a 
mi- nor asymmetry, suggesting the presence of small-study effects. However, Egger’s test 
was not significant (one-tailed p value of 0.420) with an intercept of −0.267 (95% CI: 
−3.158, 2.623) and a t-value of 0.21 with df = 11. The Duval and Tweedie’s Trim and Fill 
showed that the adjusted effect size (black diamond) would be 0.05 (95% CI: −0.10, 0.21) if 
the imputed studies had been included in the analysis. Even in the likelihood of small-study 
effects or publication bias (De Bruin, Treccani, & Della Sala, 2015), the adjusted effect size 










Figure 9 Funnel plot on age of dementia diagnosis 
 




While some studies have linked bilingualism to a delay in AD symptom onset and dementia 
diagnosis (Perani et al., 2017; Perquin et al., 2013; Schweizer et al., 2012), others have not 
reported such benefits (Mukadam et al., 2017). Some authors have argued that education and 
immigration status, among other confounders, may influence the relationship between 
bilingualism and dementia in cross-sectional studies (Mukadam et al., 2017). As such, further 
research is needed (Del Maschio et al., 2018; Grundy & Anderson, 2017; Woumans, Versijpt, 
Sieben, Santens, & Duyck, 2017).  
 
Mild cognitive impairment 
Meta-analytic results did not suggest that bilingualism delays the diagnosis of MCI. Due to 
the small number of included studies (k = 4) and small sample sizes (monolinguals n = 131; 
bilinguals n = 169), it is likely that this meta-analysis was underpowered and consequently, a 
type II error is possible (Hedges & Pigott, 2001). Studies had recruited participants with 
different types of MCI including single-domain amnestic and multiple-domain amnestic MCI 
(Ossher et al., 2012), amnestic and non-amnestic MCI (Ramakrishnan et al., 2017), or did not 
specify the subtype (Bialystok et al., 2014). Given the low number of included studies in this 
meta-analysis, we could not conduct a subgroup analysis to explore whether bilingualism was 
associated with a delayed diagnosis of MCI in relationship to the different subtypes of MCI. 
Of note, while MCI is a risk factor for dementia and AD, not all individuals with MCI will 
progress to AD or dementia (Albert et al., 2011). Therefore, the putative beneficial effects of 
bilingualism may be more salient at the beginning of the AD clinical spectrum rather than in 
milder forms of cognitive impairment such as MCI. Notably, a longitudinal study showed 
that foreign language instruction during childhood and adolescence lowered the risk of non-
amnestic MCI but not amnestic MCI (Wilson et al., 2015), which supports some of the 
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primary cross-sectional studies (Bialystok et al., 2014; Ossher et al., 2012; Ramakrishnan et 
al., 2017). 
 
Age of AD Symptom Onset 
Our meta-analysis showed that bilinguals experienced AD symptoms on average 4.7 years 
later than monolinguals. While we did not observe significant heterogeneity, given the low 
number of studies (k = 7), caution in interpreting these findings as homogenous is warranted 
(Ioannidis, Patsopoulos, & Evangelou, 2007). These findings are in line with previous studies 
which show that speaking multiple languages is associated with better cognitive health in old 
age (Ihle, Oris, Fagot, & Kliegel, 2016; Kavé, Eyal, Shorek, & Cohen-Mansfield, 2008). 
Notably, the included studies did not provide a comprehensive profile of participants’ spoken 
languages, and because of this, we could not further investigate whether second-language 
proficiency, frequency of use, and age of acquisition played a moderating role in the 
observed delay in AD symptom onset (Del Maschio et al., 2018). When assessing AD 
symptom onset, researchers asked participants to retrospectively recall the age at which 
participants first began noticing AD symptoms. However, participants’ recall is often 
inaccurate and recall bias might have distorted participants’ reported estimates questioning its 
accuracy (Van den Bergh & Walentynowicz, 2016). In this meta-analysis (Fig. 2) studies 
tended to have small sample sizes (N median: 68.5) questioning the precision of the observed 
effect sizes (Cumming, 2014). Consequently, whether the estimate is close to the true value 
in this meta-analysis remains uncertain. 
 
Age of Dementia and AD Diagnosis 
Bilinguals were diagnosed with dementia on average 3.3 years later than monolinguals. 
According to the 95% PI (−1.9 to 8.5), we could expect that in some 95% of all populations 
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comparable to those in this meta-analysis (Fig. 4), the association between bilingualism and 
dementia may be strong, while in others, this association may be absent or may even tend to 
be in the opposite direction (Riley et al., 2011). Therefore, the beneficial association between 
bilingualism and delayed dementia diagnosis may appear only in some populations. While 
there are several possible explanations for wide PIs such as high risk of bias, we explored 
whether clinical differences across studies may be associated with the magnitude of the 
observed effect size in the meta-analysis in Fig. 4 (Sterne et al., 2011; Thompson, 1994). To 
address this, we conducted a post hoc subgroup analysis (Borenstein & Higgins, 2013; 
Oxman & Guyatt, 1992) comparing studies including participants with dementia (irrespective 
of etiology) to studies including participants with AD (specific etiology). In this analysis, 
bilinguals were not older than monolinguals at dementia diagnosis (mean difference: 1.9 
years) but were 4.2 years older at AD diagnosis. Here, the between-subgroup mean difference 
did not differ. Low statistical power, as indicated by wide CI, the low number of studies per 
subgroup (dementia: k = 5; AD: k = 8), and a low sample sizes per study might explain the 
lack of difference in the dementia subgroup and in the between-subgroup analysis (Riley et 
al., 2011). 
However, subgroup analyses are by default observational and because of this, we 
cannot be certain that participants in each subgroup were similar other than in the type of 
diagnosis. For example, the AD subgroup might have included a large portion of participants 
who could speak several languages and the dementia subgroup might have included 
bilinguals who spoke only two languages. Therefore, while bilinguals vs. monolinguals were 
older at AD but not at dementia diagnosis, we cannot be certain that this was due to 
differences in the type of diagnosis, and that findings should only be interpreted as 
hypothesis-generating (Thompson & Higgins, 2002). 
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Risk of dementia  
The meta-analysis including prospective studies showed no significant risk reduction in 
developing dementia among bilinguals compared to monolinguals. Our effect size favored 
bilinguals more than the effect size from the previous meta-analysis [odds ratio: 0.89; 95% 
CI: 0.68–1.16; (Mukadam et al., 2017)]. From our systematic review, we decided to exclude 
one study because it did not clearly define its control group as monolingual (Sanders et al., 
2012), but it was included in the previous meta-analysis (Mukadam et al., 2017). The 
difference in the included studies between our and the previous meta-analysis might explain 
the difference in the magnitude of the effect sizes. Moreover, while results showed no risk 
reduction in dementia among bilinguals, the trend favoring bilinguals in our meta- analysis 
(Fig. 7) needs to be carefully considered. Given the low number of studies (k = 5), our meta-
analysis might not have reached sufficient statistical power to detect a true effect (Hedges & 
Pigott, 2001). The CIs in each study were relatively wide indicating low statistical power and 
poor precision (Cumming, 2014). Therefore, each study was also likely under- powered to 
detect a true effect, if such an effect existed (Ioannidis, 2005, 2008). We did not find 
evidence of heterogeneity in this meta-analysis. Given the low number of studies in this 
meta-analysis, the Q statistic was likely underpowered, however. Notably, lack of 
heterogeneity does not necessarily indicate homogeneity (Ioannidis et al., 2007); interpreting 
a non-significant heterogeneity test in a meta-analysis with few studies is problematic 
(Rücker, Schwarzer, Carpenter, & Schumacher, 2008). 
 
Possible mechanisms and disease severity at dementia diagnosis  
Some authors have argued that while cross-sectional studies generally tend to show a later 
dementia diagnosis for bilinguals vs. monolinguals, these studies are more susceptible to the 
confounding effects of education or cultural differences (Mukadam et al., 2017). Given that 
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our meta-analyses included studies that had adjusted for education, it is unlikely that 
education had confounded the observed delays in dementia and AD diagnoses among 
bilinguals. We also conducted a subgroup meta-analysis comparing studies that had adjusted 
for immigration to those that did not explicitly mention participants’ immigration status. This 
analysis found that bilinguals were older than monolinguals at dementia diagnosis regardless 
of subgroup membership. This suggests that immigration might not have played a role in 
delaying the age of dementia diagnosis in bilinguals relative to monolinguals in these studies. 
It is noteworthy to highlight that while some studies had mentioned participants’ migration 
status, it was occasionally problematic to discern whether authors had in fact adjusted for 
migration status because there was no statement explicitly addressing the analytical approach 
for adjusting for this variable. 
 Even if bilinguals were delaying seeking medical attention due to cultural differences, 
we would still expect them to demonstrate greater cognitive impairment than monolinguals at 
dementia diagnosis. However, we found no difference (Hedges’ g = 0.05, 95% CI: −0.13, 
0.24) between mono- and bilinguals on disease severity at dementia diagnosis. This suggests 
that in some settings, bilingualism may be more beneficial than monolingualism to help 
maintain cognitive function for a longer period of time despite the presence of ongoing 
neuropathology (Gold, 2015). It is possible that bilingual- ism may help in maintaining 
cognitive health for a longer period of time, protecting against the impending effects of AD 
on cognition (Bak et al., 2014; Gold, 2015). There is evidence to suggest that bilingualism is 
associated with higher cognitive function in old age (Ihle et al., 2016; Kavé et al., 2008) even 
after adjusting for differences in intelligence levels during childhood (Bak et al., 2014). Some 
authors have advanced the proposition that bilingualism may enhance cognitive reserve, 
which refers to the ability to maintain functioning levels of cognition despite the presence of 
a neurodegenerative disease such as AD (Perquin et al., 2013; Stern, 2012).  
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Supporting findings from our meta-analysis on disease severity, behavioral data 
indicated that mono- and bilinguals did not significantly differ in executive functions at AD 
diagnosis despite bilinguals being significantly older (Bialystok et al., 2014). Computed 
tomography scans also revealed greater atrophy of the medial temporal lobe at AD diagnosis 
in bilinguals vs. monolinguals matched for disease severity and despite monolinguals having 
higher education and job status (Schweizer et al., 2012). The medial temporal lobe is a region 
particularly affected by AD (Clerx et al., 2013; Visser et al., 2002). Moreover, bilinguals 
showed greater cerebral hypometabolism than monolinguals, which is indicative of greater 
neurodegeneration, and outperformed monolinguals in short- and long-term verbal and 
visuospatial memory, but not in language tasks (Perani et al., 2017). Given the disagreement 
in the field regarding the exact underlying mechanisms of bilingualism thought to promote 
cognitive reserve (García- Pentón et al., 2016a, 2016b), we are currently conducting a 
systematic review investigating the underlying brain mechanisms of bilingualism in non-
clinical and clinical individuals with MCI or dementia (Brini et al., 2018a). 
Because studies did not generally measure participants’ socioeconomic status, it was 
not possible to examine whether this factor might have contributed to the observed delays in 
dementia diagnosis among bilinguals. The incidence of dementia is higher in certain ethnic 
minorities than in Caucasian individuals (Mehta & Yeo, 2017), suggesting that 
socioeconomic and cultural factors may play a role in the observed relationship between 
bilingualism and dementia. Researchers have extensively debated how to quantify 
bilingualism (Del Maschio et al., 2018; Luk & Bialystok, 2013). While studies have tended to 
categorize participants between mono- and bilinguals (Del Maschio et al., 2018), 
bilingualism is a multidimensional variable that extends on a continuum (Luk & Bialystok, 
2013). For example, factors including the number of languages one can speak, age of 
acquisition, proficiency, and frequency of use in the second language likely interact with one 
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another and may explain differences in the observed delay in dementia among bilinguals (Del 
Maschio). However, the studies included in our meta-analysis did not formally assess these 
factors (Table 5–6), and because of this, we could not examine whether the different 
dimensions of bilingualism (Del Maschio et al., 2018; Luk & Bialystok, 2013) contributed to 
the observed heterogeneity in some of our meta-analyses. 
 
Sources of uncertainty and risk of bias in cross-sectional and prospective longitudinal studies 
From our risk of bias assessment within studies, it is clear that one major source of 
uncertainty concerned how representative the samples were and whether the exposure had 
been measured appropriately (Table 5). In cross-sectional studies, because no study formally 
assessed monolingualism, the extent to which participants were truly monolinguals remains 
unclear. This would have been an important factor to assess because exposure to foreign 
languages through schooling or the media is ubiquitous nowadays (Laine & Lehtonen, 2018), 
questioning whether the monolinguals in our included studies were in fact, truly 
monolinguals. Generally, bilingualism was poorly defined, measured, or did not carry a 
specific definition. While researchers commonly defined bilingualism as “speaking two or 
more languages,” they did not routinely measure additional languages. This would have been 
a relevant factor to measure because some studies point to a dose- response relationship 
(Antoniou & Wright, 2017) with in- creasing number of languages generating a greater delay 
in the onset of dementia (Alladi et al., 2013; Chertkow et al., 2010; Clare et al., 2016), 
protection against cognitive impairment (Perquin et al., 2013), and greater cognitive health in 
older individuals (Ihle et al., 2016).  
 The assessment of participants’ language profiles and by extension, their 
representativeness, was also questionable in longitudinal prospective studies (Table 6). In one 
study, bilingualism was not associated with reduced dementia risk but those reporting 
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speaking a second language very well had a 14% lower risk of developing dementia than 
those who reported not at all well (Zahodne et al., 2014). This questions whether participants 
who reported speaking a second language “not at all well” should have been classed as 
bilinguals or monolinguals and supports the notion that participants’ language profiles should 
be treated as a continuous rather than a dichotomous variable (Luk & Bialystok, 2013). While 
other studies did not show a risk reduction in dementia among bilinguals, it is likely that they 
were underpowered. For example, one study included 736 monolinguals but only 82 
bilinguals with 102 developing dementia in the monolingual group and 10 among bilinguals 
(Ljungberg et al., 2016). Furthermore, only three studies adopted a questionnaire to measure 
bilingualism (Hack et al., 2019; Ljungberg et al., 2016; Zahodne et al., 2014). Thus, 
differences in the operationalization and measurement of bilingualism, as well as relatively 
small sample sizes, question the internal validity of the longitudinal prospective studies 
(IntHout, Ioannidis, Borm, & Goeman, 2015). 
Further, while some cross-sectional studies adjusted for important confounders such 
as education and occupation status, several studies did not specify whether they had adjusted 
for other likely confoudners nor did they routinely report participants’ immigration status 
(Fuller-Thomson, 2015; Fuller- Thomson & Kuh, 2014) or levels of physical activity. Levels 
of physical activity may be an important factor to assess as bilingualism may benefit 
sedentary individuals (Brini et al., 2018b) differently than highly physically active 
individuals (Sterne et al., 2011). Since the majority of studies did not provide evidence of 
power calculations, it was unclear whether they had sufficient statistical power to detect an 
effect if one existed particularly when adjusting for genes (Ioannidis, 2008; Sham & Purcell, 
2014). For example, bilingualism may benefit participants with the apolipoprotein E (APOE) 
ε4 allele, the main genetic risk factor for AD (Galimberti & Scarpini, 2016; Liu, Kanekiyo, 
Xu, & Bu, 2013), differently than those without the APOE ε4. 
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Similar to the cross-sectional studies, longitudinal prospective studies did not consider 
participants’ baseline risk of dementia. Although one study adjusted for the APOE ε4 
(Ljungberg et al., 2016), which is a risk factor for AD (Brini, Sohrabi, et al., 2018b), no other 
prospective study considered other genetic risk factors implicated in AD (Naj, Schellenberg, 
& Consortium, 2017). Only 147 participants (across mono- and bilinguals) were APOE ε4 
carriers (Ljungberg et al., 2016). Of note, whether APOE ε4 increases the risk of vascular 
dementia (Rohn, 2014), frontotemporal dementia (Verpillat et al., 2002), dementia with Lewy 
bodies (Lovati et al., 2010), and Parkinson’s disease (Fagan & Pihlstrøm, 2017) is unclear 
(Lovati et al., 2010). Therefore, adjustment for the APOE ε4 likely did not reach sufficient 
statistical power (Sham & Purcell, 2014) in this study (Ljungberg et al., 2016) and its clinical 
relevance to other dementia etiologies may have been limited (Lovati et al., 2010). The 
authors also did not analyze other variants of the APOE including the ε2, which may confer 
protection against AD (Liu et al., 2013). 
 
Small-study effects 
While our funnel plots showed slight asymmetry indicating possible small-study effects 
(Sterne, Egger, & Smith, 2001), Egger’s tests were not significant. However, results from 
Egger’s test should be interpreted with caution, because in the absence of severe bias, this test 
has low statistical power (Sterne, Gavaghan, & Egger, 2000). One possible source of small-
study effects is publication bias (Egger, Smith, Schneider, & Minder, 1997), which is 
prevalent in the social (Franco, Malhotra, & Simonovits, 2014) and cognitive sciences 
(Ioannidis, Munafo, Fusar-Poli, Nosek, & David, 2014). More notably for this systematic 
review, it is likely present in the field of bilingualism research, too (De Bruin et al., 2015); 
although others (Bialystok, Kroll, Green, MacWhinney, & Craik, 2015) have contested these 
findings (De Bruin et al., 2015). Therefore, despite the non-significant Egger’s tests, there are 
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reasons to believe that publication bias may be present in this field of research. In light of 
this, the Duval and Tweedie’s Trim and Fill test (Duval & Tweedie, 2000) showed that after 
imputing the estimated missing studies, bilinguals would be on average 2.7 years (95% CI: 
1.3, 4.1) older than monolinguals at the time of dementia diagnosis. Even in the likelihood of 
publication bias (De Bruin et al., 2015), the observed effect size in this meta-analysis (Figure 
4) would not change by a large margin. 
Several of our included studies had small sample sizes, which can increase the risk of 
type I error (Ioannidis, 2005) and inflate the effect size (Ioannidis, 2008), which can result in 
funnel plot asymmetry (Sterne et al., 2011). For example, if the association between 
bilingualism and dementia is driven by a dose-response relationship (Alladi et al., 2013; 
Chertkow et al., 2010; Clare et al., 2016; Ihle et al., 2016), smaller studies with a higher 
portion of multilingual participants may generate greater effect sizes resulting in funnel plot 
asymmetry (Egger et al., 1997). Moreover, as mentioned previously, bilingualism may 
benefit participants who occupy a higher baseline risk of dementia (e.g., by virtue of genetic 
risk) differently, which could also explain funnel plot asymmetry (Sterne et al., 2011). 
However, because most studies did not report data on the number of spoken languages or 
participants’ baseline dementia risk, we could not explore whether multilingualism may have 
contributed to funnel plot asymmetry. 
 
Limitations 
A limitation of our meta-analyses was the inclusion of all cross-sectional studies regardless of 
language status. Most studies did not precisely report how many languages were spoken by 
their bilingual cohorts. Therefore, from our meta-analyses, it remains unclear whether the 
number of languages a person can speak plays a role in delaying the onset of dementia. As 
noted above, however, some evidence suggests that the number of languages could play a 
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role in the risk and delay of dementia (Chertkow et al., 2010; Clare et al., 2016). 
Additionally, in a subgroup meta-analysis, we compared studies that recruited participants 
with dementia and AD. In the dementia subgroup, however, participants were diagnosed with 
different forms of dementia. This is a limitation because, from this subgroup, it was not 
possible to discern whether bilingualism was distinctively related to different dementia 
etiologies. Furthermore, this subgroup analysis was likely underpowered given the small 
number of studies (k = 5) and the associated large CIs. 
While the results of our meta-analyses on the age of dementia and AD diagnosis are 
interesting, it is crucial to stress that the observed relationship between bilingualism and 
dementia is not causal. Cross-sectional studies are useful when examining the relationship 
between two variables and help to generate hypotheses that may be further tested for causal 
effects in experimental studies. Particularly for this review, our risk of bias assessment 
uncovered several sources of uncertainty due to bias within studies. For example, several 
factors such as the poor measurement of bilingualism, the inclusion of varying types of 
dementia etiologies, and lack of control over confounding factors in several of the included 
studies, leave us questioning the beneficial link between bilingualism and dementia. 
Most studies did not report how bilinguals had acquired the second or third language, 
or participants’ immigration status. This is a limitation in our meta-analyses because some 
participants might have acquired the second language through schooling whereas others 
might have acquired it due to migrating to a new country. In the former case, participants 
might have been diagnosed in their native language (e.g., English) whereas in the latter case, 
participants might have been diagnosed in their non-native language (e.g., a language other 
than the recipient country’s national language). As such, cultural differences (Chandra et al., 
2001; Chin et al., 2011) or language barriers (Lindesay, 1998; Nielsen et al., 2011) might 
have contributed to the observed delays in dementia diagnosis and possibly confounded the 
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relationship between bilingualism and age of dementia diagnosis. Since there was insufficient 
information regarding what language was used to provide a diagnosis of MCI or dementia 
among bilinguals, we could not further explore whether the language of the assessment 
played a role in the observed delays in any of our outcomes. 
 
Strengths  
Unlike a previous systematic review (Mukadam et al., 2017), results from cross-sectional 
studies were meta-analyzed to determine whether bilingualism is associated with a delayed 
onset of dementia and AD. This allowed us to generate a more precise estimate of the effect 
size. In response to previous criticisms (Fuller-Thomson, 2015; Fuller-Thomson & Kuh, 
2014; Mukadam et al., 2017), we explored whether immigration status might have been 
related to differences in the age of dementia diagnosis by conducting a sub- group meta-
analysis. We have included more recently published studies that had not been included in the 
previous systematic re- view (Mukadam et al., 2017) and therefore, provide a more up to date 
review of the available literature. We also registered a study protocol a priori for this 
systematic review. 
 
Suggestions for future research  
Given the lack of a standard definition and measurement tool for mono- and bilingualism 
across our included studies, it is critical for future research to improve the measurement of 
participants’ language profile. This could mean quantifying the spectrum of language 
knowledge on a continuum and by measuring proficiency, frequency of use, and the age of 
second language acquisition (Anderson, Mak, Chahi, & Bialystok, 2018; Li, Zhang, Yu, & 
Zhao, 2019; Luk & Bialystok, 2013). Researchers could then apply multiple linear regression 
(Plonsky & Oswald, 2017) or Bayesian inference (Ross & Mackey, 2015) to explore whether 
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language skills can predict the age of dementia symptom onset and diagnosis. Researchers 
can apply objective measures for bilingualism (Clare et al., 2016; Estanga et al., 2017), rather 
than asking participants or family members to self-report language status (Alladi et al., 2013; 
Chertkow et al., 2010). Formal assessments of second language proficiency while treating the 
degree of bilingualism as a continuous variable (DeLuca, Rothman, Bialystok, & Pliatsikas, 
2019; Laine & Lehtonen, 2018; Luk & Bialystok, 2013) should be applied. Authors have 
recently developed questionnaires to quantify participants’ language profiles on a continuum 
(Anderson et al., 2018) and to measure language proficiency, dominance, as well as 
immersion (Li et al., 2019). Researchers might want to establish a priori whether they wish to 
measure bilingualism, the ability to speak two languages (Anderson et al., 2018) or 
multilingualism, the ability to speak three or more languages (Li et al., 2019). Clearly 
reporting participants’ immigration status will also be beneficial. 
Increasing statistical power will enable partitioning of participants into different 
dementia etiologies (Nelson et al., 2019) and to conduct sub-group analyses. While 
categorizing participants into dementia subtypes poses several challenges (De Reuck et al., 
2016), applying biomarkers could help researchers in classifying dementia subtypes (Jack et 
al., 2016; Perneczky et al., 2016). Future studies should consider adjusting for variables such 
as physical activity, which is associated with the risk of dementia (Brini, Sohrabi, et al., 
2018b). Researchers wishing to adjust for genetic risk would need to recruit a large number 
of mono- and bilinguals to reach sufficient statistical power for this type of analysis (Sham & 
Purcell, 2014) and exclude participants for which the APOE ε4 may not be clinically relevant 
(Lovati et al., 2010). Additionally, while bilinguals vs. monolinguals were older at dementia 
diagnosis, the observed delay does not imply disease-modifying effects (Galimberti & 
Scarpini, 2016). Combining behavioral measures with surrogate biomarkers such as brain 
data will provide more robust evidence as to whether bilingualism can help maintain 
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cognitive function despite presence of neuropathology due to dementia (Bialystok, Anderson, 
& Grundy, 2018; Brini, Sewell, et al., 2018a) and could reveal potentially disease-modifying 
properties (Galimberti & Scarpini, 2016). Researchers wishing to conduct conditional power 
calculations for future studies based on our meta-analyses need to take into consideration 
heterogeneity when estimating sample size (Roloff, Higgins, & Sutton, 2013). Finally, to 
enhance reporting for observational studies, authors should follow and clearly state that their 
study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) Statement (Von Elm et al., 2014). 
Implications and conclusion  
Identifying factors that can delay the onset of dementia and AD is a major public health 
priority (Winblad et al., 2016; Wortmann, 2012). This is because, a delay in the onset of AD 
of five years could reduce AD prevalence by 57% with concomitant savings of US$627 to 
US$344 billion in Medicare costs worldwide (Sperling et al., 2011). At the individual level, 
delaying the symptom onset of dementia and AD can also have important benefits for 
patients, families, and, by implication, the overall incidence of AD (Cummings, Morstorf, & 
Zhong, 2014). Our findings suggest that speaking two or more languages may be related to an 
ability to maintain functional cognition for a longer time compared to monolinguals. The 
observed effect sizes may be superior, under certain settings, to available pharmacological 
therapies that delay cognitive decline by 6–12 months and only target symptoms without 
modifying the pathogenic or clinical course of AD (Yiannopoulou & Papageorgiou, 2013). 
 While bilingualism appears to be associated with delayed AD 
symptom onset, dementia and AD diagnosis, the substantial heterogeneity and several 
sources of bias challenge the interpretation of our findings. Until future studies improve the 
measurement of participants’ language profiles, increase sample sizes, comprehensively 
report sample characteristics including participants’ ethnicity and birthplace, adjust for 
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baseline dementia and AD risk (separately), it will be problematic to discern under which 
settings and to what extent bilingualism may be beneficial. Precisely because of these 
unanswered questions, we think it is premature to remove public health policy 
recommendations on bilingualism as a strategy to delay dementia as previously suggested 
(Mukadam et al., 2017). We also disagree that longitudinal prospective studies were “large 
high quality prospective studies” (Mukadam et al., 2017). We argue that longitudinal 
prospective studies were likely underpowered and carried serious methodological limitations 
and that, it is incorrect to conclude evidence of no effect (Mukadam et al., 2017) from no 
evidence of an effect (Schünemann et al., 2019). Given that the observed effect sizes may be 
superior to available pharmacological therapies (Yiannopoulou & Papageorgiou, 2013), we 
agree with others that researchers should improve study methodology and continue 
investigating the link between bilingualism and dementia (Del Maschio et al., 2018). 
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Between-chapter (3-4) rationale  
In Chapter 3, we found that bilinguals demonstrated a later onset of AD symptoms and 
diagnosis. The results indicate that bilingualism may be a potential factor that could be 
modified to delay the onset of AD in the community. Chapter 3 also revealed several sources 
(e.g. poor measurement of participants’ language profiles) of uncertainty which led us 
questioning whether our estimates are close to the true value. Given these uncertainties and to 
gather additional evidence to determine whether bilingualism may be used as a potentially 
modifiable risk factor for delaying AD, we sought to explore the underlying brain 
mechanisms implicated in bilingualism. We argued that bilingualism may render the brain 
areas affected by AD more resilient against neuropathology thereby also delaying the clinical 























Chapter 4 The bilingual brain in healthy and 
neuropathological aging: a systematic review and 
























Authors: Stefano Brinia,b,c,d, Behnaz Shahtahmassebic, Hamid, R. Sohrabie,f,g, Mira 
Karraschh, Ralph N. Martinse,f,g, Timothy J. Fairchildc,  
 
aDepartment of Psychology and Speech-Language Pathology, University of Turku, Turku, 
Finland  
bTurku Brain and Mind Center, Turku, Finland 
cSchool of Psychology and Exercise Science, Murdoch University, Perth, Western Australia, 
Australia 
dHealth Services Research and Management School of Health Sciences, City, University of 
London, London, United Kingdom   
eSchool of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, 
Australia  
fDepartment of Biomedical Sciences, Macquarie University, New South Wales, Australia 
gAustralian Alzheimer’s Research Foundation, Perth, Western Australia, Australia 
hDepartment of Psychology, Åbo Akademi University, Turku, Finland  
Highlights 
1. We systematically reviewed neuroimaging findings in aged bilinguals 
2. We identified candidate brain regions protecting bilinguals against dementia  
3. We identified several sources of uncertainty and inconsistent findings in the field 









There is evidence showing that speaking more than one language (bilingualism) as opposed 
to one (monolingualism) is associated with a delay in the diagnosis of dementia up to four 
years. However, it is not yet known what brain mechanisms may be responsible for 
supporting the observed delays in dementia diagnosis among bilinguals. Here, we 
systematically reviewed the literature assessing the relationship between bilingualism and the 
brain. We searched for studies comparing monolinguals and bilinguals on structural and 
functional neuroimaging outcomes. Out target population included healthy adults and those 
diagnosed with dementia. We applied brain mapping to synthesize the available evidence and 
show what brain areas related to bilingualism had been investigated in previous studies. 
Results from our brain mapping showed that bilingualism is associated with stronger 
frontostriatal and frontoparietal circuits in healthy adults and those diagnosed with dementia, 
which are brain areas severely affected by dementia. Our findings indicate that bilingualism 
may strengthen these brain areas and render the brain more resilient against 
neuropathological changes present during natural course of dementia. However, risk of bias 











Identifying protective strategies against late onset dementia has become a global public health 
priority (Winblad et al., 2016; Wortmann, 2012). This is because age is a major risk factor for 
dementia and with increased global life expectancy (Kontis et al., 2017) the number of 
individuals expected to develop dementia will significantly increase (Prince et al., 2013). 
Projections from the World Health Organization (WHO) suggest the number of individuals 
aged 65 years old and over will rise from 524 million in 2010 to 1.5 billion by the year 2050, 
with a concomitant increase in the number of people with dementia from 35.6 million in 2010 
to 115.5 million by the year 2050 (Prince et al., 2013). The worldwide costs of dementia are 
estimated to reach two trillion United States dollars by the year 2030 (Wimo et al., 2017).  
Modifying particular everyday behaviours such as increasing physical activity (Brini 
et al., 2018) and attaining higher levels of education (Xu et al., 2016) are linked to 
maintenance of cognitive health across the lifespan and a lower risk of dementia. It has been 
suggested that modifying these behaviours can result in greater cognitive reserve (CR), which 
is the ability to maintain cognitive functioning in the presence of neuropathology (Stern 
2012). Another everyday behaviour, bilingualism (the ability to speak two or more 
languages), has also been linked with greater CR (Gold, 2016), which is thought be 
responsible for the observed delayed in the onset of dementia among bilinguals (Bialystok, 
Abutalebi, Bak, Burke, & Kroll, 2016). While it has been suggested that bilingualism might 
increase CR and render the brain more robust against neuropathology, the specific 
mechanisms underlying this process in the bilingual brain are still unclear (García-Pentón et 
al., 2016a, 2016b).  
 Some behavioural evidence shows that bilinguals are older than monolinguals at the 
time of dementia diagnosis by up to five years but demonstrate similar global cognitive 




average five years older than monolinguals at the time of Alzheimer's disease (AD) 
diagnosis, and they also demonstrated greater impairment in cerebral glucose uptake, which 
is a marker of neurodegeneration (Perani et al., 2017). Moreover, a study in participants with 
AD who were matched on disease severity, cognitive performance, and years of education 
demonstrated that several neural indices associated with AD were more prominent in 
bilinguals as compared to monolinguals (Schweizer et al., 2012). More specifically, temporal 
lobe atrophy as measured by the radial width of the temporal horn and the temporal horn ratio 
was more pronounced in bilinguals as compared to monolinguals (Schweizer et al., 2012). 
These parallel lines of research suggested that bilingualism might enhance CR, thereby 
allowing bilinguals to cope better with advancing neuropathology than monolinguals, at least 
up to a certain point of the disease progression. 
The exact mechanisms responsible for this link however have not been systematically 
explained; although interesting hypotheses have been developed. For example, bilinguals 
learn to engage the context-appropriate language (Bialystok, Anderson, & Grundy, 2018) 
while inhibiting the context-inappropriate language without considerable effort (Calabria, 
Costa, Green, & Abutalebi, 2018; Kroll et al., 2014). While certain cognitive processes (e.g. 
adopting novel strategies and developing a routine through extensive practice in language 
selection) could alleviate the cognitive load arising from this linguistic conflict, bilinguals 
may still experience a higher cognitive load needed to resolve the struggle arising from the 
linguistic conflict (Calabria et al., 2018; Costa & Sebastián-Gallés, 2014). Therefore, we 
could expect the resultant increase in cognitive load to affect frontostriatal and frontoparietal 
circuits, which interestingly tend to be more structurally and functionally developed in 
bilinguals than in monolinguals (Li, Legault, & Litcofsky, 2014). For example, bilinguals had 
more grey matter in the parietal lobe (Abutalebi et al., 2015) and in the left anterior temporal 




cognitive impairment. Because other CR-related factors had been held constant, differences 
in the brain were attributed to bilingualism. Also, higher proficiency in the second language 
positively correlated with brain volume in the left anterior temporal lobe (Abutalebi et al., 
2014). Moreover, despite similar performance in executive functioning, older bilinguals did 
not show the canonical posterior-anterior shift in aging in brain activity (Ansaldo et al., 2015) 
that has been associated with brain degeneration (PASA, Davis, Dennis, Daselaar, Fleck, & 
Cabeza, 2007). More specifically, bilinguals did not recruit prefrontal cortex as much as 
monolinguals, but instead showed higher activity in the posterior parietal cortex.  
Conveniently, the language-related brain regions meeting higher demands in 
bilinguals vs. monolinguals are also responsible for both verbal and non-verbal executive 
functions (Abutalebi & Green, 2007; Garbin et al., 2010; Prior & Gollan, 2011). Both 
language processing and executive functions emerge from the interaction of complex brain 
networks that are highly dependent on one another (Salmi, Nyberg, & Laine, 2018). For 
example, while the prefrontal cortex plays a key role in several executive functions, parietal 
regions (e.g. inferior parietal lobule) are likely also important in tasks assessing updating in 
the domain of executive functions (Collette et al., 2007). Given that frontostriatal and 
frontoparietal circuits also responsible for processes involving executive functions, the 
constant monitoring of each language in bilinguals may indirectly enhance executive 
functions (Bialystok, Anderson, & Grundy, 2018). Indeed, there is some evidence that older 
bilinguals outperform monolinguals in conflict resolution (Bialystok & Craik, 2010), 
although this relationship may not be observed in younger bilinguals (Lehtonen et al. 2018).  
Whether bilingualism can promote neuroplasticity and enhance CR is, however, still 
highly controversial. While others clearly argue for the benefits of bilingualism (Gold 2015; 
Grundy, Anderson, & Bialystok, 2017), there are several others who disagree (García-Pentón 




reviews on the bilingual brain in healthy aging and dementia have not been systematic nor 
have pulled together the vast array of neuroimaging methods (García-Pentón et al., 2016a 
2016b; Grundy, Anderson, & Bialystok, 2017). Moreover, while some argue that findings in 
this field are largely consistent (Grundy, Anderson, & Bialystok, 2017), studies have 
produced mixed findings with some showing that bilingualism might be related to changes in 
frontostriatal and frontoparietal circuits as already mentioned and others showing no such 
relationship (García-Pentón, Fernández García, Costello, Duñabeitia, & Carreiras, 2016a, 
2016b; Gold, Johnson, & Powell, 2013; Li, Legault & Litcofsky, 2014; Olsen et al., 2015). In 
particular, no previous review has systematically explored how the observed differences in 
frontostriatal and frontoparietal circuits among bilinguals may translate into protective effects 
against dementia. Also, small sample sizes as well as varying methods used in measuring 
bilingualism and brain functions may partially explain the variability in study outcomes 
(García-Pentón et al., 2016a, 2016b; Gold, Johnson, et al., 2013; Olsen et al., 2015). As such, 
findings from single studies need to be interpreted with circumspection, and the available 
evidence should be systematically reviewed (Bialystok, Anderson, & Grundy, 2018).  
 
Objectives  
There is some evidence linking bilingualism to differences in grey matter density in both 
whole brain and regional white matter integrity across the lifespan (Li, Legault & Litcofsky, 
2014). Others have identified candidate systems linked to bilingualism including the inferior 
parietal cortex (Age of Acquisition, AoA and proficiency of the second language or L2), 
temporal pole (L2 picture naming), anterior cingulate gyrus (conflict monitoring), inferior 
prefrontal cortex (AoA), caudate nucleus (language switching), and cerebellum (procedural 
memory; Li, Legault & Litcofsky, 2014). It is plausible that the brain areas linked with 




dementia, and development of these areas in the bilingual brain may directly promote 
resilience against dementia. In this case, the brain areas that are distinct for bilinguals with 
dementia would be expected to be similar to those in bilinguals at other age groups and no 
signs of differential development of dementia would be observed. Alternatively, bilinguals 
might use other brain areas to compensate for degeneration of dementia-affected regions. 
Therefore, we could expect bilinguals to demonstrate differences in frontostriatal and 
frontoparietal circuits compared to monolinguals in health cohorts. By extension, these 
differences should be reflected in the way these brain circuits cope with advancing 
neuropathology in bilinguals with dementia; for example, by showing a greater degree of 
neuropathology in age- and performance-matched bilinguals compared to monolinguals.  
To clarify the existing evidence in terms of these two alternatives, we systematically 
reviewed i) the structural and functional brain differences between mono- and bilinguals in 
non-clinical older individuals, and ii) differences in brain pathology between older mono- and 
bilinguals with dementia. Despite the considerable variability of the brain imaging methods 
used in the prior studies (see Methods section and Table 2), brain mapping allowed us to 
condense the data from a heterogeneous pool of studies onto a single brain map. Actually, 
multiple different neural indices associated with bilingualism in dementia could even be 
considered as stronger evidence than replication of the findings with one particular approach. 
Without a replicable pattern of brain abnormality linked to a specific bilingualism- or 
dementia-related brain system, it would be difficult to determine the mechanism that might 
mediate the potential bilingual advantage in dementia. Because the previous review pulling 
together the data on bilingual brain in healthy aging was published was not systematic, did 
not include individuals with dementia, and since its publication (Li, Legault & Litcofsky, 




exploring the link between bilingualism and the brain in healthy participants and those 
diagnosed with dementia.  
Therefore, we hypothesized that i) bilinguals would demonstrate more structurally 
developed frontostriatal and frontoparietal circuits than monolinguals in healthy cohorts and 
that ii) bilinguals would demonstrate greater neuropathology than monolinguals at the time of 
dementia diagnosis in the same brain circuits. We also hypothesized that iii) bilinguals would 
demonstrate more efficient functional use of relevant brain regions than monolinguals in 
healthy cohorts and that iiii) this more efficient use of brain resources would translate into 




This systematic review accords with the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses Statement (PRISMA; Moher, Liberati, Tetzlaff, Altman, & Group, 2009). 
Eligible studies had to compare monolingual vs. bilingual participants on functional or 
structural neuroimaging outcomes. We retrieved studies that mentioned having recruited 
mono- and bilinguals. We did not apply a specific definition of mono- and bilingualism. We 
included participants with mild cognitive impairment (diagnosed by standardized measures), 
dementia of all causes (diagnosed by standardized measures), any neuroimaging methods 
assessing brain morphology, biomarkers (tangles/plaques), or functional or structural changes 
using Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), 
Functional Magnetic Resonance Imaging (fMRI), or Diffusion Tensor Imaging (DTI) and 
participants with a mean age of 60 years or above as well as articles in any language. We 




impairment or dementia. We also excluded studies without neuroimaging measures and those 
that did not compare monolinguals to bilinguals/multilinguals. Finally, we excluded 
editorials, commentaries, case reports, and studies that had not been peer-reviewed. We did 
not place restrictions of the year of publication.  
One author initially searched for studies without any resection on the type of study 
design in PubMed, Embase, Web of Science, Scopus, and PsychINFO. Filters were used to 
exclude animal studies, but no restrictions were placed on time and language. The initial 
search was performed on the 31st of January 2018. Screening for title and abstract as well as 
full-text, data extraction, and risk of bias were conducted independently by pairs of review 
authors (S.B and B.S.). Disagreements were resolved through consensus and discussion with 
a third review author when necessary. We requested further information from corresponding 
authors when necessary. Specifically, because some primary studies did not report the 
coordinate data to accurately locate the brain regions differentiating the demented bilinguals 
from healthy ones in a standard brain atlas, we contacted authors to retrieve such coordinates. 
However, authors either did not respond or did not have the specific coordinate data we 
needed. Details of the protocol for this systematic review were registered a priori on 
PROSPERO (CRD42017026839).   
 
Data extraction and risk of bias 
We extracted demographic data including sample size, percentage of female participants, 
mean age per group, degree of cognitive impairment, and mean level of education (Tables 1 
and 2). Participants were considered cognitively healthy if they had not received a diagnosis 
of any dementia type. For studies in participants with dementia, we also extracted data on the 
type of dementia and the tools used to diagnose dementia and to assess the degree of 




Newcastle-Ottawa Scale (NOS) for cross-sectional studies (Wells et al., 2015). The NOS 
allows to assign a total of 10 stars to each study on three domains: selection of study groups 
(range 0–5), comparability of study groups (range 0–2), and exposure/outcome ascertainment 
(range 0–3). 
 
Data analysis and synthesis 
The primary outcomes included brain structure and function such as differences in brain 
volume and regions of interest as well as surrogates of dementia neuropathology such as 
accumulation of beta amyloid. All studies reporting information about the affected brain 
areas were included to brain maps illustrating the key results (Figure 2). In addition, we 
performed a separate activation likelihood estimation (ALE) based analysis for the studies 
that reported coordinate data. ALE was performed with GingerALE software (version 2.3.6, 
www.brainmap.org, Eickhoff et al., 2009; Turkeltaub et al., 2012). This software models 
coordinate data as spatially smoothed 3D Gaussian probability distributions capturing the 
uncertainty associated with each locus. ALE values were calculated by the voxel-wise union 
of the probabilities in the modeled activation maps. ALE maps were thresholded at corrected 
p < 0.05 (cluster level p < 0.05, clusters defined through 100 permutations).  
 
Results 
Overview of the included studies 
We retrieved a total of 17 studies including cross-sectional studies with a non-clinical 
population and studies with a clinical population. The total number of participants was 715 
individuals including 468 healthy older adults (234 monolinguals and 234 bilinguals) and 247 





Studies including healthy participants  
There were 12 studies that included healthy older individuals (Table 1). To measure 
bilingualism, some authors administrated validated language questionnaires (Anderson et al., 
2018; Ansaldo, Ghazi-Saidi, & Adrover-Roig, 2015; Berroir et al., 2017; Borsa et al., 2018), 
while in some studies it was unclear whether questionnaire or self-reporting measures were 
validated tools (Abutalebi, Canini, Della Rosa, Green, & Weekes, 2015; Abutalebi et al., 
2014; Abutalebi, Guidi, et al., 2015). Some studies also used a picture-naming task including 
the Snodgrass and Vanderwart’s picture set to assess bilingualism (Abutalebi, Canini, et al., 
2015; Abutalebi et al., 2014; Abutalebi, Guidi, et al., 2015; Borsa et al., 2018). Most studies 
also reported data on the age of second language acquisition which ranged from 10 years old 
or younger to 18 years of age (Abutalebi, Canini, et al., 2015; Abutalebi et al., 2014; 
Anderson et al., 2018; Berroir et al., 2017; Gold, Johnson, et al., 2013; Gold, Kim, Johnson, 
Kryscio, & Smith, 2013; Grady, Luk, Craik, & Bialystok, 2015; Luk et al., 2011; Olsen et al., 
2015).  
There were nine studies that employed structural neuroimaging including MRI which 
used techniques such as VBM and DTI (Abutalebi, Canini, et al., 2015; Abutalebi et al., 
2014; Abutalebi, Guidi, et al., 2015; Anderson et al., 2018; Borsa et al., 2018; Gold, Johnson, 
et al., 2013; Gold, Kim, et al., 2013; Luk et al., 2011; Olsen et al., 2015). There were five 
studies that employed functional neuroimaging including functional fMRI (Ansaldo et al., 







Table 1       
Cross-sectional studies on the relationship between bilingualism and brain structure/function in healthy older individuals using neuroimaging methods 
 Study characteristics Results 
Study n/group (% of females); M age (SD); 
MMSE/MMSE short/MoCA; M education 
(SD) 
 








30 (53%); 61.85 (6.71); 28.81 (0.95); 12.33 
(4.54) 
BL 
30 (57%); 63.2 (5.86); 28.77 (0.78); 13.45 
(4.8) 
Self-report of daily exposure, picture naming task (revised version 
of the Snodgrass and Vanderwart’s picture set): L1: 80%, L2: 61%   
 18.27 (13.2) 
 
Structural (MRI - 
VBM) 
 
No correlation between GMV and age in either group in left inferior parietal lobule 
Negative correlation between GMV and age in right inferior parietal lobule for ML only 





19 (53%); 60.93 (5.81); 28.95 (1.03); 13.16 
(4.86) 
BL 
19 (58%); 61.68 (5.34); 28.63 (0.9); 13.76 
(3.98) 
ML 
L1 naming (% accuracy): 99 (0.01) 
12.68 (10.71) 
BL 
Translation task (% accuracy): 52.47 (10.07); L1 naming (% 
accuracy): 82% (1.0) L2 naming (% accuracy): 66 (1.0); Exposure 
(hrs/day): 2.92 (3.40)  
 
Structural (MRI - 
VBM) 
 
Negative correlation between age and GMV for all participants  
 GMV in dorsolateral prefrontal cortex correlated with increased conflict effects in ML only  






23 (57%); 61.92 (6.80); 28.74 (0.92); 12 
(4.41) 
BL 
 23 (61%); 62.17 (5.36); 28.91 (0.67); 13.87 
(5.25) 
Picture naming (revised version of the Snodgrass and Vanderwart’s 




Structural (MRI - 
VBM) 
 
↑ GMV in BL compared to ML in left temporal pole, right temporal pole, and left/right 
orbitofrontal region 
Positive correlation between ↑ GMV in left temporal pole and second language naming 
performance 





23 (74%); 74.43 (2.95); 29.26 (0.86); 3.96 
(0.98) 
BL 
23 (65%); 74.09 (4.28); 29.43 (0.66); 4.13 
(0.76) 
(Matched sample data reported) 
 




Structural (DTI) ↑ AD in BL compared to ML in the left superior temporal longitudinal fasciculus, bilateral 
superior posterior corona radiata, right external capsule, corpus callosum, and anterior inferior 
frontal occipital fasciculus 
↑ RD in nearly all white matter brain regions in BL compared to ML, however this effect 
disappeared when the sample was matched   
↑ FA in the internal capsule, the anterior corpus callosum, the corona radiata and the inferior 
and superior longitudinal fasciculi in BL compared to ML, however this effect disappeared 





 10 (N/A); 74.5 (7.1); 27.7 (1.1); 16.1 (3.28) 
BL  






(During the Simon 
task) 
ML had ↑ activation in the right middle frontal gyrus compared to BL while completing the 
Simon task 
BL had ↑ activation in the left inferior parietal lobule compared to ML while completing the 
Simon task 
Berroir 2017 ML 
10 (60%); 74.5 (7.1); MoCA: 27.7 (1.2); 16.1 
(3.28) 
BL 
 10 (60%); 74.2 (5.2); 27.5 (1.6); 17.2 (3.1) 
 
LEAP 
 16.7 (8.5) 
Functional (fMRI)  
 
Results were recorded during the Simon task 
↑ connectivity in BL compared to ML in left inferior temporal sulcus  
↑ connectivity in ML compared to BL in left superior frontal gyrus, left lateral orbital sulcus, 
right inferior opercular frontal gyrus, right medial lingual occipito-temporal gyrus and the 
right parieto-occipital sulcus  
 
Borsa 2018  ML 
20 (55%); 61.46 (7.26); 29 (0.94); 13.10 
(4.17) 
BL 
20 (60%); 63.70 (7.17); 29.4 (0.83); 13.65 
(4.17) 
LBQ and picture naming task (revised version of the Snodgrass and 
Vanderwart’s picture set) 
N/A 
Structural (MRI) No difference between BL and ML in mean GMV  
 mean GMV in ACC predictive of  cognitive control in BL but not ML 
Age negatively correlated with cognitive control in ML but not BL  
 daily exposure to L2 correlated with  GMV in the ACC and  cognitive control  
Negative correlation between age and GMV for ML in inferior frontal gyri, insula and inferior 
parietal lobule  
Negative correlation between age and GMV for BL in left inferior parietal gyrus, inferior 
parietal lobule, insula and caudate  





BL: Negative correlation between GMV and cognitive control except in the left and right 
caudate  
 
Gold 2013a  ML 
20 (50%); 64.4 (5.1); 28.2 (1.6); 17.5 (2.6) 
BL 
20 (50%); 63.9 (4.0); 27.8 (1.2); 17.4 (2.2) 
Language questionnaire  
AoA: 10 years or younger 
Structural (MRI -
VBM and DTI)  
DTI 
 FA in BL compared to ML in inferior longitudinal fasciculus, inferior fronto-occipital 
fasciculus, fornix and corpus callosum 
↑ RD in BL compared to ML in inferior fronto-occipital fasciculus, corpus callosum and 
parietal and frontal lobes  
No differences between ML and BL in AD or MD in any ROIs (inferior longitudinal 
fasciculus, inferior fronto-occipital fasciculus, the fornix and corpus callosum) 
VBM 
No differences in ROIs in either direction for both ML and BL  
 
Gold 2013b  ML  
15 (53%); 63.3 (3.8); N/A; 17.5 (2.6) 
BL 
15 (53%); 64.1 (4.4); N/A; 17.4 (2.2) 
Language questionnaire  




(MRI - VBM)  
fMRI  
All measured while completing task switching 
No main effects of language group 
 switching costs for BL compared to ML in left dorsolateral prefrontal cortex, left 
ventrolateral prefrontal cortex, and ACC 
↑ activation in left middle temporal gyrus in BL compared to ML  
BL had  activation in left DLPFC, left VLPFC, and ACC but better performance on task 
switching when compared to ML   
VBM 
No group differences in either direction for any ROIs (Left DLPFC; Left VLPFC; Right 
DLPFC; Right VLPFC; ACC; Left SMG; Right SMG) 
 
Grady 2015 ML 
 14 (50%); 70.6; MMSE short form: 16.9 
(NA); 16 (NA) 
BL 
14 (57%); 70.3; MMSE short form: 17.0 
(NA); 17.7 (NA) 
 
Self-report (non-validated) 
AoA < 12 years 
Functional (fMRI) 
(Resting and during 
Simon Task)  
BL had stronger connections compared to ML in default mode network and frontoparietal 
control network  
BL had stronger correlations compared to ML between executive control connectivity and task 
modulation ability  
Stronger frontoparietal control network connectivity in BL associated with task related 
increases in frontal and parietal cortices    
Luk 2011 ML 
14 (50%); N/A; MMSE short form: 16.9 (0.4); 
16 (2.8) 
BL 
14 (57%); N/A; MMSE short form: 17 (0); 
17.7 (2.1) 
Whole sample age: 70.5 (3) 
Self-report 
AoA < 12 years 
Structural (DTI) ↑ FA and RA in corpus callosum in BL compared to ML  
↑ FA in BL compared to ML in right inferior frontal gyrus   
No group differences in AD for ML and BL  
BL had stronger functional connectivity between inferior frontal gyri and posterior brain 
regions compared to ML 
ML had stronger connections between inferior frontal gyri and anterior regions compared to 
BL 
 
Olsen 2015 ML 
14 (50%); 70.6 (3); MMSE short form: 16.9 
(0.4); 16.0 (2.8) 
BL 
14 (57%); 70.4 (3.7); MMSE short form: 16.9 
(0.3); 17.8 (2.0) 
Self-report 
AoA < 12 years 
Structural (MRI)  No significant differences between BL and ML in GMV and WMV across the whole brain  
BL had ↑ WMV in frontal and temporal lobe compared to ML  
Negative relationship between temporal pole thickness and age for ML but not BL 
ACC: anterior cingulate cortex; AD: axial diffusivity; ML: monolinguals; BL: bilinguals; DLPFC: dorsolateral prefrontal cortex; DTI: diffusion tensor imaging; FA: fractional anisotropy; fMRI: functional magnetic resonance imaging; GMV: grey matter volume; 
LBQ: language background questionnaire; LEAP: Language Experience and Proficiency Questionnaire; LSBQ: Language and social background questionnaire; L1: 1st language; L2: 2nd language; MD: mean diffusivity; MMSE: mini-mental state examination; 
MoCA: Montreal Cognitive Assessment; MRI: magnetic resonance imaging; RD: radial diffusivity; ROI: region of interest; SMG: supramarginal gyrus; VBM: voxel-based morphometry; VLPFC: ventrolateral prefrontal cortex; WMV: white matter volume; : 





Grey matter differences in healthy bilinguals vs. monolinguals  
Some studies (k = 3) found significantly greater GMV in bilingualism vs. monolinguals 
(Abutalebi et al., 2015a; Abutalebi et al., 2015b; Abutalebi et al., 2014), particularly in the in 
left and right inferior parietal lobules (Abutalebi et al., 2015a), anterior cingulate cortex 
(Abutalebi et al., 2015b), left temporal pole, right temporal pole, and left/right orbitofrontal 
cortex (Abutalebi et al., 2014). However, other studies (k = 2) did not find differences in 
overall lower GMV (Abutalebi et al., 2014) or mean GMV (Borsa et al., 2018) between 
mono- and bilinguals. Moreover, one study found that decrease in grey matter volume in the 
dorsolateral prefrontal cortex was associated with a greater conflict effect in the Erikson 
Flanker task, which measures a participant’s ability to suppress inappropriate responses 
within a certain context, in monolinguals only (Abutalebi et al., 2015b). Similarly, another 
study found that a decrease in GMV in the inferior parietal lobule (IPL) was associated with 
greater age in monolinguals only, but bilinguals showed greater GMV in the left IPL 
compared to monolinguals (Abutalebi et al., 2015a). Another study found a significant and 
positive correlation between greater GMV in left temporal pole and performance in a task 
assessing second language naming (Abutalebi et al., 2014). A study found that daily exposure 
to a second language was associated with lower GMV in the anterior cingulate cortex (Borsa 
et al., 2008). The same study also found that age was negatively associated with GMV in the 
inferior frontal gyri, insula and inferior parietal lobule in monolinguals and in the in left 
inferior parietal gyrus, inferior parietal lobule, insula, and caudate in bilinguals (Borsa et al., 
2008).  
White matter differences between mono- and bilinguals in healthy participants  
Some studies (k = 3) applied DTI to investigate differences in WM integrity between mono- 
and bilinguals (Anderson et al., 2018; Gold et al., 2013a; Luk et al., 2011). Table 1 includes 




compared to monolinguals across different WM regions (Anderson et al., 2018). They did not 
find significant differences between mono- and bilinguals in radial diffusivity and fractional 
anisotropy in several WM regions after matching participants across verbal as well as spatial 
intelligence quotient, Trail-Making-Task, MMSE scores, age, education, and gender 
(Anderson et al., 2018). Another study found lower fractional anisotropy in bilinguals vs. 
monolinguals but greater radial diffusivity across different WM regions as well as no 
significant differences in axial mean diffusivity in several WM regions of interest (Gold et 
al., 2013a). Finally, one study found significantly greater WM integrity particularly in the 
corpus callosum and in the superior and inferior longitudinal fasciculi lifelong bilinguals vs. 
monolinguals (Luk et al., 2011). Monolinguals however showed stronger connections in other 
brain regions; there we also no significant differences in axial diffusivity between mono- and 
bilinguals (Luk et al., 2011).  
 
Brain activity in healthy bilinguals vs. monolinguals 
Some studies (k = 4) used functional neuroimaging methods (see Table 1 for details on these 
methods). Details of the specific brain regions and cognitive tasks used during functional 
neuroimaging are presented in Table 1. Results suggested that bilinguals vs. monolinguals 
showed greater activation of the left IPL and monolinguals vs. bilinguals showed greater 
activation of the right middle frontal gyrus during The Simon task (Ansaldo et al., 2015). One 
study found that to resolve conflict in the Simon task, monolinguals compared to bilinguals 
showed greater connectivity in brain regions responsible for executive functions and 
interference control as well as motor and visual processing (Berroir et al., 2017). Bilinguals 
compared to monolinguals showed greater connectivity in one brain region responsible for 
visuospatial processing (Berroir et al., 2017). Bilinguals showed greater performance in 




activation across the left lateral frontal cortex and cingulate cortex (Gold et al., 2013b). See 
Table 1 for specific brain regions. Finally, one study found that bilingualism showed a 
stronger correlation between frontoparietal control network and greater task-related activity 
in the prefrontal and parietal brain areas (Grady et al., 2015). Furthermore, bilinguals 
compared to monolinguals showed greater intrinsic functional connectivity in the 
frontoparietal control network and default mode network (Grady et al., 2015).  
 
Studies including participants with mild cognitive impairment and AD 
We retrieved four studies which included participants with Mild Cognitive Impairment (MCI) 
or dementia (Table 2). These studies used different methods assessing bilingualism including 
a single verbal question (e.g. whether a participant can speak a second language; Duncan et 
al., 2018) a validated questionnaire (Perani et al., 2017), and language status interview for the 
participant and significant other (Schweizer et al., 2012). One study did not report the 
bilingualism measure (Kowoll et al., 2016). With regards to the neuroimaging methods, 
studies used MRI to measure cortical thickness and tissue density (Duncan et al., 2018), two 
studies used [18F]-fluorodeoxyglucose PET (FDG-PET) to measure cerebral glucose 
metabolism (Kowoll et al., 2016; Perani et al., 2017), and one study used Computed 
Tomography (CT) to measure brain atrophy (Schweizer et al., 2012). Participants’ diagnoses 
included MCI or AD (Duncan et al., 2018; Kowoll et al., 2016) and probable AD (Perani et 
al., 2017; Schweizer et al., 2012).  
 
Grey matter differences between mono- and bilinguals with dementia 
One study detected significantly thicker cortex and more grey matter density in multilinguals 
compared to monolinguals across language and cognitive control brain areas (see Table 2 for 




greater gray matter density in brain areas typically affected by AD (see Table 2 for each brain 
region; Duncan et al., 2018). While another study did not detect significant differences 
between mono- and bilinguals in cortical thickness across some brain regions (see Table 2 for 
each brain region), bilinguals showed significantly greater cortical thickness than 
monolinguals in brain areas typically affected by AD (Schweizer et al., 2012). Additional 



















Table 2        
Cross-sectional studies on the relationship between bilingualism and brain pathology in older clinical populations using neuroimaging methods  
 Study characteristics Results 
Study n/group (% of 
females); M age 
(SD) 
Immigration status (n, %) 
M education level (SD) 
 
Language measure; # of languages; L2 AoA 
 
Dementia dx/type; M MMSE 
(SD) scores at scan 




ML: 34, (50%), 
73.6 (SE 0.9) 
MLT: 34, (44%), 
73.7 (SE 1.0) 
 
AD 
ML: 13, (62%), 
78.5 (SE 1.5) 
MLT: 13, (23%), 
78.0 (SE 1.5) 
MCI 
ML: 7, 21%, 12.5 (SE0.7) 




ML: 8, 62%, 12.7 (SE 1.0) 
BL: 3, 25%, 12.1 (SE 1.1) 
Interview 
Two or more languages 
~ half spoke two languages (BL) 
~ half spoke three or more (MLT) 
aMCI or aMCI+, AD 
NINCDS-ADRDA 
ML: 22.5 (SE 0.9) 




 Cortical thickness analysis & voxel-based morphometry 
 
Language and cognitive control  
↑ CT for MLT in all language and cognitive control areas (p < 0.026 
uncorrected for multiple comparisons) LIFG, RIFG, LATG, RATG, 
LIPL, LC, RC,  RCT, LSG, RSG 
↑ CT for MLT in the right inferior front gyrus, right ventromedial 
prefrontal cortex, right cerebellum, and right cerebellar tonsil after 
adjusting for Family-wise Type I error 
 
Disease-related  
↑ grey matter tissues density in MLT collapsed across MCI and AD in 
left and right hippocampi even after adjusting for multiple comparison  
Kowoll 2016 ML: 14, (57%), 
71.6 (7.9) 
BL: 14, (50%), 74.6 
(6.8) 
ML: 2, (14%), 11.7 (3.7) 
BL: 12, (86%), 15.3 (3.6) 
N/A 
19 participants were BL 






ML: 23.9 (3.1) 




 Sig.  in FDG uptake in BL vs. ML in right & left frontal, 
temporal/parietal cortices, & left cerebellum 
 
Perani 2017 ML: 40, (52.5%), 
71.42 (4.88) 
BL: 45, (71%), 
77.13 (4.52) 
N/A 
ML: 10.5 (4.07) 
BL: 8.26 (4.55) 
Questionnaire derived from the Bilingual 
Aphasia Test; 
the bilingualism index ranging from 0 
(completely ML) to 1 (completely BL) was 
obtained for each participant 
Probable AD 
NIA-AA 
ML: 21.10 (4.84) 
BL: 22.4 (4.19) 
Functional 
(FDG-PET) 
 Network for executive control 
↑ long-distance (anterior-posterior) metabolic connectivity in parietal and 
dorsolateral prefrontal cortex in BL compared to ML 
↑ connectivity in superior parietal cortices for BL only 
↑ connectivity in the bilateral caudate nucleus for BL only 
 
Default mode network 
Sig. metabolic correlations within posterior cingulum/precuneus in ML 
& BL 
Sig. metabolic correlations within the cingulate cortex, orbitofrontal 
cortex, caudate nucleus, & thalamus, bilaterally in BL only 
Sig. metabolic connectivity between frontal regions posterior cingulum 




ML: 20, (70%), 
77.2 (7) 
BL: 20, (70%), 78.9 
(7.6) 
N/A 
ML: 13.6 (3.5) 
BL: 11.6 (4.5) 




 Cortical volume ratios 
NS difference in bicaudate ration, Huckman’s number, Evans ratio, 
suprasellar cistern ratio between ML & BL 
Sig. ↑ in temporal horn ratio and 3rd ventricle ratio measures in BL vs. 
ML  
Sig. ↑ radial width of the temporal horn in BL vs. ML 
MCI paper        
AACD: aging-associated cognitive decline criteria; AD: Alzheimer’s disease; aMCI: amnestic mild cognitive impairment; BD: block design; BL: bilinguals; BNA: behavioural neurology assessment; CDR: clinical dementia rating; CDT: clock drawing test; 
CERAD-NP: consortium to establish a registry for Alzheimer's disease neuropsychological assessment battery; CT: cortical thickness; CT* computed tomography; DRVR: delayed recall visual reproduction; FDG-PET: fluorodeoxyglucose positron emission 
tomography; GDS: geriatric depression scale; GDS*: Global Deterioration Scale; IRVR: immediate recall visual reproduction; LDVR: long delay verbal recall; LP: language production; L2 AoA: 2nd language age of acquisition; M: mean; MCI: mild cognitive 
impairment; ML: monolinguals; MLT: multilinguals; MMSE: mini-mental state examination; MRI: magnetic resonance imaging; N/A: not available; NIA-AA: National Institute on Aging and Alzheimer's Association; NINCDS-ADRDA: National Institute of 
Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association; NS: non-significant; SCW: Stroop Colour Words; SD: standard deviation; SDVR: short delay verbal recall; SE: standard error; SI: Stroop 
Interference; SST: spatial span total; TMT: trail making test; VLTM: verbal long-term memory; VSSTM: visuospatial short-term  memory; VSTM: verbal short-term memory; WMS-R: Wechsler memory scale revised; (LIFG) Left inferior frontal gyrus; (RIFG) 
Right inferior frontal gyrus; (LATG) Left anterior temporal gyrus; (RATG) Right anterior temporal gyrus;(LIPL) Left inferior parietal lobule; (LC) Left cerebellum; (RC) Right cerebellum; (RCT) Right cerebellar tonsil; (LSG) Left supramarginal gyrus; (RSG) 




Brain physiological function between mono- and bilinguals with dementia  
In one study, bilinguals showed significantly lower glucose uptake as measured by [18F]-
fluorodeoxyglucose, which is a surrogate of neurodegeneration, across brain areas 
responsible for speech, language, and areas typically affected by AD such as frontotemporal 
and parietal areas including Brocas’ areas 9 (right), 21 (right), 40 (right and left), and 47 (left) 
(Kowoll et al., 2016). In the other study, cerebral hypometabolism was more severe in 
bilinguals vs. monolinguals in brain regions typically affected by AD (Perani et al., 2017).  
Regarding the executive control network, bilinguals showed greater metabolic connectivity in 
brain areas responsible for cognitive control and in default mode networks relative to 
monolinguals (Perani et al., 2017). Indeed, there was increased long-distance metabolic 
connectivity between the inferior and superior lobules, angular gyrus and the dorsolateral 
prefrontal cortex (Perani et al., 2017). Also, bilinguals but not monolinguals showed 
increased metabolic connectivity between the bilateral middle and superior frontal gyri with 
the superior parietal cortices (Perani et al., 2017). Increased metabolic connectivity was also 
observed between the bilateral caudate nucleus with the anterior, middle, and posterior 
cingulate cortex, the right insula, the right inferior frontal gyrus, and the right parietal 
operculum in bilinguals but not monolinguals (Perani et al., 2017). Regarding the dorsal 
default mode network there were significant metabolic autocorrelations within the posterior 
cingulum/precuneus in both cohorts but only bilinguals showed additional metabolic 
correlations within the cingulate cortex, the orbitofrontal cortex, the caudate nucleus, and the 
thalamus, bilaterally (Perani et al., 2017). Also, only the bilinguals showed significant 
correlation in the anterior default mode network between the anterior cingulate cortex and 
medial frontal cortex with the posterior cingulum (Perani et al., 2017). Additional study 







Figure 0.1 Brain map 
A summary of the regional effects in brain imaging studies in bilinguals vs. monolinguals without 
dementia (top) and bilingual advantage in dementia (bottom). The figure illustrates all regional effects 
reported in relevant studies (see Tables 1 and 2). The scale for the coloured circles represents the 
number of studies reporting significant group differences (bilinguals vs. monolinguals) in the 
respective brain regions. At the top image, the activation cluster at the left parietal cortex comes from 
an ALE analysis for the coordinate data (corrected p<0.05). To make this cluster visible, the centre of 
the circle illustrating the number of studies with significant effects for this particular brain region is 
empty. A) refers to maximal intracranial width, B) to temporal horn diameter, and C) to minimal 
intercaudate distance (Schweizer et al. 2012). Other indices reported by Schweizer et al. (2012) are 
not visualized in the image as they either do not reflect regional brain differences (width of the third 




Risk of bias  
Studies including non-clinical participants 
Results from risk of bias for non-clinical participants are presented in Table 3. All studies 
employed an acceptable sampling method, but no study reported power calculations. Most 
studies including non-clinical participants applied a validated measure of bilingualism while 
others either use a non-validated tool or did not provide specific information on how they had 
obtained data on bilingualism. For example, some studies applied validated measures of 
bilingualism while other studies only asked participants whether they could speak a second 
language. All studies controlled for important confounders either statistically or 
methodologically. We considered confounders to be important if previous literature identified 
them as confounders in the field of bilingualism research. All studies applied the appropriate 
statistical techniques including between-group statistical models. 
 
Studies including participant with dementia 
Results from risk of bias are for studies including participants with dementia are presented in 
Table 4. Every study employed an acceptable sampling method, but no study provided 
information of power calculation. While only one study adopted a validated questionnaire to 
measure bilingualism, another did not provide information on how bilingualism was 
measured, and another two studies used non-validated measures including interviews. Each 
study controlled for important covariates including degree of cognitive impairment, 






Our aim was to systematically review the literature exploring the relationship between 
bilingualism and the brain. We sought to clarify whether bilingualism is associated with 
differences in certain brain structures generally implicated in language processing and 
executive function in healthy individuals. We also sought to explore whether bilingualism 
was associated with differences in brain areas typically affected by AD in individuals with a 
diagnosis of AD. Previous behavioural evidence has shown that despite a similar degree of 
cognitive impairment, bilinguals vs. monolinguals were older at the time of dementia and AD 
diagnosis by up to five years, respectively (Bialystok, Craik, Binns, Ossher, & Freedman, 
2014; Bialystok, Craik, & Freedman, 2007). This evidence indicates that bilingualism 
contributes to CR allowing bilinguals to maintain functional cognition longer and delay 
clinical symptom onset (Gold, 2016). The executive control network might regulate the 
activation of multiple languages in the language network resulting in functional and structural 
changes in relevant brain areas (Green & Abutalebi, 2013). However, studies that investigate 
the underlying mechanisms responsible for the observed relationship between bilingualism 
and CR have not been previously systematically reviewed.  
 In the brain maps (Figure 1) we outlined several key brain regions implicated in 
bilingualism. While most studies did not find between-group differences in overall GMV, 
two studies showed that older healthy bilinguals vs. monolinguals demonstrated greater 
GMV, particularly in the inferior parietal lobule after matching participants for several CR-
related variables and cognition (Abutalebi et al., 2014; Abutalebi et al., 2015). However, the 
measure used for matching participants on cognition (Mini-Mental Status Examination) in 
these studies (Abutalebi et al., 2014; Abutalebi et al., 2015), lacks sensitivity in assessing 
cognition in healthy cohorts; therefore, similar scores on this measure does not signify 




studies assessing cognition more comprehensively (Olsen et al., 2015; Gold, Johnson, & 
Powell, 2013), there were no differences between older mono- and bilinguals in grey matter 
volume, questioning findings from others (Abutalebi et al., 2014; Abutalebi et al., 20 15).  
While our included studies did not always observe differences between mono- and 
bilinguals on global measures of grey matter, several studies consistently showed that 
bilinguals had greater volume in the inferior parietal lobule. Previous studies in young 
cognitively intact adults support our findings by showing that the inferior parietal lobule may 
be implicated in bilingualism (Li et al., 2014), particularly when the second language is learnt 
before the age of five years and the proficiency in speaking the second language is high 
(Mechelli et al., 2004). Also, while performance on a reaction time task was similar between 
mono- and bilinguals, when completing the task, monolinguals showed activation of the 
prefrontal cortex, which is responsible for cognitive control, and bilinguals showed activation 
of the inferior parietal lobule, which is responsible for language (Ansaldo et al., 2015).  
Moreover, one study found that multilinguals vs. monolinguals with MCI and AD 
matched for memory performance demonstrated greater cortical thickness in the left inferior 
parietal lobule (Duncan et al., 2018). Another study found greater cerebral glucose uptake in 
parietal brain regions in bilinguals vs. monolinguals after adjusting for disease severity 
(Kowoll et al., 2016). Another study using a more robust measure of bilingualism 
documented more severe glucose hypometabolism in the left inferior parietal lobule among 
bilinguals vs. monolinguals (Perani et al., 2017). The inferior parietal lobule is a brain region 
which is particularly vulnerable to aging and AD (Perani et al., 2017). Overall, our included 
studies indicate that bilingualism may promote neuroplasticity in the inferior parietal lobule 
and may protect against MCI and AD.  
Bilinguals also demonstrated greater WM connectivity compared to monolinguals 




monolinguals showed greater WM integrity projecting to the bilateral superior longitudinal 
fasciculi, the right fronto-occipital fasciculus, and the uncinate fasciculus (Luk et al., 2011). 
Also, WM connectivity was associated with resting-state functional connectivity in frontal 
areas which might indicate that lifelong bilingualism might have promoted changes in brain 
structure and function simultaneously (Luk et al., 2011). By contrast, in another study with a 
larger sample size, monolinguals, as opposed to bilinguals, showed greater WM integrity 
inferior and superior fronto-occipital fasciculi (Gold, Johnson, et al., 2013). More recently 
however, bilinguals vs. monolinguals matched on verbal and spatial IQ, age, education, Trail-
Making-Task performance, disease severity, and gender, showed greater WM integrity in the 
superior longitudinal fasciculus (Anderson et al., 2018).  
There are also alternative explanations for some of the observed relationships between 
bilingualism and structural and well as functional changes to relevant brain areas. For 
example, participants in the included studies might vary in factors associated with brain 
health and risk of dementia such as physical activity (Brini et al., 2018). Moreover, what 
“WM integrity” precisely means and its clinical relevance have been a point of contention 
and some have argued that its use should be discontinued (Jones, Knösche, & Turner, 2013). 
Finally, evidence gathered herein are all cross-sectional and therefore should only interpreted 
as hypothesis generating. More studies with longitudinal design need to be conducted before 
concluding that i) bilingualism modifies relevant brain regions and ii) that such changes in 
the brain carry any translational impact on the onset and risk of dementia. 
While our findings indicate that bilingualism may promote certain brain areas 
implicated in the neuropathology of AD, our findings need to be interpreted in light of 
clinical and methodological differences as well as limitations within studies. For example, 
lack of validated measures of bilingualism, particularly in studies including participants with 




multidimensional construct encompassing several factors such as frequency, proficiency, and 
age of acquisition. Therefore, bilingualism is likely not a dichotomous variable, rather it is a 
construct that extends on a continuum from monolingualism to bilingualism (ability to speak 
two languages) to multilingualism (ability to speak three or more languages) while including 
several dimensions (Luk & Bialystok, 2013). Some studies also did not collect data on age of 
acquisition. Moreover, some studies did not assess the extent to which monolinguals had 
been exposed to foreign languages or whether they spoke a dialect. This questions whether 
monolingual participants were in fact, truly monolinguals (Laine & Lehtonen, 2018). As 
such, future research should consider applying validated measures of bilingualism and as well 
as measure it on a continuum rather than dichotomizing participants between mono- and 
bilinguals (Luk & Bialystok, 2013). Future studies will also benefit from increasing sample 
sizes, particularly in light mixed findings in this field of research.  
Differences in sample size may have contributed to the conflicting findings in this 
field of research (García-Pentón et al., 2016a, 2016b). The average total sample size in 
studies with non-clinical and clinical populations was 18 (SD = 5.69) and 27.63 (SD = 12.09) 
participants, respectively. Small samples increase the probability of Type I and Type II error 
and inflate the estimated effect size thereby affecting precision (Ioannidis, 2005, 2008). 
Conflicting results from some of our included studies is not surprising considering that 
statistical power in the field of neuroscience is generally low ranging from approximately 8% 
to 31% (Button et al., 2013; however, see Bacchetti, 2013 for an opposing view on the 
importance of sample size in neuroscience). Interestingly, not one of our included studies 
reported power calculations. Also, in a field where studies have small samples such as in 
neuroscience, a non-significant finding may be less likely to be published resulting in 
publication bias (Button et al., 2013). While, we could not conduct formal statistical tests for 




Simonovits, 2014), neuroimaging research (Jennings & Van Horn, 2012), and bilingualism 
research (De Bruin, Treccani, & Della Sala, 2015). Therefore, it is a possibility that 
publication bias be found in the field of bilingualism neuroscience as well.  
In conclusion, the extant limited evidence indicates that several brain areas 
consistently appear to be implicated in bilingualism. Generally, bilingualism was linked with 
differences in affect frontostriatal and frontoparietal circuits, particularly in brain regions 
responsible for language and executive functions. This supports the hypothesis that changes 
to brain areas responsible for language including the temporoparietal lobes, may extend to 
brain areas implicated in cognitive control including the prefrontal cortex (Green & 
Abutalebi, 2013). These changes appear consistent across the lifespan and may promote 
neuroplasticity and protect against neurodegeneration. However, the included studies carried 
important limitations such as small sample sizes and poor measurement of both 
monolingualism and bilingualism. Also, in this field of research we could identify only a 
limited number of studies. As such, while the evidence appeared somewhat consistent and 
agrees with some studies in younger populations, when considering the limited number of 
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Between-chapter (4-5) rationale  
In Chapter 3, we observed that bilinguals experienced a later onset of AD symptoms than 
monolinguals. In Chapter 4 we also observed that bilinguals tend to show greater 
frontostriatal and frontoparietal circuits as well as greater white and grey matter than 
monolinguals in brain that are severely affected by AD. Taken together these findings suggest 
that bilingualism may render the brain more resilient against AD neuropathology and 
translate into a later onset of AD symptoms and diagnosis. However, in Chapter 3 and 4 four, 
participants were individuals with a diagnosis of dementia or AD and studies generally 
operationalised bilingualism as speaking two or more languages. None of the included studies 
had considered language acculturation as a variable that might be associated with cognition. 
Therefore, in the following chapter, we explored whether language acculturation was linked 

















Chapter 5 Language acculturation predicts cognitive 
performance in older Hispanic and Asian 
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Ethnic minorities living in the United States experience a higher incidence of dementia 
compared to their Caucasian counterparts. Therefore, identifying modifiable factors 
associated with cognitive health in seniors from ethnic minorities is an important public 
health priority. Acculturation may be one such factor. Although some studies have linked 
higher acculturation with better performance in verbal but not in non-verbal tasks, others 
have observed the opposite trend. Differences in the operationalization of acculturation and 
varying sample sizes (range: 50-503) may explain the mixed findings. Here, we explored the 
link between self-reported language use at home, one index of acculturation, and cognition in 
a larger sample (N = 890) of Hispanic and Asian participants living in the United States. This 
is the first study adopting language preference at home as a proxy for acculturation using a 
large representative sample of the civilian non-institutionalized United States population. We 
retrieved data from the National Health and Nutrition Examination Survey on self-reported 
language use at home, verbal fluency, psychomotor speed and memory performance, as well 
as demographic information. We replicated previous evidence by showing that higher level of 
acculturation predicted higher verbal fluency. However, contrary to previous evidence, we 
found that higher levels of acculturation also predicted higher psychomotor speed. In 
conclusion, language acculturation is an important factor contributing to cognitive health in 










Individuals from Hispanic and Asian backgrounds living in the United States experience 
poorer health when compared to their Caucasian counterparts (Mehta & Yeo, 2017; Vega, 
Rodriguez, & Gruskin, 2009). For example, the incidence of dementia, particularly among 
ethnic minorities, is significantly higher than among Caucasian Americans (Mehta & Yeo, 
2017). Given the projected increase in life expectancy (Kontis et al., 2017) and prevalence of 
dementia (Prince et al., 2013) in industrialized countries, identifying factors that can be 
modified to maintain cognitive health into old age has become a public health priority 
(Wortmann, 2012). Importantly however, research exploring the relationship between ethnic 
disparities and cognitive health is still lacking (Babulal et al., 2019). One factor linked with 
cognitive health among older individuals from ethnic minorities is acculturation (Lara, 
Gamboa, Kahramanian, Morales, & Hayes Bautista, 2005; Xu, Zhang, & Wu, 2017). This 
refers to the acquisition of certain cultural properties (e.g. language) of the recipient society 
(Lara et al., 2005).  
However, acculturation is a complex phenomenon including multiple cultural 
properties (Portes & Rumbaut, 2001; Zhou, 2014). Importantly, there is little consistency in 
the way researchers have measured acculturation. For example, years lived in a country, years 
lived and educated in a country and age at which the local language was first learned, or 
language spoken every day at home, have been commonly used to measure acculturation 
(Boone, Victor, Wen, Razani, & Pontón, 2007; Flores et al., 2017; Touradji, Manly, Jacobs, 
& Stern, 2001). Studies adopting language as a proxy for acculturation (Flores et al., 2017; 
Lara et al., 2005; Xu et al., 2017) have occasionally measured it with a language 
questionnaire (Coffey, Marmol, Schock, & Adams, 2005; Razani, Murcia, Tabares, & Wong, 
2007). In addition to the variability in the operationalization and measurement of 




cognition have generally included relatively small sample sizes ranging from 50 to 503 
participants (Arnold, Montgomery, Castañeda, & Longoria, 1994; Flores et al., 2017; Manly, 
Byrd, Touradji, & Stern, 2004; Touradji et al., 2001; Xu et al., 2017). Importantly, studies 
linking acculturation with cognition have produced mixed findings. 
For example, greater acculturation predicted higher performance in a verbal task 
among 87 foreigner-born non-Hispanic participants (Touradji et al., 2001). However, it is 
unclear if higher acculturation reflected a better command of English or greater cognitive 
performance (Lehtonen et al., 2018) because the language of the cognitive tasks was not 
reported (Touradji et al., 2001). Across different ethnic minorities (N range: 50-161), 
acculturation positively correlated and predicted scores on verbal tasks and executive 
functions (Boone et al., 2007; Coffey et al., 2005) but not non-verbal intelligence (Razani et 
al., 2007). Conversely, in 94 Hispanic-Spanish individuals living in the United States, and for 
whom tests were administered in Spanish, lower acculturation predicted lower attention and 
inhibition control while higher acculturation predicted higher working memory (Flores et al., 
2017). In a larger sample (N = 503) however, the effect size between acculturation and 
cognition diminished and became non-significant after multivariate adjustment of covariates 
(Manly et al., 2004). Recently, a systematic review linked acculturation with greater 
cognition in migrants, but the mechanism of this association remained unclear (Xu et al., 
2017). 
When language use is adopted as a proxy for acculturation, there is evidence showing 
that higher levels of acculturation (higher use of the local language) is associated with better 
health outcomes (Perez-Escamilla, 2010). This link may relate to individuals from ethnic 
minorities in the United States who reported greater use of English also having greater access 
to the healthcare system (Derose & Baker, 2000; Fiscella, Franks, Doescher, & Saver, 2002). 




cognition in older healthy individuals even after adjusting for multiple covariates (Kavé et al., 
2008; Padilla, Mendez, Jimenez, & Teng, 2016; Razani et al., 2007). Indeed, the phrase 
‘bilingual advantage’ is often used to refer to this association (Bialystok, 2017). There is also 
evidence indicating that language preference at home in ethnic minorities may be linked with 
cognition (Flores et al., 2017).  
Given the link between language and cognition, the small sample sizes in previous 
studies, and the equivocal results in the extant literature, it is timely to investigate the role of 
language acculturation with a larger and representative sample of the civilian non-
institutionalized United States population. As such, we hypothesized that participants who 
reported speaking English at home (high acculturation) would show greater verbal and non-
verbal skills compared to participants who reported speaking either their native language (low 




We used data from the National Health and Nutrition Examination Survey (NHANES), which 
is an ongoing survey that is conducted in the United States by the National Center for Health 
Statistics of the Centers for Disease Control and Prevention. The NHANES Survey Methods 
and Analytic Guidelines can be found here: 
https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx. We combined data from the 
2011-2012 and 2013-2014 cycles of the study. This study adopted a cross-sectional design. 
The predictor variable included language status with three levels: mostly non-English 
(reference group), both equally, and mostly English. The outcomes included psychomotor 




To identify individuals who are representative of the civilian non-institutionalized 
United States population, participants were selected through a complex stratified, multistage 
national probability sampling design. Individuals living in nursing homes, soldiers, 
institutionalized persons, or United States nationals living outside of the United States were 
excluded. Each sample person is given a sample weight. A sample weight reflects the number 
of individuals in the populations that are represented by that sample person in NHANES 
while taking into account unequal probability of selection, nonresponse adjustment, and 
adjustment to independent population controls. Also, the NHANES oversamples certain 
subgroups from within the population to increase reliability and precision of the outcome 
estimates. Therefore, to account for the complex sampling design and oversampling we 
created the appropriate weights.  
We retrieved data from the NHANES website on demographics, language status, and 
cognitive function. The cognitive tasks were administered only to participants aged 60 years 
and above; therefore, we restricted our analysis to this age group. While cognitive decline is 
present across most of an individual’s lifespan, the rate of decline accelerates from 
approximately the age 60 years onward in healthy individuals (Salthouse, 2009, 2019). The 
response rate for the years 2011-2014 in the unweighted interviewed sample ranged between 
64.4 and 65.6% for participants aged 60-69 years, 59.2 and 61.4% for those aged 70-79, and 
47.9 and 51.7% in participants aged 80 years and above. Ethics approval for the NHANES 
was given by the National Center for Health Statistics Research Ethics Review Board.  
 
Materials  
The NHANES provides a freely accessible dataset from which researchers can retrieve 
variables of interest. For this study, we retrieved three datasets from the NHANES website 




dataset we retrieved age, sex, education, country of birth, ethnicity, citizenship status, and 
annual family income. From the acculturation variables we retrieved information on the 
languages spoken at home for Hispanic and Asian participants. From the cognitive 
functioning dataset, we retrieved the Digit Symbol Substitution Test (DSST), Animal 
Fluency (AF), and the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) 
neuropsychological battery Word Learning (W-L) subtest. Participants could choose their 
preferred language for the cognitive testing. The languages from which they could choose 
included English, Spanish, Korean, Vietnamese, and Chinese.  
 
Demographics and covariates 
Age was recorded as the age in years at screening. Sex was a categorical variable in which 
participants reported being males or females. This variable was coded as male = 1 or female 
= 2. Therefore, the reference group for this variable was males.  
The variables education and annual family income included multiple categories and the 
number of participants within some categories was small. Therefore, to increase the number 
of participants in each category so as to increase statistical power, we collapsed several 
categories and created variables with fewer categories. Details of each category in the 
education and annual family income variables are explained below.  
To attain participants’ level of education, participants were asked “What is the highest 
grade or level of school completed or the highest degree {you have/s/he has} received?” with 
the choices being: “Less than 9th grade”, “9-11th grade (includes 12th grade with no 
diploma)”, “High school graduate/GED or equivalent”, “Some college or AA degree”, or 
“College graduate or above”. We collapsed the first three categories into a single category 
and the last two into one category to differentiate between participants whose highest levels 




We also retrieved data on country of birth with two levels: 1) born in 50 United States or 
Washington, District of Columbia; and 2) born in other countries, including United States 
territories. Therefore, country of birth was entered as a categorical variable.  
Participants were asked to report their annual family income by selecting one of the 
following categories: “$0 to $ 4,999”, “$ 5,000 to $ 9,999”, “$10,000 to $14,999”, “$15,000 
to $19,999”, “$20,000 to $24,999”, “$25,000 to $34,999”, “$35,000 to $44,999”, “$45,000 to 
$54,999”, “$55,000 to $64,999”, “$65,000 to $74,999”, “$20,000 and Over”, “Under 
$20,000”, “$75,000 to $99,999”, or “$100,000 and Over”. We collapsed categories to create 
three groups: i) between $0 and $24,999; ii) $25,000 and $64,999; and iii) over $65,000. We 
removed the category “$20,000 and Over” because it did not provide an upper limit. We 
chose these cut points because they provided the most even distributions of income.   
 
Language Acculturation  
At the home of participants, trained interviewers had used the Computer-Assisted Personal 
Interviewing system to ask participants questions about their language status. We retrieved 
two variables including information on language use at home for Mexican American, other 
Hispanic and non-Hispanic Asian participants. Those who self-identified as Mexican 
American, other Hispanic, or were asked to report what languages they use at home by 
selecting one of the following four options: only Spanish, more Spanish than English, both 
equally, more English than Spanish, or only English. For participants who self-identified as 
non-Hispanic Asian they were asked whether they spoke only a non-English language, more 
non-English than English, both equally, more English than non-English at home.  
 However, the acculturation variable includes questions about language use for 
Hispanic and Asian populations. Therefore, to increase the overall sample size for the 




and 2: non-Hispanic Asian) and collapsed the Only Spanish and More Spanish than English 
categories into one category named Mostly Spanish and collapsed More English than Spanish 
and Only English and created another category named Mostly English. We applied the same 
procedure for the non-Hispanic Asian variable. Therefore, this procedure allowed to increase 
sample size in each language category by generating three categories: mostly non-English, 
both equally, and mostly English.  
 
Digit Symbol Substitution Test (DSST) 
The DSST is a subscale of the Wechsler Adult Intelligence Scale (WAIS III) that measures 
processing speed, sustained attention, and working memory (Wechsler, 1981). In this test, 
participants are given a paper at the top of which there was a key including nine numbers 
coupled with symbols where participants were asked to copy the symbols in 133 boxes that 
match the numbers. Before starting the test, participants were instructed to complete one trial 
run and those who could not match the symbol with the number, did not participate in the 
main trial.  
 
Animal Fluency (AF) 
The AF is a test that measures categorical verbal fluency (Strauss, Sherman, & Spreen, 2006). 
In this test, participants were instructed to name as many animals as possible and for each 
correct animal they received one point. Before starting the test, participants were instructed to 
name three pieces of clothing as a practice trial. Those who were unable to name three items 





Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) neuropsychological 
battery Word Learning (W-L) 
The CERAD W-L is used to measure immediate and delayed learning ability of newly learnt 
information (Fillenbaum et al., 2008). This test included three consecutive trials and one 
delayed recall in which participants were instructed to learn 10 unrelated words. In the 
immediate learning condition, participants were presented the 10 unelated words and were 
asked to read them aloud one by one. At the end of each trial, participants were asked to 
recall as many words as they could. The sequence of the words was different in each trial. In 
each trial, participants could achieve a maximum score of 10 points. We calculated the 
summary score by adding the scores of each trial. Participants could achieve a maximum total 
score of 30 (i.e. 10 correct responses across the three trials). Higher scores indicate better 
learning performance. Participants completed the delayed learning condition after completing 
the DSST and AF tasks (8-10 minutes later). Also, data on the number of incorrect words that 




Data from the NHANES 2011-2012 and 2013-2014 cycles were used because these were the 
only NHANES cycles that included information on cognitive function. The primary objective 
was to explore whether language status was associated with cognitive function. To explore 
this question, we conducted a complete-case analysis using Multiple Linear Regression while 
adjusting for age, sex, education, annual family income, and country of birth. We identified 
participants for whom sufficient data on language status and cognitive function were 




conducted multiple imputation for each outcome and conducted Multiple Linear Regression 
using the imputed dataset. All data were analysed at an alpha level of .05 with STATA: Data 
Analysis and Statistical Software Version 15. Of note, STATA does not allow the analyst to 
calculate β values with the appropriate weights. Therefore, each β value was calculated 
without appropriate weights and, as such, does not necessarily reflect a precise estimation of 
the magnitude of each relationship. 
 
Results 
We analysed data from 890 Hispanic and Asian participants. The median age of the whole 
sample was 69 years. Participants’ demographic profiles are presented in Table 1. 
Table 1. Demographic characteristics of the analytic sample.  
Variable Acculturation  
Mostly non-
English 
Both equally Mostly English 






Sex 661 99 286 
Males  320 52 133 
Females 341 47 153 
Education  661 98 286 
Secondary  485 63 111 
Tertiary  176 35 175 
Country of birth  661 98 284 
Born in the US 24 45 168 
Born outside the US 637 53 116 
Ethnic origin  661 99 286 
Mexican American  172 46 116 
Other Hispanic 249 41 73 
Non-Hispanic Asian 240 12 97 
Citizenship status 657 95 284 
Citizen by birth/naturalization  434 90 265 
Not a citizen of the US 223 5 19 
Annual family income 576 94 258 
US$0 - $24,999 280 48 72 




over US$65,000 100 12 84 
SD: Standard deviation; US: United States 
 
We conducted the Multiple Linear Regression to test whether acculturation including 
covariates significantly predicted DSST, AF, and CERAD scores. The regression model was 
statistically significant (R2 = .42, F(7, 27) = 115.73, p < .001)  expanding 42% of the variance 
in DSST scores. Participants who reported speaking mostly English at home scored 5.57 
points higher (p = .002) in the DSST task compared to the Mostly non-English group 
(reference group; Table 2). The regression equation for the AF task was also statistically 
significant (R2 = .16, F(7, 27) = 17.00, p < .001), explaining 16% of the variance in AF 
scores. Here, participants who reported speaking both languages equally at home generated 
1.72 significantly (p = .006) fewer words relative to the reference group (Table 2). The 
regression model for the CERAD word learning (R2 = .21, F(8, 25) = 47.43, p < .001), 
delayed recall (R2 = .21, F(8, 25) = 78.53, p < .001), and intrusion (R2 = .04, F(8, 25) = 4.41, 
p = .002) were also statistically significant. Participants who reported speaking mostly 
English at home scored 1.05 points significantly higher than participants reporting speaking 
Mostly non-English (reference group; Table 2). We conducted multiple imputation on each 
predictor and outcome and conducted additional analyses on the imputed dataset. Results did 
not change in the analysis using the imputed dataset relative to the results in the unimputed 
dataset.   
 
Table 2. Results of the Multiple Linear Regression (N = 890).  
 
Statistics 
Variable Coef. Linearized SE T p 95% CI β 
DSST 
      
Age -1.00 0.10 -10.37 0.000 -1.20, -.80 -0.31 
Sex 3.02 0.88 3.45 0.002 1.23, 4.80 0.08 
Education 14.81 1.44 10.30 0.000 11.89, 17.74 0.39 
Country of birth -4.64 1.73 -2.68 0.012 -8.17, -1.11 -0.11 
Annual family income 




$25,000 and $64,999 3.95 1.76 2.24 0.032 .35, 7.54 0.10 
over $65,000 8.21 2.33 3.53 0.001 3.47, 12.95 0.19 
Acculturation 
      
Both equally  1.97 1.85 0.30 0.295 -1.80, 5.75 0.03 
Mostly English 4.79 1.62 0.01 0.006 1.49, 8.08 0.12        
AF 
      
Age -0.22 0.03 -7.45 0.000 -.28, -.16 -0.27 
Sex -0.44 0.23 -1.90 0.067 -.91, .03 -0.04 
Education 1.42 0.44 3.23 0.003 .52, 2.31 0.14 
Country of birth -2.10 0.41 -5.07 0.000 -2.94, -1.26 -0.19 
Annual family income 
      
$25,000 and $64,999 0.35 0.34 1.04 0.305 -.33, 1.04 0.03 
over $65,000 1.16 0.55 2.11 0.043 .04, 2.29 0.10 
Acculturation 
      
Both equally  -1.75 0.63 -2.77 0.009 -3.04, -.46 -0.10 
Mostly English 0.05 0.50 0.10 0.920 -.97, 1.07 0.00        
CERAD word learning 
      
Age -0.27 0.03 -8.76 0.000 -.337, -.210 -.32 
Sex 1.31 0.43 3.08 0.004 .443, 2.176 .13 
Education 2.22 0.43 5.20 0.000 1.348, 3.084 .21 
Country of birth -0.36 0.62 -0.58 0.565 -1.634, .908 -.03 
Annual family income 
      
$25,000 and $64,999 0.48 0.44 1.09 0.283 -.417, 1.383 .05 
over $65,000 0.06 0.68 0.09 0.925 -1.316, 1.445 .00 
Acculturation 
      
Both equally  1.41 0.75 1.88 0.069 -.114, 2.928 .08 
Mostly English 1.05 0.47 2.22 0.033 .088, 2.018 .10        
CERAD delayed recall 
      
Age -0.12 0.01 -7.89 0.000 -.15, -.09 -0.29 
Sex 0.73 0.18 3.96 0.000 .35, 1.10 0.15 
Education 1.08 0.21 5.10 0.000 .65, 1.51 0.22 
Country of birth 0.01 0.28 0.04 0.965 -.56, .58 0.00 
Annual family income 
      
$25,000 and $64,999 0.11 0.28 0.39 0.696 -.46, .68 0.02 
over $65,000 0.42 0.32 1.33 0.194 -.23, 1.07 0.07 
Acculturation 
      
Both equally  0.63 0.29 2.19 0.036 .04, 1.22 0.08 
Mostly English 0.55 0.30 1.86 0.072 -.05, 1.16 0.11 
       
CERAD intrusion       
Age 0.01 0.01 1.83 0.077 -.00, .03 0.07 
Sex 0.05 0.09 0.54 0.591 -.13, .22 0.02 
Education -0.28 0.10 -2.63 0.013 -.49, -.06 -0.12 
Country of birth 0.31 0.10 2.97 0.006 .10, .52 0.12 
Annual family income       




over $65,000 -0.15 0.13 -1.16 0.254 -.40, .11 -0.05 
Acculturation       
Both equally  0.30 0.18 1.69 0.100 -.06, .67 0.08 
Mostly English 0.25 0.15 1.74 0.091 -.04, .55 0.11 
p < .05; p values in bold represent statistically significant relationships; SE: standard error; CI: 
confidence intervals; DSST: Digit Symbol Substitution test; AF: Animal Fluency; CERAD: 
Consortium to Establish a Registry for Alzheimer’s Disease; β values are standardized  
 
Discussion  
We explored the relationship between language acculturation and cognition among older 
Hispanic and Asian individuals living in the United States. Our findings revealed that 
language acculturation is an important predictor of verbal and non-verbal cognitive 
performance. Overall, our findings add to the extant evidence linking language acculturation 
to cognition by showing that language use at home may contribute to maintaining cognitive 
health among ethnic minorities living in the United States (Coffey et al., 2005; Derose & 
Baker, 2000; DuBard & Gizlice, 2008; Fiscella et al., 2002; Lara et al., 2005; Solis, Marks, 
Garcia, & Shelton, 1990; Weinick & Krauss, 2000; Xu et al., 2017). Results from the 
imputed dataset were not largely different compared to the results from the original dataset.  
 
Digit Symbol Substitution Test   
Results supported our hypothesis that higher acculturation significantly predicted greater 
performance in the DSST, which assesses non-verbal skills (Wechsler, 1981). Our findings 
disagree with some previous studies, which did not observe associations between 
acculturation and non-verbal tasks (Boone et al., 2007; Razani et al., 2007). Results however, 
agree with a study that had adopted the Acculturation Rating Scales for Mexican Americans 
for measuring acculturation, which includes items related to language use (Coffey et al., 
2005) and with a study showing that acculturation significantly predicted performance on the 




In this study however, acculturation accounted for only 2% of the variance in Rosen Drawing 
Test scores (Manly et al., 2004). Furthermore, as the DSST assesses psychomotor speed, it is 
widely used to investigate cognitive changes as a function of age (Hoyer, Stawski, 
Wasylyshyn, & Verhaeghen, 2004), and is a robust predictor of mortality and incident 
disability (Rosano, Newman, Katz, Hirsch, & Kuller, 2008). Clinically, our findings are 
interesting because they show that language use at home in ethnic minorities may contribute 
to psychomotor speed and memory in old age.  
 
Verbal tasks  
Contrary to our hypothesis, the middle acculturation group generated 1.72 fewer words on 
average than the reference group in the AF task. The confidence intervals in this group 
however, were wide indicating poor precision and low statistical power (Cumming, 2014). 
Analyses of the imputed dataset did not reveal any between-group differences in the AF task. 
Supporting our hypothesis, the higher acculturation group remembered on average one 
additional word than the reference group in the CERAD word learning task. Moreover, the 
middle acculturation group remembered on average 0.6 more words than the reference group 
in the CERAD delayed recall task. The effect size was small suggesting that the strength of 
the relationship between language acculturation and verbal fluency including its clinical 
relevance may be trivial. Also, acculturation did not predict performance in the intrusion and 
percent savings outcomes. Our findings disagree with a previous study with a smaller sample 
size (N = 279) showing worse performance in Hispanic compared to Non-Hispanic White 
individuals in the List Sorting Test which has a heavy verbal load component (Flores et al., 
2017). These findings were observed irrespective of which language participants were tested 




Some of our results are at variance with previous studies showing that higher levels of 
acculturation are linked with greater performance in verbal tasks (Boone et al., 2007; Nielsen, 
Vogel, & Waldemar, 2012; Razani et al., 2007). Our findings disagree with a study linking 
higher acculturation with greater performance in the Supermarket Fluency test, which is 
similar to our AF task (Nielsen et al., 2012). Also, because the authors did not report in what 
language the cognitive task was administered (Nielsen et al., 2012), it is unclear whether 
higher acculturation reflected a better command of the language of the recipient country or 
greater cognition (Lehtonen et al., 2018). Alternatively, less acculturated individuals might 
have received less exposure to the language of the recipient country and may have been less 
familiar with the test items (Razani et al., 2007). Importantly however, our findings are 
consistent with a large study (N = 503), which did not detect a link between acculturation and 
verbal fluency (Manly et al., 2004). Possibly, previous studies with smaller samples were 
statistically underpowered and committed a type I or II error (Ioannidis, 2005).  
 
Possible mechanisms  
One explanation for some of the positive findings relates to bilingualism, which is the ability 
to speak two languages (G. Luk & E. Bialystok, 2013). Bilingualism is associated with 
protection against cognitive decline in older adults (Bialystok et al., 2018), a lower risk of 
mild cognitive impairment (Wilson et al., 2015), and a delayed onset of dementia (Bialystok 
et al., 2007; Craik et al., 2010). Although a recent meta-analysis of four longitudinal 
prospective studies concluded that bilingualism relative to monolingualism does not reduce 
the risk of dementia (Mukadam et al., 2017). Of note, given the low number of studies 
included in the meta-analysis and the poor operationalization as well as measurement of 
monolingualism and bilingualism within each study among other of this review (Mukadam et 




(Grundy & Anderson, 2017; Woumans et al., 2017). Another study found that among 
Japanese individuals living in the United States, exposure to the Japanese language in 
childhood and adulthood was associated with a lower risk of cognitive decline (Graves et al., 
1999). Also, while we could not partition participants between mono- and bilinguals, 96% of 
participants in the reference group, 54% in the both equally group, and 41% in the mostly 
English group reported having been born outside of the United States. This indicates that over 
half of the whole sample could have been bilingual. Therefore, in our study, we cannot 
discount the possibility that bilingualism played a role.  
 
Limitations 
Our measure of language acculturation did not include language proficiency, which may be 
an important factor contributing to cognition (Lara et al., 2005). We also did not have data on 
whether participants were bilinguals or monolinguals and the degree of biculturalism, which 
could be considered when investigating the relationship between language and cognition (G. 
Luk & E. Bialystok, 2013). Also, we did not control for length of residence in the United 
States due to the large portion of missing data in this variable. This is a limitation because 
length of residence in the United States is linked to several health outcomes (Lara et al., 
2005). Also, we did not have data to investigate whether language use acted as a proximal or 
distal factor in contributing to cognitive performance. For example, better use of English in 
ethnic minority groups could facilitate communication with public health officials resulting in 
greater use of healthcare services which may be associated with maintenance of cognitive 
health (Derose & Baker, 2000; DuBard & Gizlice, 2008; Fiscella et al., 2002; Solis et al., 
1990; Weinick & Krauss, 2000). It is also possible however, that learning the language of the 
recipient country while still using the heritage language on a daily basis could help maintain 




possible to discern which of the two mechanisms, or whether the combination of the two, was 
responsible for the observed relationships.  
 
Strengths 
Unlike previous studies (Boone et al., 2007; Coffey et al., 2005; Razani et al., 2007; Touradji 
et al., 2001), we had access to a larger sample of participants and were able to adjust for 
multiple covariates thereby generating more precise estimates of our outcomes. Moreover, 
our measure of acculturation is clinically relevant because collecting data on language use at 
home is practical and time-effective and public health practitioners can easily collect these 
type of date at the patient- and population-level (Lara et al., 2005). Additionally, the 
NHANES adopts a complex stratified, multistage national probability sampling design which 
allows to sample individuals who are representative of the civilian non-institutionalized 
populations of the United States. Also, while our sample included only two ethnic minorities 
(Hispanic and Asian individuals), each cohort included multiple nationalities rendering our 
analytic sample ethnically diverse (Mexican-American or other Hispanic, Korean, 
Vietnamese, and Chinese individuals). Finally, unlike a previous studies (Touradji et al., 
2001), participants in our study were tested in their chosen language. 
 
Suggestions for future research  
Future research could aim to also collect data on bilingualism, biculturalism, and language 
proficiency as additional predictors to explore whether these factors also contribute to 
cognitive performance (G. Luk & E. Bialystok, 2013) in ethnic minorities. Because language 
acculturation and bilingualism may be mutually inclusive (Portes & Rumbaut, 2001), their 
interaction could produce an additive effect on cognitive health. Future research may also 




and allow for multivariate adjustments of important covariates such as sex (Coffey et al., 
2005; Nielsen et al., 2012; Razani et al., 2007). While sex difference in cognitive abilities are 
generally small (Hyde, 2005), women tend to have marginally better verbal skills with the 
greatest magnitude found for verbal fluency than men while men tend to show marginally 
greater spatial performance than women (Hyde, 2014; Zell, Krizan, & Teeter, 2015). Future 
research should also consider conducting prospective longitudinal studies to assess whether 
within-group levels of acculturation and between-group differences across migrants and 
native-born individuals account for differences in cognition (Xu et al., 2017). 
 
Implications 
Results from our study have some implications for clinical practice and governments. First, 
our findings show that choice of language use in an ethnically diverse minority group living 
in the United States was an important predictor of cognition. From a neuropsychological 
perspective, this finding is clinically relevant because performance on the DSST task has 
been shown to predict individuals at risk of mortality and incident disability (Rosano et al., 
2008) as well as age-related cognitive decline (Hoyer et al., 2004; Salthouse, 2019). 
Therefore, encouraging individuals in ethnic minorities from attaining higher levels of 
language acculturation may be a useful strategy for protecting against age-related decline in 
psychomotor speed performance. Second, from a public health perspective, governments may 
be interested in considering preference of language use when collecting data for large-scale 
epidemiological surveys in ethnically diverse and immigrant populations (Lara et al., 2005). 
Some of our results are consistent with some evidence showing that after adjusting for 
acculturation, between-group differences across ethnic minorities disappeared, indicating that 
language acculturation can be applied to increase the accuracy of diagnosis in clinical 






To our knowledge, this is the first study exploring the relationship between language use at 
home and cognition using a large epidemiological and ethnically diverse sample of older 
cognitively intact Hispanic and Asian individuals living in the United States. Our results add 
to the growing body of literature by showing that language acculturation may be an important 
factor linked with cognition in older individuals who are part of an ethnic minority. 
Therefore, language acculturation may be important to consider when exploring factors 
linked with cognitive health in older individuals at the patient and population level.  
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Between-chapter (5-6) rationale 
Throughout the previous chapters, we found that i) increasing PA in seniors at a higher risk 
of developing AD might generate more clinically relevant outcomes than in individuals with 
a diagnosis of AD, ii) bilingualism as opposed to monolingualism is linked with a delayed 
onset of AD possibly by rendering the brain areas affected by AD more resilient against 
neuropathology, and iii) language acculturation is linked with greater cognition in seniors 
from ethnic minorities living in the USA. The evidence gathered in this thesis indicates that 
modifying PA and a person’s language profile could be used as potential strategies for 
improving cognitive outcomes in individuals at a higher risk of developing AD. However, 
modifying just one putative risk factor may not be sufficient for improving health-related 
outcomes. To our knowledge, there is not experimental study that would have investigated 
the effects of increasing PA in combination with studying a foreign language on cognitive 
outcomes in individuals at a higher risk of AD such as those with SCD. The following 
chapter outlines the proposal for a randomized-controlled trial investigating whether 
combining increased PA with studying a foreign language in monolingual English seniors 



















 Chapter 6: Study protocol for a randomized 
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foreign language with physical activity on 





















This Chapter was drafted for submission to the journal Trials. The referencing style accords 
with the journal’s requirements. This manuscript accords with The Standard Protocol Items: 
Recommendations for Interventional Trials (SPIRIT) 2013 Checklist: Recommended Items to 
Address in a Clinical Trial Protocol and Related Documents. This chapter was written 
following a Structured Study Protocol Template 
(https://trialsjournal.biomedcentral.com/submission-guidelines/preparing-your-
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Some observational evidence shows that bilingualism is associated with delayed symptom 
onset and clinical diagnosis of dementia of all types and specifically, dementia due to AD. 
Moreover, increased physical activity has been shown to improve cognition in older 
individuals at a higher risk of AD. Whether studying a foreign language (bilingualism) 
combined with increased physical activity can be implemented and is beneficial to cognition 
in older adults at a higher risk of AD has not been explored yet. This paper is the study 
protocol describing the methodology for the proposed randomized-controlled trial aiming to 
address this question.  
Method  
This 18-month randomized-controlled trial will investigate the effects of studying a foreign 
language and increasing levels of physical activity in SCD individuals. Participants will be 
randomly allocated to either a language-learning with physical activity condition or a 
physical activity-only condition. The primary outcome is cognitive performance.  
Conclusion  
This protocol will provide a study design for a randomized-controlled trial investigating the 
impact of foreign language-learning and increased PA on cognitive performance in older 
adults with subjective cognitive decline.  
Keywords  
subjective cognitive decline, Alzheimer’s disease, bilingualism, physical activity, 
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Background and rationale {6a} 
The effects of modifying certain behavioral factors including physical and mental activity on 
cognition in people diagnosed with Alzheimer’s disease (AD), the most common form of 
dementia, have shown limited translation impact (1, 2). Individuals with AD have likely 
accumulated such an advanced degree of neuropathology that behavioral interventions may 
fail to generate clinically relevant improvements in health-related outcomes (1). Therefore, 
implementing interventions before widespread brain damage and the clinical symptoms of 
AD manifest, for example, those with SCD, might have some translational impact (3-6).  
Here, SCD refers to self or informant reported departure from the normal state of 
cognitive performance into a chronic subjective experience of cognitive decline (4) despite 
normal neuropsychological performance (3). Although there is some evidence of lower 
performance in immediate and delayed verbal recall (7) as well as psychomotor 
performance (8) before the onset of SCD. Nevertheless, individuals with SCD are considered 
at a higher risk of AD (7) and therefore, SCD is likely an important time point in the clinical 
spectrum of AD (1, 3).     
The National Academy of Medicine has suggested that learning a foreign language 
and increasing physical activity (PA) as potentially protective factors could be applied as 
interventions (9), as they may be particularly beneficial in the preclinical phase of AD (3, 5, 
6). Moreover, there is some evidence showing that when cognitive interventions are delivered 
together with structured PA programs, the magnitude of the effects on cognition is greater 
relative to when each is delivered in isolation (10). Therefore, we argued that increasing PA 
in combination with studying a foreign language might generate a greater effect on cognition 




Bilingualism and foreigner-language learning 
Broadly defined, bilingualism refers to the ability to speak at least two languages as opposed 
to one (12). Bilinguals, compared to monolinguals, are diagnosed with AD about four to 
seven years later (13, 14) and studying a foreign language in adolescence has been linked to a 
lower risk of mild cognitive impairment (MCI), the prodromal phase of AD (15). These 
studies indicate that bilingualism may promote cognitive reserve (CR), which is the ability to 
maintain cognitive performance despite the presence of AD pathology (16). For these 
reasons, studying a foreign language may be an important strategy for maintaining cognitive 
function in individuals with SCD (9, 17).   
To our knowledge, however, only one pilot study has investigated the feasibility and 
effects of studying a foreign language on cognition in elderly individuals (18). Results 
showed that language learning was feasible in this age group (M= 75.42; SD = 8.93) and that 
participants reported that the program was stimulating and enjoyable. However, there was no 
significant improvement in global cognitive function as measured via the Montreal Cognitive 
Assessment (MoCA). This is likely due to the small sample size (N = 14), lack of a control 
group, and low sensitivity of the MoCA to detect cognitive changes in healthy individuals. 
One ongoing RCT is testing the effects of cognitively stimulating activities (e.g. studying 
Spanish) on cognition (19). In this trial, however, participants will not engage in a structured 
PA program and researchers will not specifically monitor language learning among 
participants (19). Therefore, it is necessary to replicate the methodology of these studies 
while addressing their limitations (18, 19).  
 
Mechanisms of action in bilingualism 
During oral communication, bilinguals demonstrate simultaneous activation of both 




compete to control speech output (21). Therefore, when speaking, the bilingual needs to 
inhibit the context-inappropriate language and focus on the target language (21). By 
implication, the administration of competing languages should exercise brain areas 
responsible for cognitive control and promote executive function (21) with some evidence 
supporting this theory (22).  
For example, older bilinguals had greater white matter integrity in both the left and 
right prefrontal cortex (23) and greater white matter in the frontal lobe (24) compared to 
monolinguals. Higher grey matter volume in brain areas responsible for cognitive control 
have also been observed in bilinguals vs. monolinguals (25). However, others were either 
unable to replicate previous evidence, for example, the greater grey matter volume (24), or 
detected the opposite trend with bilinguals showing reduced microstructural integrity in white 
matter despite similar cognitive performance relative to monolinguals (26). This evidence 
suggests that bilingualism may strengthen white matter rendering the brain more resilient 
against neuropathological changes associated with AD (26, 27). The neuropathological 
effects of AD on white matter integrity may already be present at the SCD phase (28).  
Further, in participants with mild cognitive impairment and early AD, bilinguals 
demonstrated more impairment than monolinguals in cerebral glucose uptake in brain areas 
responsible for language, which is a marker of neurodegeneration (29). Participants also 
showed similar levels of cognitive impairment suggesting that bilingualism might have 
helped participants in maintaining functional cognition despite the presence of 
neurodegeneration associated with AD (29). These findings have also been replicated in 
participants occupying a more advanced stage in the clinical spectrum of AD (30). Structural 
neuroimaging studies have also shown that in participants with mild cognitive impairment 
(31) and AD (32) matched for degree of cognitive impairment, bilinguals demonstrated 




There is also experimental evidence showing that studying a foreign language can 
promote neuroplasticity (22). For example, after a nine-month intensive course in Modern 
Standard Chinese, participants in the experimental group showed changes in language brain 
areas; namely the left and right hemisphere as well as in the frontal lobe compared to controls 
(33). In another study, military interpreters taking a three-month intensive language course 
showed increased cortical thickness across brain areas responsible for language as well as in 
right hippocampal volume (34). The hippocampus is one of the first brain areas that is 
severely affected by AD and individuals with memory complaints or SCD relative to controls 
show more hippocampal atrophy (35). Also, atrophy of the hippocampus has been shown to 
precede SCD (36). Overall, from these findings, it appears that studying a foreign language 
may be linked with changes in brain areas involved in the neuropathology of AD. What 
remains unknown, however, is whether these putative changes in relevant brain areas 
following a foreign language course translate into improved cognition in individuals already 
experiencing SCD.  
Moreover, cross-sectional studies assessing differences in relevant brain areas 
between monolinguals and bilinguals generally often applied non-validated measures of 
bilingualism (22). Also, studies testing the effects of studying a foreign language on the brain 
tended to have small sample sizes (range N = 27 to 31), did not apply random allocation of 
participants (33, 34), and one study did not assess changes in cognition (33). Therefore, while 
some cross-sectional and experimental studies appear to suggest that bilingualism and 
studying a foreign language might be linked with changes in brain areas typically affected by 
AD (22), whether studying a foreign language might improve cognition in individuals with 





Physical inactivity is one of the greatest modifiable risks factor of AD (37). While increasing 
PA has only modest positive effects on cognition among individuals in the clinical phase of 
AD (5), there is reason to believe that increasing PA may be more beneficial on cognition in 
individuals at the preclinical phase of AD (5, 38, 39). However, there is limited research 
assessing the effects of PA on cognition in individuals with SCD (5), particularly with studies 
combining non-pharmacological and PA interventions.  
            One randomized-controlled trial (RCT) found that increased PA improved cognitive 
performance in individuals with memory complaints (39). Here, participants were classed as 
memory complainers if they had answered yes to the question: “Do you have any difficulty 
with your memory?”. Another RCT tested the effects of a multidomain intervention of diet, 
mental activity, and exercise in older individuals at a higher risk of AD and found 
improvements in cognitive tasks assessing processing speed and memory (38). In another 
RCT, older participants (including some with SCD) showed improved cognition and cerebral 
glucose metabolism after receiving a combination of mental and physical exercise than 
participants in the control group or those receiving each treatment in insolation (40). Here, 
while participants were at higher risk by virtue of their advanced age, SCD was not 
specifically assessed, however (40). Although one study did assess memory complaints, the 
authors did not apply other important criteria for establishing SCD in their cohort of 
participants (39). Therefore, in this study, it remains unclear whether SCD was due to early 
AD or other reasons such as depression, anxiety, or another type of dementia (41). 
 
Objective {7} 
Our objective will be to test the effects of studying a foreign language together with 




we hypothesize that by the end of the intervention we will observe between-group differences 
in cognitive performance favouring the intervention relative to the control group.   
 
Trial design {8} 
We will adopt a two-group parallel design, with a 12-month intervention and a six-month 
follow-up period. This study will be reported using the guidelines for reporting RCTs 
according to the Consolidated Standards of Reporting Trials (CONSORT) statement (42). 
The recommended content for the schedule of enrolment, interventions, and assessments is 
presented in Table 2 (43). The SPIRIT 2013 Checklist: Recommended Items to Address in a 
Clinical Trial Protocol and Related Documents is presented in Appendix A (43). 
Methods: participants, interventions, and outcomes  
Study settings {9} 
The data will be collected at the Exercise Science laboratories at Murdoch University in 
Perth, Western Australia.  
 
Eligibility criteria {10} 
According to the United States National Institute on Aging-Alzheimer's Association 
framework criteria for research, SCD refers to the transitional stage from normal cognition to 
AD presenting with biomarker indicators of AD in the absence of objective cognitive 
impairment (44). The working group of the Subjective Cognitive Decline Initiative provides a 
list of factors to apply in order to increase the likelihood of greater specificity for AD in 
individuals with SCD (45). We will also follow selection criteria according to published 




presented below. See Table 1 for a list of selection criteria.  
 
Participants 
Psychiatric disorders are often responsible for SCD and therefore the presence of a current or 
past major psychiatric disorder according to the ICD-10 or DMS-V should be considered an 
exclusion criterion. Age is another factor that should be considered. As such we will recruit 
participants within the age range (60 and 85 inclusive) in which the presence of SCD is more 
likely due to pre-clinical AD rather than other factors (45). To increase the probability that 
our target sample will include participants at a higher risk of developing AD, participants will 
be screened with the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) application 
(45). The total scores (possible range: 0–15 points) will be based on factors including age, 
sex, education, systolic blood pressure, body-mass index, total cholesterol, and physical 
activity. This application has been used previously to screen for participants' baseline AD risk 
(38). A list of selection criteria is presented in Table 1. 
  
Inclusion criteria  
We will include individuals who report subjective decline in memory, rather than other 
domains of cognition, who experienced the onset of SCD five years before screening for 
study eligibility, are aged 60 years or above but not older than 85, have concerns associated 
with SCD and carry a feeling of worse performance than others of the same age group, with 
at least one the apolipoprotein ε4 allele and have biomarker indicators of AD. Participants 
answering yes to both: “Do you feel like your memory has become declined” and “Are you 
worried about this?”. We will recruit male and female English monolinguals. Monolingual 
status will be determined at the screening phase during a phone interview by asking 




form of language instruction (e.g. face-to-face or online) in the last 30 years. Prospective 
participants will also need to have access to an electronic device with an internet connection 
because the language course will be delivered online. We will recruit individuals within the 
age range of 60 and 80 years inclusive. This is because this age range is more predictive of 
AD than other dementia aetiologies (41, 46). Participants with a CAIDE scored of six or 
above will be eligible to participate (38, 47). We will include participants with a Mini-Mental 
State Examination (MMSE) score of 25 points or above, a global Clinical Dementia Rating 
(CDR) score of 0 points, and a Montreal Cognitive Assessment (MoCA) total score above 20 
points (19).   
  
Exclusion criteria 
Factors such as different dialects within a language, having studied a foreign language in 
school, or exposure to other languages in the media question the extent to which an individual 
may be truly monolingual. Therefore, we will exclude individuals who report having studied 
a foreign language within the last 30 years. Also, participants with uncontrolled hypertension 
or type 2 diabetes mellitus will be excluded as they may increase cognitive complaints due to 
neuropathy unrelated to AD (4). Participants who have currently been diagnosed with a major 
psychiatric condition using the International Statistical Classification of Diseases and Related 
Health Problems or the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. 
Further, because participants will be asked to increase their PA levels, those who report the 
presence of an acute or chronic condition that may be negatively affected by increased PA or 





Table 1 Selection Criteria for study protocol 
Inclusion criteria 
1.     Age: 65 to 85 years 
2.     Sex: all  
3.     Age at SCD onset ≥ 60 years 
4.     Onset of SCD within the last 5 years 
5.     SCD in memory performance as opposed to other cognitive domains 
6.     English monolinguals 
7.     MMSE score ≥ 25 
8.     CDR score of 0 
9.     MoCA score of above 20 
Exclusion criteria 
1.     Received foreigner language instruction within the last 30 years 
2.     Presence of substance use, psychiatric, neurological, or medical conditions 
known to affect cognition 
3.     Presence of major psychiatric conditions according to ICD-10 
4.     Unable to perform PA (e.g. walking) unhindered  
5.     Acute or chronic conditions that may be exacerbated by physical exercise: 
stage one of the APSS screening tool  
6.     A CAIDE risk score of 5 or below 
7.     Inaccessibility to an electronic device (e.g. computer, tablet, etc.) with an 
internet connection 
8.     Known history of HIV 
SCD: Subjective Cognitive Decline; MMSE: Mini-Mental State Examination; CDR: Clinical 
dementia rating scale; MoCA: Montreal Cognitive Assessment; ICD-10: International 




Screening System; PA: physical activity; CAIDE: Cardiovascular Risk Factors, Aging and 
Dementia; HIV: human immunodeficiency virus 
 
Who will take informed consent? {26a} 
A trial coordinator will be responsible for screening and recruiting as well as taking informed 
consent from eligible participants.  
 
Additional consent provisions for collection and use 
of participant data and biological specimens {26b} 
Not applicable.  
Interventions 
Explanation for the choice of comparators {6b} 
In this trial, we compare one group receiving a PA program combined attending an online 
foreign language course to a group receiving a low dose PA program combined with 
attending an online foreign language course without receiving language instruction. The 
reasons for comparing these two groups are threefold: 1) moderate-high PA with an aerobic 
component with high frequency is necessary to generate improvements in health-related 
outcomes, 2) since the language course is delivered online, there is a possibility that engaging 
with the online environment may be mentally stimulating for some of the participants and as 
such, it is necessary to control for this by allowing participants to engage with the online 
content without studying a language, and 3), both components of the intervention group 
expose participants to social engagement which may contribute to an observable 




level of social engagement participants receive in each group (48).  
 
Intervention description {11a} 
Language 
We will let participants chose from Italian, Spanish, and French. Participants will be able to 
choose which one of these three languages they prefer to study by using an online language 
course using a free-of-charge application (www.duolingo.com). Upon receiving an e-mail 
inviting participants to sign up to the website, they will be able to choose their preferred 
language. Participants will be instructed to work from the beginner through to the 
intermediate and advanced levels. Each of these three levels includes multiple language-
learning-based activities. To progress forward, the user needs to successfully complete each 
activity. The successful completion of one activity unlocks a subsequent activity. Once all 
activities within one level (e.g. beginner) have been successfully completed, the user can 
move forward to the following level (e.g. intermediate). Participants will be able to progress 
at their own pace but will be encouraged to work at least three to four hours per week for 12 
months. Moreover, this website allows researchers to track participants’ progress through the 
language course. This will provide information as to whether participants are adhering to the 
language program in real-time. A researcher will call participants who do not comply with 
the language-learning tasks and encourage them to continue studying the language.  
 
Physical activity 
The 12-month PA protocol will consist of moderate-high intensity aerobic and resistance 
training activities (5). The overall volume of PA will be at least 150 minutes of PA per week, 
which is the minimum amount of PA recommended by the American College of Sports 




(RPE) scale (49), and all participants will be trained in the use of this scale during the 
assessment and supervised exercise sessions. This training is particularly relevant to 
individuals unaccustomed to moderate-intensity PA and will occur by monitoring heart-rate 
in conjunction with the RPE during supervised sessions, so that participants may directly 
compare their perceived-rating relative to the physiological measures. Participants will be (i) 
encouraged to maintain their current PA activities; (ii) asked to complete one session per 
week of up to 30 minutes of high-intensity aerobic exercise in an exercise laboratory; (iii) 
complete home-based resistance training exercises two times per week.   
The 30 minutes of high-intensity aerobic exercise will comprise cycling on a Velotron 
bicycle for five minutes at 60% of maximal oxygen consumption (VO2peak) and then 
increasing toVO2peak to 95% across four intervals of four minutes. In between each interval, 
participants will be asked to decrease the exercise intensity back to 60% for two minutes. The 
home-based resistance exercise sessions will be supported by five exercise sessions in an 
exercise laboratory, which will be supervised by an accredited exercise physiologist. These 
sessions will be weekly for the first three weeks and repeated in week 6 and week 12 (50). In 
these sessions, home-based resistance (bodyweight) exercises will be demonstrated and 
participants will be educated on is the movements as well as regressions (how to make these 
easier) and progressions (how to make these harder; e.g. single limb progression or increasing 
resistance with therabands). The home-based resistance exercises will comprise i) three 
exercises for the lower body, sit-to-stand, lying leg extensions, heel raises; ii) glute bridge; 
iii) two upper body exercises, wall push-up, band row (using a therapy band). Participants 
will be asked to perform 8-12 repetitions of each exercise and to perform each exercise twice, 
on at least two occasions per week.  
The circuit is expected to take 20 minutes, and the total target for PA is, therefore, 




which will include additional questions concerning motivation to exercise and follow-up 
phone calls. We set the compliance criterion as adhering to 80% of the PA program. To 
increase adherence to the PA intervention we will develop a written schedule tailored for 
each participant outlining the dates and times of each PA session in the laboratory and at 
home for the study duration as well as send prompts and reminders via mobile phone and 
follow-up with phone calls throughout the trial (50).  
 
Active control 
Previous evidence has shown that seniors learning how to use a computer showed 
improvements in general wellbeing and a sense of empowerment (51). As such, to render the 
intervention and control group as similar as possible, participants in the active control 
condition will be asked to sign up to www.duolingo.com and create an account. They will 
also be asked to engage with the website by completing exercise without engaging with the 
language learning component. Participants in the active control group will be asked to engage 
with the activities within the beginner’s level but without actually studying the language and 
passing the activity. For example, the participant will be able to answer questions within the 
activity incorrectly which will prevent the subsequent activity to be unlocked. As such, we 
will be able to monitor if some participants in the active control group engage in studying the 
language by verifying that subsequent activities remain unlocked. In case we observe that 
some participants in the active control group unlock subsequent activities, this would signal 
that the participant has engaged in language learning and will be asked to discontinue the 
language learning by unlocking subsequent activities. To match the control group to the 
intervention group, participants in the control group will be instructed to attend an organized 





Criteria for discontinuing or modifying allocated interventions {11b} 
We expect some participants might experience adverse events during the PA program in 
either group. Any adverse event which may include but is not limited to physical injury that 
may occur in participants during the trial will be recorded and reported as an adverse event. 
In case a participant cannot adhere to the level of intensity or frequency of the PA program, 
trial the exercise scientist will modify intensity or frequency or both to a level that is 
manageable to the participant.    
 
Strategies to improve adherence to interventions {11c} 
Participants in the intervention group will be asked to progress in the online language course 
at their own pace so as to ensure that participates do not feel overburden and decide to drop-
out of the study. Similarly, missing data due to participants who need to discontinue 
participating in the trial because of adverse events or any other reason will be handled at the 
analysis stage with the appropriate statistical techniques including multiple imputations and 
intention-to-treat analysis with sensitivity analysis to assess the robustness (52). More details 
about handling missing data at the statistical level are reported in the Statistical methods 
section below. We will also apply several recommendations for limiting missing data during 
the trial including hiring researchers with previous knowledge on recruiting and monitoring 
participants and training them in retaining participants in the trial until completion, reducing 
burden to participants that may be due to completing the intervention by allowing participants 
to progress at their own pace, among others (52).  
 
Relevant concomitant care permitted or prohibited during the trial {11d} 
Participants will be permitted to continue using any medications for comorbid conditions 




before or during the trial. We will collect information regarding any medications that 
participants had begun taking before starting the trial will any will continue to do so 
regarding medications that participants might have started using during the trial. Participants 
who are already maintaining the recommended 150 of PA per week or attending PA-based 
classes will be encouraged to continue maintaining their habitual level of PA.  
 
Provisions for post-trial care {30} 
During the completion of this trial, the university’s insurance will cover all participants for 
indemnity due to negligent harm or researchers’ departure from conducting the trial in 
accordance with this protocol. The university will cover costs or compensations related to any 
harm due to protocol violation form the part of the researchers.  
Outcomes {12} 
Primary outcome 
The primary outcome will be the between-group difference at post-intervention in cognition 
using the Alzheimer Disease Cooperative Study Preclinical Alzheimer Cognitive Composite 
(ADCS-PACC), which can be used to assess cognition in individuals at the asymptomatic 
phase of AD such as those with SCD (53). A composite score component for each participant 
is calculated from four cognitive tests: 1) Total Recall score from the Free and Cued 
Selective Reminding Test (FCSRT; 0-48 words), Delayed Recall score on the Logical 
Memory IIa subtest from the Wechsler Memory Scale (0-25 story units), The MMSE total 
score (0-30 points). Change scores from each component are divided by the standard 
deviation of the baseline sample of that particular component. This will generate 
standardized z scores, which will be summed to generate the composite scores. A change of 




score.   
 
Secondary outcome 
As secondary outcome will include changes from baseline in Alzheimer's Disease 
Cooperative Study—Activities Daily Living—Prevention Questionnaire (ADCS-ADL-
Prevention Questionnaire) scores (54). Another secondary outcome will include an official 
language test at the end of the trial to assess participants’ knowledge in the chose language 
after completing the course. Scores will be presented descriptively for the intervention group 
for the post-intervention time point at six months. This language test will be administered by 
a qualified language teacher in the language that the participant chose to study during the 
trial.  
Demographic factors  
We will collect demographic data on age, sex, occupation, socio-economic status, education, 
and marital status. These will be collected with standardized forms asking participants to 
report their age (continuous), sex (categorical: male or female), job type (nominal), years of 
formal education (continuous), and marital status (categorical: whether they are married, 
divorced, etc.). We will use the Adult Pre-Exercise Screening System (APSS) Screening Tool 
to identify participants with pre-existing conditions that may be exacerbated by increasing 
PA. To identify participants at a higher risk of AD, we will use the CAIDE application, 
which collects information on age, educational level, hypertension, hypercholesterolemia, 
obesity, and PA (47).  
 
Neuropsychiatric symptoms  
Depression and anxiety are highly prevalent in individuals with SCD and have been found to 




participants with major neuropsychiatric disorders including depression and anxiety 
according to the International Statistical Classification of Diseases and Related Health 
Problems (ICD-10). We will screen participants using the Geriatric Depression Scale, which 
is a self-report measure of depression including 30 items consisting of yes/no questions (55). 
Scores range from 0 to 30 and we will exclude participants scoring 10 points or above. To 
screen participants for the presence of anxiety, we will administer the Geriatric Anxiety Scale 
with higher scores indicating higher anxiety and exclude participants scoring > 9 points (56).  
 
Participant timeline {13} 
A description of the timeline content is presented in Table 2.   
Assessment of eligibility  
Researchers will screen potentially eligible participants against selection criteria over the 
phone and explain the procedure of the experiment. Participants who meet inclusion criteria 
and are interested in participating will be asked to attend baseline testing. Participants 
meeting any of the exclusion criteria will not be eligible to participate.   
 
Baseline 
Baseline testing is estimated to last approximately 60 minutes. Within this timeframe, 
participants will be asked to read the information letter and sign the consent form. The 
baseline testing will involve collecting demographic data and cognitive tests. The order of 
administering the cognitive measures will be counterbalanced across participants to account 
for fatigue effects. We will also collect PA levels using Actigraph accelerometers which will 




into contact with water (e.g. while showering or swimming). At the end of testing, 
researchers will book a suitable date for post-intervention testing.  
Post-intervention testing 
At the end of the intervention, participants will be asked to come back and complete the same 


















Table 2 Participants’ timeline for study protocol     
    Study period 






TIMEPOINTS: -t1 0 0 t1   tx 
Assessment of eligibility X           
Informed consent   X         
Allocation     X       
INTERVENTIONS:             
PALL     
 
      
PA     
 
      
ASSESSEMENTS:             
Primary             
Demographics X           
Memory Complaints Questionnaire X           
Geriatric Depression Inventory  X           
Executive functioning   X   X X   
Processing speed   X   X X   
Memory   X   X X   





Sample size {14} 
We used GLIMMPSE to conduct power analysis (https://glimmpse.samplesizeshop.org/#/) 
for LMM. We will assume that the between-group difference, if one exists, will be relatively 
small. A priori power calculation with an alpha level of .01, power at 90%, to detect a small 
effect size gave a sample size of 216 participants. We will include an additional 20% of 
participants to account for possible attrition rate, which will result in an additional 54 
participants. Therefore, the total sample size will be 270 (135 participants per group).   
 
Recruitment {15} 
The method of recruiting participants with SCD can affect the characteristics of the study 
sample. To increase the probability that SCD in our participants is due to pre-clinical AD, we 
will recruit participants from memory clinics (57) in and outside the metropolitan area of 
Perth, Western Australia. We will send recruitment fliers to multiple memory clinics and 
retirement centers in Perth and ask the clinical team to distribute the fliers to participants who 
appear to meet our selection criteria in the first instance.  
Assignment of interventions 
Sequence generation {16a} 
To randomly allocate participants to the intervention and control group, we will use the 
method of simple randomization (58) as it is an appropriate method in trials with at least 60 





Concealment mechanism {16b} 
A researcher who will not be involved in any other aspect of the trial will generate the 
random sequence and prepare opaque envelopes and number them sequentially containing the 
participants’ allocation.  
 
Implementation {16c} 
These envelopes will be opened and given to participants after completion of the baseline 
assessment. Given the nature of the intervention, it will not be possible to blind participants 
to the interventions.  
 
Data collection, management, and analysis 
Plans for assessment and collection of outcomes {18a} 
Research fellows qualified in delivering the PA activities and administering cognitive tests 
will be responsible for implementing the intervention and collecting data. The researchers 
will collect data at baseline, post-intervention, and follow-up.  
 
Plans to promote participant retention and complete follow-up {18b} 
The plan for increase adherence in the PA program is described under item 1.1 Intervention 
description {11a}. The study coordinator will also monitor participants’ language learning 
progress in real time online and will identify those not adhering to it. The coordinator will 
help participants not adhering to the language program find appropriate solutions in dealing 
with potential barriers. The study coordinator will also send reminders and prompts to 




Data management {19} 
The data will be saved and stored in a secure database whose access will be restricted with a 
password to the researchers involved in the trial. Two researchers not involved in data 
analyses will conduct checks for quality and range checks for data values.  
Statistical methods 
Statistical methods for primary and secondary outcomes {20a} 
To minimize bias, one investigator who will be blind to the conditions, will receive the 
dataset and conduct the statistical analyses. A second investigator also blinded to the 
conditions, will re-analyze the dataset to confirm the results. The data will be analyzed at an 
alpha level of 0.05.  
The statistical analysis will involve a Linear Mixed Modelling (LMM), which will 
also include an intention-to-treat analysis (ITT) on each outcome variable. The LMM with an 
AR(1)/AD(1) covariance matrix will be used to explore the effects of studying a foreigner 
language coupled with increasing PA on cognitive performance. Time will be one factor in 
the analysis and will be entered as a random factor. We will have three time-points: baseline 
(T1), post-intervention (T2: 12 months since baseline), and follow-up (T3: 18 months since 
baseline). We will examine the main effect of treatment group vs control group, the main 
effect of time (from baseline across all follow-ups), and the interaction between group and 
time to examine if the effects of the treatment are dependent on time factors. Post hoc 
comparisons will be conducted using Bonferroni’s correction. Time will be nested within 
participants and therefore we will restructure the dataset from wide to long format. Time will 
be entered as a fixed effect with participants’ identification number as random effects in each 




variables and outcome measures will be calculated and presented in a table. Means with 
standard deviations and 95% confidence intervals for demographic variables and outcome 
measures will be calculated and presented in a table.  
To assess changes from baseline, between-group differences at post-intervention, and 
interaction effects, we will calculate reliable change indices in the primary outcome (60), as 
this is the preferred method when accounting for practice effects (61) in assessing clinically 
relevant changes in trials that include participants with SCD (6).  
 
Methods in analysis to handle protocol non-adherence and any statistical methods to handle 
missing data {20c} 
Before analyzing the dataset, the investigators will conduct the Missing Completely at 
Random (MCAR) test to determine whether the data are MCAR. If the data are MCAR, to 
handle missing covariate data we will conduct multiple imputations (MI) including all 
predictors and time points to fill the missing data. Following this, we will conduct MI for all 
relevant outcomes and covariates. The imputation model will include all variables from each 
time point, which will be imputed individually. We will create two datasets: pre-imputed and 
imputed (m = 10); the 10 sets of results will be combined with Rubin’s rule. 
  
Plans to give access to the full protocol, participant level-data and statistical code {31c}  
The dataset will be made public within one year from the completion of the trial. The SPSS 






Despite several decades of research, there is still no treatment or cure for AD (62). 
Identifying modifiable risk factors that can alter AD disease progression and ultimately the 
risk of developing it, has become a global public health priority (62). Individuals with AD 
have likely accumulated widespread neuropathology limiting the potential beneficial effects 
of non-pharmacological interventions on cognition (63). As such, targeting individuals with 
SCD before the accumulation of advanced neuropathology may generate greater translational 
impact (3, 5, 7, 41, 44, 45, 63).  
While there is currently no universally accepted measure of SCD, recruiting 
participants with certain key demographic features can increase specificity for AD (4, 6). 
Despite the need for recruiting individuals with SCD, previous RCTs testing the impact of 
non-pharmacological intervention (e.g. PA programs or studying a foreign language) in 
individuals described as having SCD, did not apply strict criteria for assessing SCD (6, 39). 
In line with one ongoing trial (19), we propose the application of specific selection criteria 
(Table 1) in the recruitment of participants with SCD (41, 45). Furthermore, there is evidence 
indicating that only modifying PA levels may not be sufficient in preventing AD (11) and 
while non-pharmacological intervention can improve cognition in individuals with SCD (d = 
0.22), the inclusion of a cognitive component (e.g. cognitive rehabilitation and stimulation) 
can generate larger improvements (d = 0.37) on cognition (6). Therefore, combining a PA 
program with studying a foreign language (17), might be a cost-effective and useful strategy 
to improve cognition in individuals with SCD.   
The rationale for this study is based on previous evidence showing that bilingualism is 
associated with a later onset of AD (14) and that studying a foreign language early in life is 
linked to a lower risk of mild cognitive impairment (15). Also, that increasing levels of PA 




improvements on cognition among individuals in the preclinical phase of AD (39). To our 
knowledge, no RCT has yet been conducted testing the effects and feasibility of studying a 
foreigner language and increasing PA on cognition in older adults with SCD. This study will 
also provide information regarding whether the combination of studying a foreigner language 
and increasing PA is comparable or greater effects on the currently documented effects sizes 
of non-pharmacological interventions (6).   
            To maximize the impact of the intervention on cognition, the exercise program needs 
to include several components. For example, while there is some evidence suggesting that 
both aerobic and anaerobic exercise in isolation can improve cognition, combining aerobic 
and anaerobic exercise for at least 150 minutes per week appears to generate greater effects 
on cognition in individuals at the preclinical phase of AD (5, 64). Moreover, multimodal (e.g. 
running, strength training, etc.) exercise program including an aerobic component appears to 
be more beneficial than exercise program with only one component such as running (5, 64). 
Previous studies testing the impact of PA on cognition in individuals with preclinical AD did 
not consider these details in the delivery of the PA program (39, 40). For this RCT, we 
purposely designed the PA program while addressing the methodological weaknesses in 
previous trials. 
            In conclusion, we will conduct an RCT investigating the impact of increasing PA and 
studying a foreign language on cognition in older individuals with SCD. The choice of our 
intervention was based on previous evidence suggesting that increasing PA and bilingualism 
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Due to the lack of an effective treatment or cure for AD, identifying modifiable risk factors to 
reduce its future incidence has become a global public health priority (Brookmeyer, Abdalla, 
Kawas, & Corrada, 2018; Livingston et al., 2017; Nichols et al., 2019). While the link 
between several modifiable risk factors including poor diet, obesity, smoking, and sedentary 
behavior with AD has already been established (Baumgart et al., 2015; Lee et al., 2010), the 
role of risk factors such as PA and monolingualism may play in preventing AD remains 
equivocal (Gold, 2015; M. Kivimäki et al., 2019; National Academies of Sciences, Division, 
Policy, & Impairment, 2017). For example, experimental studies testing the impact of 
increasing PA on cognition in individuals with AD have shown limited improvements in 
cognitive performance questioning the clinical utility of PA interventions in clinical phases of 
AD (Sperling, Jack, & Aisen, 2011; Öhman, Savikko, Strandberg, & Pitkälä, 2014). Also, 
while there is evidence suggesting that bilingualism may delay AD diagnosis, longitudinal 
prospective studies do not show a risk reduction in dementia among bilinguals relative to 
monolinguals (Gold, 2015; Mukadam, Sommerlad, & Livingston, 2017). There is also 
limited evidence testing the impact of studying a foreign language on cognition in older 
individuals at risk of AD (Ware et al., 2017).  
  
Therefore, the purpose of this thesis was to i) review the available evidence exploring the link 
between PA and dementia across the clinical spectrum by conducting a narrative review of 
the literature (Chapter 2), ii) conduct a systematic review of the literature exploring the link 
between bilingualism and dementia onset as well as risk (Chapter 3), iii) conduct a systematic 
review of literature exploring the underlying link between bilingualism and the brain 
(Chapter 4), and iv) conduct a cross-sectional study epidemiological study investigating the 




living in the United States (Chapter 5).  
 
While the link between physical inactivity and poor cardiometabolic outcomes is well 
documented, the evidence linking PA and dementia is less clear (M. Kivimäki et al., 2019; 
Wahid et al., 2016). Studies testing the impact of increasing PA on cognition and AD 
symptoms have shown limited translational impact (Öhman et al., 2014). It has been argued 
that increasing PA at the clinical phase of AD is too late in the natural history of the disease 
and that targeting the preclinical phase might be more clinically meaningful (Sperling et al., 
2011; Öhman et al., 2014). The brain damage caused by AD in the clinical phase is too 
advanced to reverse or slow down and therefore the application of behavioral interventions to 
improve clinical symptoms is less likely to carry translational impact. By contrast, modifying 
risk factors in the preclinical phase where brain damage is still limited is likely to generate 
more clinically meaningful outcomes. Although there are several existing reviews looking at 
the effects of PA interventions on cognition in individuals with MCI and AD on 
cognition (Smart et al., 2017; Öhman et al., 2014), to our knowledge there is no review 
synthesizing the available evidence focusing on the impact of PA interventions across the 
clinical spectrum of AD. 
  
In Chapter Two, this thesis found that high-moderate PA across the lifespan was linked with 
a lower risk of developing AD but increasing PA in individuals who had already reached a 
diagnosis of AD did not improve cognition or symptoms. This is in line with previous 
evidence showing that increasing PA earlier in the natural history of AD may be more 
beneficial than at the clinical phase (Sperling et al., 2011; Öhman et al., 2014). However, 
multimodal PA programs that included different types of exercises with at least one aerobic 




per week) across a long period of time (at least three to six months) was more beneficial than 
PA program only targeting anaerobic or aerobic exercise in isolation of low intensity and 
frequency across a short period of time. High-intensity PA was found to increase the 
production of growth factors (e.g. brain-derived neurotrophic factors) which may be 
implicated in neuroprotective effects in brain areas severely affected by AD including the 
hippocampus (Wang & Holsinger, 2018). However, the evidence indicated that increasing 
PA had a limited clinical impact on cognitive outcomes in individuals with AD. It was found 
that increasing PA in the earlier phases of AD such as in those with MCI or SCD might be 
more useful than targeting the clinical phase (Chapter 2). Previous studies show that non-
pharmacological interventions can improve cognition in individuals with SCD, particularly 
multimodal interventions that include at least on cognitively stimulating activity (Rabin, 
Smart, & Amariglio, 2017). Recent evidence suggests that modifying only PA is likely not 
sufficient in preventing AD (M. Kivimäki et al., 2019). As such, there is an urgent need to 
test the impact of multicomponent interventions on cognition in individuals with SCD (Mika 
Kivimäki et al., 2019; Smart et al., 2017).  
  
Modifying a risk factor such as PA in combination with promoting a cognitive stimulating 
behavior may be more effective in improving cognition in older individuals with SCD rather 
than targeting one risk factor at a time (Smart et al., 2017). There is some evidence 
suggesting that bilingualism, as opposed to monolingualism, may delay the onset of 
AD (Bialystok, Abutalebi, Bak, Burke, & Kroll, 2016; Gold, 2015) and that studying foreign 
language may be a useful strategy for preventing AD (Antoniou, Gunasekera, & Wong, 2013; 
Bialystok et al., 2016; National Academies of Sciences et al., 2017). However, one recent 
systematic review (Mukadam et al., 2017) concluded that bilingualism is not protective 




responsible for the observed delays in AD diagnosis among bilinguals that have been 
documented in previous studies (Bialystok, Craik, Binns, Ossher, & Freedman, 2014; 
Bialystok, Craik, & Freedman, 2007). However, this systematic review only meta-analyzed 
longitudinal prospective studies without meta-analyzing cross-sectional studies (Grundy & 
Anderson, 2017) and does did not include recently published longitudinal prospective studies. 
Moreover, there is currently no systematic review exploring the underlying brain mechanisms 
thought to be responsible for the observed delays in AD diagnosis among bilinguals relative 
to monolinguals. Therefore, the equivocal findings in the literature on bilingualism and AD 
prompted the completion of a systematic review to determine whether bilingualism is linked 
with a delayed onset of AD (Chapter 3) and a second systematic review exploring the 
underlying brain processes linking bilingualism with a delay in AD diagnosis (Chapter 4).  
  
Contrary to the conclusion of a previous systematic review (Mukadam et al., 2017), meta-
analytics results from Chapter Three showed that bilingualism, as opposed to 
monolingualism, may delay the age in which the first symptoms of AD appear and the age of 
diagnosis. Although immigration status and education levels might have been responsible for 
the observed delays in AD diagnosis in bilinguals relative to monolinguals (Fuller-Thomson 
& Kuh, 2014; Mukadam et al., 2017), the majority of studies included in the meta-analyses 
had adjusted for education levels (Chapter three). Also, a subgroup meta-analysis indicated 
that immigration status did not appear to contribute to the observed relationship between 
bilingualism and AD. There was no evidence to suggest that bilingualism relative to 
monolingualism is linked with a lower risk of developing dementia. It is possible that while 
no difference in the incidence of dementia between bilinguals and monolinguals exists, 
symptoms will manifest at a later age in bilingualism relative to monolinguals. There was 




time of dementia diagnosis despite bilinguals being older than monolinguals. This suggests 
that bilinguals were able to maintain a functional level of cognition for more years before 
reaching a similar level of disease severity to warrant a dementia diagnosis as monolinguals.  
  
The evidence showing that bilingualism is linked with a later onset of AD symptoms and 
diagnosis (Chapter 3) was further supported by brain mapping showing that cognitively intact 
older bilinguals demonstrated structural differences in frontostriatal and frontoparietal 
circuits relative to their monolingual counterparts (Chapter 4). Bilinguals exhibited enhanced 
white matter integrity, for example, in the corpus callosum as well as stronger 
anterior/posterior functional connectivity and greater grey matter density than monolinguals, 
particularly in the anterior cingulate cortex and in the left inferior parietal lobule (Chapter 4). 
Each of these brain regions is severely affected by dementia and AD (Daianu et al., 2013; 
Palop, Chin, & Mucke, 2006). Furthermore, older bilinguals with AD demonstrated greater 
atrophy in the radial width of the temporal horn and the temporal horn ratio, each of which is 
severely affected in AD, despite bilinguals having similar cognitive performance and levels 
of education as monolinguals. Bilinguals with AD also exhibited more severe cerebral 
hypometabolism than their monolingual counterparts despite the bilinguals being older. 
Overall, the findings suggest that bilingualism may strengthen neural connectivity in 
frontostriatal and frontoparietal circuits (Gold, 2015) which are severely affected in dementia 
and AD (Daianu et al., 2013; Palop et al., 2006). The observed differences between older 
mono-and bilinguals in frontostriatal and frontoparietal circuits have already been observed 
in younger participants (Li, Legault, & Litcofsky, 2014).  
  
It is possible that bilingualism could be used to maintain healthy neural circuits and forestall 





Results from risk of bias, however, revealed that bilingualism was generally poorly 
operationalized and measured (Chapters 3 and 4). For example, most studies simply asked 
participants whether they could speak a second language without assessing how frequently 
and how well they could speak that second language or at what age they had acquired it. 
Studies generally did not assess how many languages bilinguals could speak but included 
those who could speak two or more languages in the same analytic cohort. Participants who 
reported being unable to speak a second language were categorized as monolinguals. 
However, it is conceivable that some of these participants were able to perhaps understand a 
second language (receptive bilinguals) rendering effectively non-monolinguals. These 
participants, however, were included as monolinguals in all studies in Chapter Three. 
Assessing bilingualism on a continuum would take into account the large variability present 
within this construct including differing levels of proficiency, frequency of second language 
use, and age of acquisition (Luk & Bialystok, 2013).  
  
Findings from Chapter five support results from Chapter three and four showing that 
language acculturation is linked with cognition in older individuals from ethnic minority 
groups living in the United States of America. In this chapter, the evidence indicated that 
higher levels of language acculturation were linked with higher psychomotor speed and 
verbal fluency (Chapter 5). Low psychomotor speed (Amieva, Meillon, Proust-Lima, & 
Dartigues, 2019) and verbal fluency (Szatloczki, Hoffmann, Vincze, Kalman, & Pakaski, 
2015) in old age are associated with a greater risk of developing AD. Decline in psychomotor 
speed can lead to widespread impairment in other cognitive domains because changes in 
processing speed limit the ability to execute higher-order thought processes (Salthouse, 




the risk of AD (Amieva et al., 2019), and maybe present more than 15 years before AD is 
diagnosed (Amieva et al., 2014), preventing its decline may be a critical factor in promoting 
cognitive health in old age. Notably, moderate-high intensity aerobic PA can result in 
improved psychomotor speed with concomitant greater activation of frontostriatal and 
frontoparietal circuits (Rosano et al., 2010), which are the same brain circuits also found to 
be structurally more developed in bilinguals relative to monolinguals in Chapter four.  
 
Limitations of this thesis 
Most studies in the field of bilingualism-based research have tended to dichotomously 
categorize participants between monolinguals and bilinguals. Authors now recognize that 
bilingualism includes several dimensions such as how well and how frequently a bilingual 
speaks the second or third language, age of second language acquisition. In Chapters three 
and four, it was not possible to establish whether any of these dimensions played a role in the 
observed delays in dementia as well as differences in brain structure and function between 
mono- and bilinguals. For example, while most studies applied a definition suggesting that 
bilinguals had used the second language for most of their lives, it was not possible to discern 
whether there is a critical age at which learning a second language might be relevant in 
protective against dementia. The issue of measuring participants’ language profile was also 
evident in Chapter five. Here, participants were simply asked what languages they spoke at 
home and as such, it was not possible to establish whether the observed relationship between 
language acculturation and greater cognitive performance in the analytic sample was due to 
bilingualism promoting cognitive health has the findings from Chapter three and four would 
indicate, or greater accessibility to the healthcare system, which is also a likely possibility in 





Suggestions for future research  
In this thesis, we identified several sources of bias and uncertainty in the field of exercise 
science- and bilingualism-dementia based research. Generally, there were common 
limitations across both fields of research that challenged the interpretation of our findings. 
For example, limitations including small sample sizes, lack of operationalization and poor 
measurement of the exposure of the independent variable, and recruitment of participants 
regardless of dementia type were commonly found across both fields of research. Therefore, 
studies should consider improving upon the abovementioned limitations. Moreover, PA-
dementia based research should consider monitoring participants' adherence (van der Wardt 
et al., 2017), deliver high-intensity PA with an aerobic component for at least six months, and 
continue monitor participants for at least another six months post-intervention. In 
bilingualism-dementia based research, studies might benefit from treating participants’ 
language skills as a continuous variable while measuring dimensions such as proficiency, 
frequency of second language use, and age of acquisition, rather than as a dichotomous 
variable.  
  
By extension, the purpose of Chapter 6 was to propose a trial that addresses the limitations 
identified in the studies we reviewed in the preceding chapters. Specifically, we propose an 
RCT investigating the effects of increasing PA levels and studying a foreign language in 
English-speaking monolingual individuals with SCD while addressing the limitations of 
previous studies (Chapter: 2-5). Unlike previous studies, in this RCT we will apply recently 
published guidelines for recruiting individuals with SCD, sufficiently power our study based 
on previous evidence including similar populations while using similar cognitive measures, 
exclude participants who are not truly monolinguals, include a post-intervention follow-up 




well as apply tailor the PA intervention to each participant and provide follow-up phone calls 
to remind and motivate participants to adherence to PA (van der Wardt et al., 2017).   
 
Clinical significance 
Given the future expected increase in the number of people with dementia and the heavy 
economic burden that societies are expected to face, our findings carry important clinical 
implications. Overall our findings carry important clinical relevance at the individual and 
population level. We found that targeting PA in individuals with SCD or who are otherwise 
at a higher risk of developing dementia or AD may be more clinically useful than targeting 
PA in the clinical phase of dementia (Chapter 2). Findings from Chapters three and four 
indicate that speaking two or more languages may strengthen certain brain areas that are 
severely affected by AD and that it can delay the onset of AD symptoms and diagnosis by 4.2 
years. These are clinically relevant findings because delaying the onset of AD by 
approximately five years, can reduce the prevalence by 57% and halve its associated 
economic costs (Sperling et al., 2011). We also found that language acculturation may be 
associated with greater psychomotor speed and verbal fluency in older Hispanic and Asian 
individuals living in the United States of America (Chapter 5). This is also a clinically 
relevant finding because psychomotor speed is an important predictor of mortality and 
incident disability. Thus, findings from this Ph.D. indicate that maintaining habitual PA, 
particularly increasing PA before the development of dementia or AD and that bilingualism 
as well as language acculturation likely to contribute to cognitive health in old age and may 







Our findings show that high-intensity PA of a high frequency for longer than six months 
including an aerobic component is associated with a lower risk of dementia and 
improvements in cognition in individuals with dementia. However, the literature carries 
several notable limitations including the poor measurement of PA, the inclusion of 
participants with differing dementia aetiology into the same analytic sample, and small 
sample sizes. While a large body of evidence supports a strong link between PA levels and 
dementia risk, these limitations question what the true strength of this relationship may be 
and whether increasing PA levels in the preclinical phase of AD may carry any translational 
impact in individuals with AD.  
 
Furthermore, experimental studies showed that increasing PA levels improved global 
cognition in several studies, but these changes tended to be small in magnitude questioning 
their clinical relevance. However, because most studies had tested PA intervention 
individuals at the advanced stage of AD with only a small number of studies recruiting 
participants at the preclinical phase, it is problematic to discern whether increasing PA levels 
before the clinical onset of AD may generate clinically relevant improvements in cognition. 
Therefore, additional research in individuals with subjective cognitive decline is urgently 
needed.  
  
 It was also found that bilingualism is associated with a later onset of dementia and AD but 
not with a lower risk of developing dementia. While our findings are consistent with a 
previous meta-analysis showing no risk reduction in dementia among bilinguals relative to 
monolinguals (Mukadam et al., 2017), the meta-analysis included only five studies (k = 5) 
and as such, it might have missed a true effect by virtue of being statistically 




dementia. Moreover, unlike the previous systematic review (Mukadam et al., 2017), we meta-
analyzed cross-sectional studies and found that bilinguals were older than monolinguals at 
dementia and AD diagnosis. Results from brain mapping (Chapter 4) suggested that 
bilingualism may help maintain healthy neural circuits and slow the neuropathological 
processes of AD (Canter et al., 2016; Gold, 2015). This, in turn, could translate into a delay 
in AD symptom onset and diagnosis.  
  
Finally, the evidence we gathered within this thesis enabled us to develop a study protocol for 
a prospered RCT testing the effects of increasing PA levels and studying a foreign language 
among older monolinguals with subjective cognitive decline. Drawing from the evidence 
gathered herein, we hypothesize that administering a PA intervention of high intensity and 
frequency for at least six months with an aerobic component coupled with studying a foreign 
language before participants reach the clinical phase of AD might generate clinically relevant 
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